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Abstract 
 
Charles H. Davis: A Molecular Dynamics Study of Interactions between Amyloid-β 
Peptides and Model Lipid Membranes 
(Under the direction of Max L. Berkowitz) 
 
The Amyloid-β (Aβ) peptide is one of the main aggregate species in Alzheimer’s 
disease.  It is believed that the aggregation of Aβ is crucial to neurotoxicity, which is a 
hallmark of the disease.  While it is clear that Aβ plays a significant role in the 
deterioration of neurons during the progression of this disease, both the toxic nature of 
Aβ and the initiation of Aβ aggregation are not well understood.   
It has been observed that cell membranes, in particular anionic lipids, play a key 
role in accelerating Aβ aggregation in vivo.  Interactions with anionic lipids promote 
secondary structure changes and a much higher rate of protein aggregation.  However, it 
is unclear how interactions with cell membranes influence the earliest stages of 
aggregation, which are unavailable to the current resolution of experimental techniques.  
In this thesis, we present extensive molecular dynamics simulations performed to 
investigate the direct interaction between Aβ and anionic lipids in order to explain the 
origin of the substantial influence of cell membranes on Aβ aggregation. 
From these molecular dynamics simulations, we have observed that anionic cell 
membranes likely promote aggregation through transiently increasing the local Aβ 
concentration by favorable protein-lipid interactions on the membrane surface.  Further, 
we have determined that membranes do not directly influence Aβ structure on a 
monomer level, but the secondary structure change observed in experiments is likely due
iii 
to protein-protein interactions which are promoted on the membrane surface.  Finally, we 
have determined that anionic lipids act as a catalyst for Aβ dimerization while uncharged 
lipids likely limit aggregation to only the dimer level.  Through these molecular dynamics 
simulations, we have been able to obtain extensive data on Aβ-membrane interactions at 
a molecular level.  Data such as this will be necessary towards developing a cure to halt 
Alzheimer’s disease progression at its earliest stages. 
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 Chapter 1: 
Introduction:  The Role of the Amyloid-β  Protein and Cell Membranes in 
Alzheimer’s Disease   
Alzheimer’s Disease and the Current State of Medicine 
 
Over the past decades, a deeper understanding of the causes of disease and the 
development of a vast range of pharmaceuticals and targeted therapeutics have greatly 
improved the quality of life in the United States and throughout the developed world.  
These medical advancements have resulted in longer, fuller lives for a vast range of 
people.  In the US, between 1967 and 2007, these improvements in medical care have 
resulted in an extension of almost 8 years to the average life expectancy, from 70.6 to 
77.9 (1).  Our more advanced knowledge of the causes and genetic cues for disease has 
also provided a higher quality for the later years of life.  By improving diet and targeting 
risk factors such as high cholesterol, sedentary lifestyles or environmental toxins, people 
are able to determine potential health issues early and remain healthy, even until old age.  
The impact of these advances can be clearly seen in the data related to death from heart 
disease and cancer.  While heart disease and cancer do remain the first and second causes 
of death, respectively, in the US (1), their prevalence is decreasing.  Between 1999 and 
2007, the percentage of deaths due to heart disease has decreased from 30.3% to 25.4% 
(1) and the total number of deaths due to heart disease per year decreased as well.  For
2 
cancer, over this same time period, the percentage of deaths in the US remained at 
approximately 23% (1), which is impressive considering that the large drop in deaths due 
to heart disease did not lead to more deaths due to cancer.  Thus, over just 8 years, the 
prevalence of heart disease and cancer in US mortality rates is decreasing, in part due to 
our greater knowledge of the etiology and biology of disease. 
 
 However, these numbers mask problems that are arising with regards to health in 
the US.  According to the US Census, in 1990, the elderly (65 years old or older) 
population of the US was 31.2 million, which was 12.6% of the population.  In 2008, the 
US Census Bureau estimated that the elderly make up 12.8% of the population.  While 
that does not seem like a large increase percentage-wise, 12.8% of the US population in 
2008 would correspond to approximately 39 million elderly people, an increase of almost 
8 million in less then 20 years.  It is even more startling to realize that this does not yet 
account for the large majority of the “baby boomer” population, which will lead to a 
massive rise in the elderly population over the next 10 to 15 years.  While, on the surface, 
this appears to be a great triumph of modern medicine, there are significant reasons for 
concern.  Aside from the expansive increase in medical costs that will result due to the 
swelling of the elderly population, this population increase will result in a greater 
prevalence of diseases and disorders that specifically arise in the latest stages of life.  In 
particular, the most common and most notorious of these disorders is Alzheimer’s 
disease, which is characterized by slow deterioration of neural function and motor skills, 
loss of both short and long term memory, and eventual death.  Mortality statistics 
demonstrate the increased pervasiveness of Alzheimer’s disease in the US.  Between 
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1999 and 2007, Alzheimer’s disease moved from the 8th to the 6th most common cause of 
death in the US (1) with the percentage of deaths per year due to Alzheimer’s disease 
increasing from 1.9% to 3.1%.  Again, the percentages are deceiving as they mask that 
the number of deaths to due to Alzheimer’s disease has increased from 44,536 in 1999 to 
74,944 in 2007 (1), an increase of 168%.  It is even more startling to realize that, of the 
five causes of death that are more prevalent then Alzheimer’s disease, only the number of 
accidental deaths has significantly increased over this time (1).  While it appears that 
current medicine is doing a fantastic job preventing the most common causes of death in 
the US and extending both life expectancy and quality of life, the treatment and 
prevention of death due to Alzheimer’s disease appears to be lagging.  With the current 
aging of the population and the upcoming boom in the elderly population due to the 
“baby boomer” generation, the prevalence of Alzheimer’s disease will only increase, 
meaning that a significant public health response to this crisis and direct scientific 
progress towards a better understanding of this disease is necessary. 
 
The Biochemistry of Alzheimer’s Disease 
 
While the public health aspects of Alzheimer’s disease are rather startling and 
foreboding, the current state of scientific progress in understanding Alzheimer’s disease 
and developing an appropriate treatment is not nearly as bleak.  While Alzheimer’s 
disease was first characterized over 100 years ago (2), work over the past 20 to 30 years 
(3, 4) has greatly increased our knowledge of the direct microscopic causes of this 
disease.  Alzheimer’s disease is a member of a class of disorders known as aggregation 
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diseases (5).  In these diseases, many of which are neurodegenerative, proteins that are 
commonly endogenous to cells misfold and begin to aggregate (5-9).  The aggregation of 
these proteins leads to the disruption of important cellular functions, such as signal 
transduction or trafficking within the cell (5, 10).   Other aggregation disorders of some 
notoriety include Parkinson’s disease, Bovine Spongiform Encephalopathy (Mad Cow 
disease) and Creutzfeldt-Jakob disease (8, 10).  For these disorders, the initiation and 
progression of the disease is described by the amyloid hypothesis (4, 5, 10).  In the 
amyloid hypothesis, either a protein with a physiologically stable fold will unfold, 
exposing residues that are primed for aggregation, or an intrinsically disordered protein 
with no stable fold will undergo structural fluctuations that expose specific residues.  
Similar misfolded proteins will interact and aggregate, leading to the formation of small 
oligomers.  These small oligomeric aggregates will further coalesce to form ordered 
fibrils and eventually plaques.  It was originally believed that the build-up of these fibrils 
and plaques would disrupt neuronal processes and metabolism, and lead to neuron 
degeneration and death (4, 5, 10).  However, as more research is being performed on 
Alzheimer’s disease, this paradigm of fibril or plaque toxicity for neurons is being 
revolutionized (4, 5, 10). 
 
The Role of the Amyloid-β  Peptide in Alzheimer’s Disease 
 
 Before describing the roles of oligomers, fibrils and plaques in Alzheimer’s 
disease, it is necessary to introduce further details of this disease.  The major aggregate 
species in Alzheimer’s disease is known as the Amyloid β (Aβ) peptide.  Aβ is produced 
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as the proteolytic cleavage (Figure 1.1) of the Amyloid Precursor Protein (APP) (3, 11, 
12).  APP is a large (695-770 residues), transmembrane protein that is primarily 
expressed in neurons (3, 11-14).  While the exact role of APP in the cell is unknown, it is 
believed to play a role in synapse formation and neural plasticity (13, 14).  During the 
processing of APP by the cell, a series of secretases cleave the APP protein (Figure 1.1).  
First, APP is cleaved near its C-terminus by either an α-secretase or β-secretase enzyme 
(11, 15, 16).  Subsequently, the truncated APP produced by this cleavage event is again 
cut by a γ-secretase, producing two final fragments released from APP (11, 15, 16).  The 
α-secretase cuts further from the C-terminus of APP than β-secretase, producing a 
smaller fragment after γ-secretase processing (Figure 1.1a).  This fragment, known as p3, 
is considered non-toxic and a result of normal APP processing in the neuron.  However, 
cleavage of APP by β-secretase between residues 671 and 672 produces a truncated APP 
referred to as APP-C99 (11, 15, 16).  APP-C99 is then cleaved by γ-secretase to produce 
the Aβ peptide (Figure 1.1b), which is between 38-43 residues long (17).  The most 
common forms of Aβ produced by γ-secretase cleavage are the 40 and 42 amino acid 
fragments, known as Aβ40 or Aβ42 (6, 15, 18-20).    Further, the location of APP 
processing within the cell may play a role in the preference of Aβ40 versus Aβ42 
production (21).  Thus, after γ-secretase cleavage, the Aβ peptide is free to be either 
released in solution or remain bound to the membrane surface.  In current attempts 
towards treatment of Alzheimer’s disease, APP and the secretases which act on APP have 
become a popular target (22).  Recent work has implied that APP, due to a conserved 
GXXG motif, dimerizes (23) before secretase cleavage and that this dimerization of APP 
produces Aβ dimers that act as a seed for future Aβ aggregation, which increases the 
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importance of APP as a target for therapeutic treatment.  Further, due to the relationship 
between the localization of secretases in neurons and the existence of cholesterol-
enriched lipid rafts (24), there is interest in determining if there is a causal link between 
cholesterol levels in membranes, Aβ production, and Alzheimer’s disease (25).  While 
not the focus of this thesis, the role of APP in the earliest stages and progression of 
Alzheimer’s disease is a popular subject in current biological research (22). 
 
 After release from APP, the Aβ peptide is able to initiate the amyloid aggregation 
cascade.  There is no known biological function of Aβ within the cell.  The Aβ peptide 
has a mostly random coil structure in solution (26, 27); however, it is able to adopt 
transient β-sheet or α-helical elements during normal structure fluctuations (26-29).  The 
peptide consists of two general domains, a charged and hydrophilic N-terminus and a 
predominately hydrophobic C-terminus.  The C-terminus of Aβ represents what was a 
transmembrane region of APP before secretase cleavage, while the N-terminus represents 
an external, solvent-accessible region of APP (3, 11, 12).  Further, the production of 
multiple lengths of Aβ during secretase processing is of interest to the pathology of 
Alzheimer’s disease (10, 30-32).  While Aβ40 is the most common form of Aβ produced 
in neurons, Aβ42 is considered to be the more neurotoxic species (10, 30-32).  The extent 
of Alzheimer’s disease progression for early-onset situations tracks remarkably well with 
the amount of Aβ42 produced (33).  Further, Aβ42 is considerably more fibrillogenic 
then Aβ40 (10, 30-32).  It is unknown exactly why Aβ42 appears to be more toxic, but 
the additional isoleucine and alanine residues at the C-terminus of Aβ42 provides an even 
more hydrophobic nature to the peptide, which would promote aggregation in solution 
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and might explain the more fibrillogenic nature of Aβ42.  Nevertheless, the microscopic 
and macroscopic differences between Aβ40 and Aβ42 within the pathology of 
Alzheimer’s disease is a subject of intense on-going research and their differences have 
still not be completely clarified (10, 30).  For the purposes of the work described in this 
thesis, we have used Aβ42 for all simulations. 
 
The lack of stable structure for the Aβ peptides allows for exposed hydrophobic 
residues that promote peptide-peptide interactions in solution, which encourages 
aggregation and initiates the formation of higher order oligomers.  It was initially 
believed that the production of fibrils and, subsequently, plaques was the ideal endpoint 
for the purposes of neural degeneration (4, 5, 10).  Further, it has been observed that 
many different amyloidogenic peptides form a cross-β structure in fibrils, producing 
fibrils that are remarkably similar even with protein or peptide building blocks that share 
very little primary sequence similarity (34).  Due to a shared structure and similar overall 
toxicity to neurons, fibrils and amyloid plaques were initially considered toxic to cells.  
While it has been shown that isolated fibrils can be somewhat toxic to cells in vivo (35, 
36), recent evidence has shifted the dogma of neurotoxicity away from fibrils and 
towards smaller oligomers as the toxic elements in neurons (4, 5, 9, 37).  Thus, in these 
previous studies demonstrating fibril toxicity, it is not clear if the fibrils themselves are 
toxic or if they play a role as a reservoir of Aβ aggregates that can be released after 
disruption of fibrils (35, 36).  As technology has advanced, it has become possible for 
researchers to isolate small oligomers of Aβ.  When these oligomers are added to cells, 
the cells demonstrate classic signs of neurotoxicity and even apoptosis (10, 38-40).  It is 
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believed that these small Aβ oligomers are able to induce cell signaling mechanisms that 
start the initial stages of the cell death mechanisms within neurons and lead to neuronal 
dysfunction (10).  
 
 It is important to note that Aβ is not the only toxic species in Alzheimer’s 
disease.  The tau protein (10, 41) in neurons is also considered to be essential to toxicity 
in Alzheimer’s disease.  Upon activation, the tau protein is regulated by phosphorylation 
(10, 42), which leads to tau aggregation into neurofibrillar tangles and neuron death.  It is 
not clear if tau is directly responsible for neuron toxicity or if tau merely plays a role in 
advancing a toxic signal, but the existence of tau in the cell is important for Aβ toxicity 
(10, 41).  In particular, Aβ-related behavioral changes are dependent on tau while other 
aspects of Aβ induced toxicity, such as neurite dystrophy, are independent of tau (10).  
Recent studies (10, 43, 44) have focused on the relationship between Aβ and tau in 
Alzheimer’s disease, but the direct link is still not clear.  Further, the relationship 
between exogenious Aβ and intracellular tau is yet to be determined (10).  Thus, there 
exists an important relationship between Aβ and tau that plays a key role in neuron 
toxicity, which would not be completely possible through Aβ aggregation alone. 
 
Cell Membranes as a Catalytic Agent for Peptide Aggregation 
 
 With the newly heightened emphasis on the importance of Aβ oligomers in 
Alzheimer’s disease, the earliest stages of Aβ aggregation have become an important 
topic of biophysical investigation.  Certain aspects of Aβ aggregation are well 
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understood, such as fibril growth and branching (45).  However, the earliest stages of Aβ 
oligomerization, such as dimer or trimer formation, are still vague.  In particular, one 
important aspect of this process that is unclear is the role of monomer structure within the 
larger oligomer.  As mentioned earlier, Aβ is predominantely unstructured as a monomer 
in solution (26, 27).  However, when incorporated into an Aβ fibril, the monomeric unit 
has a very regular structure (46-49) with a β-sheet in the C-terminal section of the peptide 
(Figure 1.2).  This structure is repeated with high fidelity throughout a given fibril 
(Figure 1.2).  There is some controversy with regards to internal fibril structure as the 
monomeric or dimeric Aβ unit between two fibrils can differ (46-49).  The large-scale 
structure of the fibril, such as width and number of protofibrils encompassed by the fibril 
(50, 51), can also vary.  However, within a given fibril, the monomeric Aβ units are very 
regular (Figure 1.2).  At some time during the aggregation process, Aβ must undergo a 
structural change from unstructured monomer to structured fibril.  Early results (52-56) 
tend to indicate that small oligomers do not have the exceedingly stable structure of 
fibrils, but these results are not fully conclusive.  Further, there is some belief that Aβ 
peptides can undergo different aggregation pathways (30, 55).  These pathways involve 
varying amounts of structure formation for monomers within oligomers (30, 53), 
resulting in different oligomer structures that may be more neurotoxic (55) than others.  
This wide range of heterogeneous oligomeric structures using fundamentally 
homogeneous monomeric units implies that physical processes within the cell and unique 
conditions within a neuron are an integral aspect of Aβ aggregation.  For most systems, 
high-resolution experimental methods would be able to clarify these questions.  Methods 
such as nuclear magnetic resonance (NMR) spectroscopy or x-ray crystallography would 
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be able to identify precise structures of oligomers.  However, the Aβ peptide begins to 
aggregate at such low concentration (57-59) that small oligomeric units are not stable at 
concentrations necessary to perform these experiments at an adequate resolution.  Thus, a 
better understanding of structure within small oligomeric Aβ aggregates is necessary for 
extending our knowledge of Aβ and its role in neurotoxicity within neurons. 
 
 Another feature of the early stages of Aβ aggregation that is considered a growing 
area of research involves the concentration threshold for Aβ aggregation.  In experiments 
performed in vitro, Aβ begins to aggregate in solution at a concentration of 
approximately 10 µM (4, 60, 61).  For experiments performed in vivo, Aβ aggregation 
occurs at orders of magnitude lower concentration, approximately sub-µM (4, 58, 59).  
While many physical conditions within the cell, such as pH (62), salt concentration (63) 
and oxidation state (64) of specific residues within Aβ do play a role in the apparent 
difference in aggregation within a cell versus in vitro, it appears that the role of cell 
membranes in Aβ aggregation is substantial (4, 5, 30, 65).  Cell membranes are able to 
significantly alter peptide aggregation through a variety of means (Figure 1.3) (4, 5, 65).  
Charged lipids headgroups are able to directly interact with charged residues within the 
peptide, altering peptide structure (5, 65, 66).  By isolating the peptide to a two 
dimensional surface such as a lipid membrane, new minimum free energy structures (5, 
65, 66) might be favored, leading to either unfolding or folding of the peptide (Figure 
1.3a).  Further, localizing multiple peptides to the surface will increase the local 
concentration of the peptide (Figure 1.3b) (5, 65, 66).  By increasing the local 
concentration, the probability of peptides coming into contact and inducing aggregation 
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will be heightened, which will, in turn, increase the aggregation rate.  Finally, a more 
subtle effect involves the change in pH near the surface of anionic lipid bilayers (57, 67, 
68).  Anionic lipid headgroups attract H+ ions from solution, increasing the local H+ 
concentration and decreasing the local pH (Figure 1.3c).  While this appears to be a 
subtle effect, the results can be significant.  A recent experiment (57) using 
palmitoyloleoylphosphatidylglycerol vesicles mixed with Aβ peptides demonstrated that 
Aβ localized to the surface of the vesicles and 3 histidines in Aβ became protonated upon 
binding.  At physiological pH, Aβ has a -3 total charge.  Thus, upon binding to an anionic 
bilayer, the net charge on Aβ drastically changes.  These physical effects due to Aβ 
interactions with cell membranes considerably promote Aβ aggregation and help to 
explain the discrepancy in the concentration threshold for aggregation between in vitro 
and in vivo experiments. 
 
Direct Biological Effects of Aβ  Interactions with Cell Membranes 
 
 The interaction between Aβ and cell membranes also has biological implications 
for Aβ toxicity in Alzheimer’s disease.  As mentioned in a previous section, the Aβ 
peptide is derived from a transmembrane portion of APP.  Thus, the hydrophobic C-
terminus of Aβ is ideal for interaction with and insertion into a cell membrane.  Even 
when Aβ is cleaved, there is still some doubt as to if Aβ is immediately released or if the 
C-terminus is able to anchor the peptide in the bilayer.  Recent computational 
experiments (69) have indicated that the physiological Aβ peptide inserted as a monomer 
into the bilayer is not stable but will exit the bilayer and lay parallel to the bilayer surface.  
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Further, this strong interaction with the bilayer emphasizes one of the potential toxic 
mechanisms of Aβ.  Experimental research has demonstrated that the interaction between 
Aβ and cell membranes leads to oxidation of the acyl chains of both phospholipids and 
cholesterol within the membrane (4, 64, 70).  This oxidation event leads to the generation 
of free radicals that can be toxic to the cell.  Further, oxidation has been shown to be 
dependent on metal concentrations within the cell, with Cu2+ increasing Aβ toxicity while 
Zn2+ appears to attenuate toxicity (10, 71).  Conversely, it has also been shown that lipids 
are able to increase the oxidation of Aβ itself (4, 10, 72).  By interacting with lipid 
oxidation products and metals in the cell, residues on Aβ, such as Tyr10 and Met35, 
become oxidized.  These oxidized residues are then highly likely to form chemical cross-
links with other Aβ peptides.  Thus, oxidation near the cell membrane is able to form 
chemically stable Aβ dimers that act as a seed for further aggregation (10).  Finally, a 
recent work (73) has shown that Aβ interactions with cell membranes stimulates further 
production of Aβ from APP.  All of these factors exemplify the direct toxic nature of Aβ 
through interactions with cell membranes.  
 
Another interesting biological aspect of this system is the potential of pore 
formation by Aβ.  Early work with Aβ has shown that addition of Aβ to cells will create 
an ion current across the cell membrane (74).  Further research into this system has 
shown that this interaction between Aβ and cell membranes disrupts Ca+2 homeostasis 
across the membrane (74, 75).  Some experimental work has hinted that the role of Aβ in 
this system is to thin the membrane (76, 77) to such an extent that ions are able to flow 
through the cell membrane non-specifically.  It appears, though, that this effect is due to 
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the use of trace amounts of hexafluoro-isopropanol (78) and that the conductance across 
the membrane is due to the specific action of Aβ.  Further, some of the most exciting 
work on this system involves a recent study using atomic force microscopy (79).  In these 
experiments using a multitude of different amyloidogenic peptides, including Aβ, the 
atomic force microscopy results clearly show the formation of specific transmembrane 
pores.  Using these results, the Nussinov group has used molecular dynamics simulations 
to model Aβ pore formation (74, 80).  These simulations show that Aβ pores are not 
stable units (74, 80) similar to gated-ion channels or pores formed by antimicrobial 
peptides, but are fluctuating structures that constantly break apart and reform (Figure 
1.4).  These pores are formed out of β-hairpin units that interact through hydrogen 
bonding (Figure 1.4) (74, 80), unlike the stable ion channels that are predominantly α-
helical in nature.  Further, the β-hairpin monomers form small oligomeric units (74, 80) 
within the cell membrane, which appear to be stable.  These oligomeric units then 
transiently interact to form unstable pores that allow ions to flow across the membrane, 
disrupting ion homeostasis and leading to neuron death.  Thus, the direct biological 
consequences of Aβ-membrane interactions can be deadly to neurons in Alzheimer’s 
disease. 
 
Similar to the direct, toxic interactions that occur when Aβ binds to the membrane 
surface, membranes also play a crucial secondary role in Aβ neurotoxicity through 
strongly promoting Aβ aggregation (5, 65, 66).  Regardless of the size of the toxic 
aggregate, membranes act as a templating agent for drastically increasing aggregation of 
Aβ for both in vitro and in vivo systems (5, 58, 81-84).  Either through a concentration 
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effect, wherein the favorable interactions between Aβ and the membrane surface will 
locally increase Aβ concentration, or through direct peptide-lipid interactions, which 
could promote a secondary structure change that primes Aβ monomers for 
oligomerization (Figure 1.3), the membrane plays a key role in catalyzing aggregation (5, 
65, 66) at concentrations much lower than in solution.  In some of the earliest 
experiments (57, 82) investigating the Aβ-membrane system, the addition of lipid 
vesicles to Aβ peptides in solution induces aggregation at sub-µM concentration, similar 
to the concentration threshold for Aβ aggregation in vivo.  Further, through use of 
circular dichroism (6), it was observed that adding these lipid vesicles to Aβ in solution 
induced a secondary structure change from random coil to β-sheet (Figure 1.5) (57, 82).  
These early experiments appear to confirm the theory that a membrane alone can account 
for a substantial extent of the difference between in vitro and in vivo aggregation.  
Experimental work using atomic force microscopy (83, 85) and electron microscopy (83, 
86) has been able to visualize Aβ aggregation into both amorphous aggregates and 
protofibrils or fibrils on the surface of lipid membranes.  These experiments, along with 
other work demonstrating a direct interaction between Aβ and cell membranes (4, 5, 66, 
87), implicate Aβ-lipid interactions as an important causative factor in accelerating Aβ 
aggregation near neurons. 
 
Interaction Between Anionic Lipid Headgroups and Aβ  Peptides 
 
 One interesting property of this Aβ-lipid system that appears to play a crucial role 
in modulating the extent of the Aβ interaction with membranes is the nature of the lipid 
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headgroup.  In some of the earliest experiments with this system, it was observed that 
anionic lipid headgroups effect Aβ aggregation and structure to a much greater extent 
then zwitterionic lipid headgroups (4, 5, 57, 65, 81, 82, 88).  Anionic lipid headgroups are 
able to enhance the aggregation rate of Aβ in in vitro systems and induce significant 
structure change to β-sheet dominated aggregates (5, 57, 81, 82, 88, 89).  Also, 
depending on the peptide-to-lipid ratio, interactions with anionic headgroups are able to 
induce α-helical structure (90) in Aβ that can undergo a conversion with the canonical β-
sheet structure observed in Aβ protofibrils and fibrils.  Similar to previously mentioned 
experiments, CD (57, 81, 82), isothermal calorimetry (57), flouresence (87, 88), neutron 
and x-ray diffraction (59, 91) and electron microscopy (88) have all been used to observe 
this strong interaction with anionic lipid headgroups (Figure 1.5).  Further, 31P NMR (81) 
results have shown a direct interaction between Aβ and anionic lipids by demonstrating 
that Aβ binding causes shifts in the NMR spectra for anionic lipids.  However, for model 
zwitterionic lipids, the interaction with the lipids appears to be more transient (4, 57, 81, 
92, 93) and the secondary structure change observed with anionic lipids is much more 
restricted.  The interactions between zwitterionic lipids and Aβ can be enhanced if the 
zwitterionic lipids are in a liquid-crystalline or gel state (4, 94, 95), but these interactions 
are still somewhat weak in comparison to the anionic lipid-induced aggregation.  These 
results are consistent for lipid mixtures as well, as the influence on Aβ aggregation 
increases as the percentage of anionic lipids within the mixture increases (81, 87).   
 
 The differentiation between anionic and zwitterionic lipids and the extent of their 
roles in Aβ aggregation also has a significant biological implication.  The major 
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zwitterionic lipid headgroup used in experiments is phosphatidylcholine (4, 57, 81, 87, 
93-95).  Further, phosphatidylcholine lipids are the most common lipids found in neurons 
(96), which enhances the importance of studies performed with these lipids.  For anionic 
lipids, both phosphatidylglycerol (57, 59, 81, 82, 87) and phosphatidylserine (91, 97, 98) 
lipids have been commonly used in experiments.  Some of the earliest experiments 
studying the role of lipid headgroup charge on Aβ aggregation used phosphatidylglycerol 
lipids (57, 82).  While these anionic lipids are not found to nearly the same extent as 
zwitterionic lipids in neurons and other cells throughout the body, they play a crucial role 
in cell signaling mechanisms and with recruiting proteins to the cell membrane (99).  Of 
direct importance to the etiology of Alzheimer’s disease is the role of phosphatidylserine 
in cell death mechanisms.  Cells that are either inducing or undergoing apoptosis 
commonly move phosphatidylserine lipids to the extracellular leaflet of the cell 
membrane as a signal to extracellular proteins (100, 101).  It has been shown that the 
neuron death which accompanies Alzheimer’s disease appears to begin with weakened or 
damaged cells (98).  Also, it was determined that extracellular exposure of 
phosphatidylserine (98) was a distinctive characteristic of neurons that were particularly 
sensitive to Aβ.  Thus, it is possible that direct interactions of Aβ with phosphatidylserine 
lipids are a mechanism for targeting either Aβ monomers or aggregates to weakened 
cells.  These differences in the location and preponderance of zwitterionic versus anionic 
lipids in neurons likely play a significant role in the targeting of Aβ to specific neurons 
and in the toxicity of Aβ towards these neurons.  
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 Several caveats exist with respect to the above conclusions concerning the 
importance of Aβ interactions with anionic lipids.  The first caveat is that it is essential to 
understand how the in vitro system is prepared in arriving at these conclusions.  The 
above conclusions assume that Aβ is mixed with a preformed lipid component in 
solution.  However, it is possible to self-assemble the lipids with Aβ (4, 81).  In these 
systems, it is possible for Aβ to intercalate into the lipid mixture and strong interactions 
are observed for both anionic and zwitterionic lipids.   Also, some doubt has been shed on 
the above results with regards to the role of salt in this process (4).  Excess salt is able to 
screen the electrostatic interactions between Aβ and anionic lipids.  In particular, the 
anionic lipid headgroups will strongly attract cations from solution, which will weaken 
the electric field locally produced by these headgroups.  Also, Aβ is a charged protein at 
physiological pH, which implies that salt will also associate with various residues on the 
protein.  Salt will then screen any electrostatic interaction between lipids and proteins at 
large distances.  This will require Aβ to have to diffuse closer to the bilayer surface for 
any interaction to occur, thus decreasing the probability for strong peptide-lipid 
interactions to be initiated.  On a macroscopic scale, this should manifest as a slower Aβ 
aggregation rate in higher salt environments with less secondary structure change, which 
has been observed in experiment (4, 57, 93).  In light of these controversies, there are still 
important questions remaining regarding the role of anionic lipids in promoting Aβ 
aggregation.  Since Aβ does originate from a transmembrane protein, is Aβ already close 
enough to the bilayer surface to abrogate any effects of salt?  Do other proteins play a 
role in bringing Aβ to the bilayer surface? Is it possible that Aβ binds to transmembrane 
proteins that help recruit Aβ to anionic lipids?  These questions are still an active area of 
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research in Aβ toxicity and it does appear that interactions between Aβ and anionic lipids 
are vital to the favorable aggregation of Aβ on neurons. 
 
Other Specific Lipid-Peptide Interactions Key to Aβ  Aggregation 
 
 Along with the role anionic lipid headgroups play in Aβ aggregation, other lipids 
have shown a specificity towards promoting Aβ aggregation in neurons (4, 102).  One of 
the most biologically relevant of these aggregation-promoting species is cholesterol.  
Cholesterol is a major constituent of cell membranes and acts to rigidify nearby lipids 
(102-105).  Further, the ternary interaction between cholesterol, unsaturated 
phospholipids and saturated phospholipids leads to the formation of lipid rafts (102-105).  
These lipid rafts are highly structured domains in the cell membrane and are commonly 
surrounded by an excess of unstructured lipids.  While controversy does exist with 
regards to the size and role of lipid rafts in biological systems, it appears that lipid rafts 
play a crucial role in cell signaling and in localizing transmembrane proteins to specific 
regions of the cell membrane (102-105).  Due to the difference in thickness that exists 
between the ordered lipid raft and the disordered surrounding lipids, it has been shown 
that the edge of lipid rafts is a location of significant enzymatic activity on the cell 
surface (102, 106, 107).  Of direct importance to Alzheimer’s disease, APP appears to 
preferentially accumulate in lipid rafts (106, 107) and the secretases, which cleave APP 
and produce Aβ, are believed to be active at the interface between the raft and non-raft 
regions of the cell membrane.  Finally, one of the largest known risk factors for 
Alzheimer’s disease is high cholesterol (102).  A genetic predisposition (102) towards 
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Alzheimer’s disease has been found in populations with a specific alloform of ApoE, 
known as ApoE4.  ApoE is a cellular lipoprotein involved in cholesterol transport (108); 
yet, the role of ApoE, and the ApoE4 variant, in Alzheimer’s disease is unknown.  
However, this anecdotal genetic and biological evidence does hint at an important role of 
cholesterol in the progression of Alzheimer’s disease. 
 
In addition to the importance of lipid rafts to APP processing, it has been 
observed, similar to anionic lipids, that lipid rafts directly influence Aβ aggregation (4, 
83, 102, 109-113).  In vitro, mixing of lipid rafts with Aβ leads to direct binding of Aβ to 
the raft and increased Aβ aggregation (83, 109-113).  Further, using neurons isolated 
from rat brain (114) and from human neuroblastoma cells (115), Aβ aggregates were 
identified at significant concentrations bound to the lipid rafts when the rafts were 
isolated from neurons.  Thus, direct Aβ-raft interactions are believed to play a substantial 
role in Aβ aggregation.  In considering previous results with phosphatidylcholine lipids, 
this is not as surprising.  In studies with phosphatidylcholine, it was found that rigidifying 
the bilayer (4, 94, 95) improved the extent of lipid-protein interactions.  As lipid rafts 
commonly contain sphingomyelin lipids with zwitterionic character (102), the rigid rafts 
would have a similar structure to liquid crystalline phosphatidylcholine lipids.  However, 
the rigidification of the cell membrane within a lipid raft is not likely to be the only role 
of lipid rafts in enhancing Aβ aggregation. 
 
Lipid rafts also play a role in sequestering specific lipids within the ordered 
domain of the raft.  In particular, lipid rafts appear to preferentially sequester 
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gangliosides (4, 105).  Gangliosides are glycosphingolipids that contain large sugar 
residues as a headgroup (4).  These large sugar groups are able to extend from the cell 
membrane and interact with proteins at the periphery of the cell.  Neurons are highly 
enriched in gangliosides, especially the ganglioside GM1 (4).  It has been observed that 
Aβ peptides strongly interact with GM1 (4, 116-119).  In particular, the hydrophobic 
region of Aβ undergoes substantial interactions with these lipids (4, 119).  Experiments 
performed with Aβ40 and the truncated Aβ1-28 show that residues 29-40 of Aβ are 
necessary (119) for interactions with gangliosides.  Further, Aβ binding to the membrane 
surface increases almost directly with the amount of gangliosides in the membrane (120).  
These results imply a direct interaction between the ganglioside and Aβ, which promote 
aggregation.  It is still not clear exactly what role gangliosides play in Aβ aggregation.  
While Aβ bound directly to a ganglioside cluster can act as a seed for aggregation (4), it 
is not clear if the direct interaction between sugar residues and Aβ induces a structural 
change.  Another possibility is that the large headgroups of GM1 help to bring Aβ from 
solution near the bilayer surface.  Once near the bilayer surface, Aβ will be able to 
interact with the lipid raft and undergo conformational changes or aggregate due to the 
local concentration increase of peptide.  In either scenario, gangliosides are significant for 
any pathological effects of lipid rafts on Aβ aggregation near neurons. 
 
Experimental Restrictions to Exploring Aβ-Lipid Interactions 
 
While experiments have been able to classify the extent of interactions that can 
occur between Aβ and a range of different membrane constituents, the nature of the Aβ 
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peptide creates a significant problem in understanding these systems at a molecular level.  
While many of the experiments mentioned in previous sections are able to clearly show 
an interaction between Aβ and cell membranes, the aggregation state of the peptide is 
either unknown or at an advanced state, such as a protofibril or fibril.  For experiments, 
such as CD, which only provide generic values such as global secondary structure (57, 
81, 82), it is unknown what aggregation state the peptide has obtained.  This is a crucial 
point that must be significantly explored as it is difficult to make definitive conclusions 
regarding Aβ-membrane interactions without knowledge of the aggregation state when 
the measurement is made.  This is especially true for interactions between Aβ and anionic 
lipids.  The aggregation rate is enhanced (5, 57, 81, 82, 88, 89) to such an extent that 
aggregation begins at very low concentration of protein.  In order to force the system to 
aggregate at a slow enough rate to observe discrete steps in aggregation, such as Aβ 
dimerization, the protein concentration would need to be at levels below concentrations 
that are able to be reputably observed by experimental techniques.  While some new 
methods show promise at alleviating this issue in solution, such as mass spectrometry 
(53), these methods have not yet been adapted for use in studying Aβ-membrane 
interactions. 
 
Due to these difficulties in resolving protein-lipid interactions from the protein-
protein interactions inherent to the aggregation of Aβ, the earliest stages of Aβ 
aggregation on cell membranes is still not fully explored.  As Aβ derives from a 
transmembrane protein (3, 11, 12), studies of monomer or dimer interactions with cell 
membranes are crucial to understanding the catalytic role of membranes in this process.  
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In particular, further investigations into the influence of anionic lipids on small Aβ 
aggregates, or even Aβ monomers, is necessary.  As there are multiple means (4, 5, 65) 
for a membrane to influence aggregation, understanding the role of each of these 
processes on aggregation will be important for developing treatments to halt this 
progression.  It is still unclear if direct interactions between the Aβ peptide and anionic 
lipids are able to lead to a secondary structure change (Figure 1.3a).  It is possible that the 
secondary structure change observed in CD (57, 81, 82) is due to the membrane forcing 
an Aβ monomer to adopt a β-sheet conformation.  However, it is also possible that the β-
structure formed on the membrane is not due to direct protein-lipid interactions but is due 
to protein-protein interactions that are facilitated by the membrane during aggregation 
(Figure 1.3b).  In such a case, the role of the membrane would be to attract Aβ monomers 
to the surface, thus binding peptides to a limited area and transiently increasing 
concentration (5, 65).  Even if interactions between anionic lipids and Aβ promote a 
secondary structure change, this concentration effect would still exist and would help to 
explain the increase in aggregation rate on anionic lipids.  Finally, the anionic lipids 
induce a local pH change (57, 67, 68) that would shift bound Aβ from a net negative 
charge to a neutral charge (Figure 1.3c).  It has been observed that, in solution, the 
aggregation rate of Aβ peaks at a pH of approximately 5 (62), which is similar to the 
proposed pH on the surface of anionic bilayers (67, 68).  This pH change could 
significantly effect the protein-protein interactions enhanced by membrane binding and 
possibly alter the structure of Aβ dimers and other small oligomers.  The influence of this 
pH change implies the importance of further studying the difference between Aβ 
aggregation near an anionic versus a zwitterionic bilayer and understanding exactly why 
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anionic lipids promote aggregation while zwitterionic lipids have little influence on this 
process.  All of these templating effects of membranes on Aβ monomers or small 
aggregates are crucial to the enhancement of aggregation at the membrane surface; 
however, current experimental techniques are not able to extract the contribution of each 
of these effects to the total enhancement.  To an even greater extent, the description of 
these factors does not even touch on the role of Aβ insertion into the membrane and the 
role of Aβ pore formation (74) in neurotoxicity of this system.  A better understanding of 
these factors is necessary in order to develop therapeutic approaches to prevent the 
earliest stages of aggregation before toxic oligomers can be formed. 
 
One approach that has shown promise for investigating Aβ-membrane 
interactions is computer simulations, in particular molecular dynamics (MD) simulations 
(27-29, 69, 74, 121-139).  In these MD simulations, model systems are used to 
extrapolate the roles of specific factors in promoting Aβ aggregation.  Such simulations 
have been used to great success for studying Aβ dynamics and aggregation in solution 
(27-29, 121-135).  These simulations have employed Aβ fragments (123, 124, 126-128, 
130, 132, 135), full length Aβ monomers (27-29, 121, 135), small Aβ oligomers (122, 
125-127, 131-133, 135) and Aβ fibrils (129, 134, 135).  These simulations have been 
performed using explicit (27, 29, 123, 124, 127-131, 133) water molecules in solution 
and using implicit solvent (28, 121, 122, 125, 126, 132, 134, 135) techniques, which 
employ dielectric mediums in the place of explicit water molecules as a method for 
extending the time scale available to the simulation.  These simulations have used either 
all-atom (27-29, 121-124, 127-130, 133-135) representations of Aβ, in which all heavy 
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atoms are explicitly defined, or coarse-grain (126, 131, 132) techniques, in which atoms 
are grouped together and represented by a reduced model, which also increases the length 
of potential simulations.  Finally, some simulations with Aβ use advanced MD 
techniques (28, 121-125, 132, 135), such as replica exchange, to extend the available 
simulation times and to help the simulated proteins overcome free energy barriers that 
would be impossible to traverse in normal simulations.  Some of these simulations have 
effectively supported (27-29, 121, 123, 124, 126, 132, 135) a random-coil structure of Aβ 
but have also shown that significant structural fluctuations within the Aβ monomer are 
important for oligomerization.  Other simulations have investigated the stability (122, 
125, 126, 131-133) of Aβ oligomers in order to help predict potential oligomer structures 
in experiment.  MD simulations have been used to describe the process by which Aβ 
monomers are added to the growing end of Aβ fibrils, known as the “dock-lock 
mechanism” for fibril growth (134).  However, as can be expected, all of these 
simulations have significant limitations.  As common to all MD simulations, the largest 
limitation is that it is difficult for the system to be ergodic in the time limits of modern 
simulations (140).  Because of the inherent limits to the speeds of modern 
supercomputers, even the most advanced simulations are limited to a microsecond 
timescale.  Techniques such as coarse-graining or replica exchange are able to extend 
these simulations to higher timescales, but they still do not fully reach the timescales of 
biological processes in the millisecond to second timescales.  Thus, most simulations are 
not able to explore the full configurational space of a peptide in a reasonable time (140).  
Also, there always exists the question of the quality of the approximations being made to 
the system.  The largest issue here is with the choice of the force fields used to describe 
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all interactions in the system.  Also, another important limitation is the much smaller size 
of the system used in simulations, which may not be a fair representation for biological 
length scales.  While these limitations are critical to the interpretation of results obtained 
from MD simulations, the directed use of MD simulations to answer questions 
appropriate to the available timescales of simulations is still a reasonable approach to 
studying biological systems. 
 
While MD simulations have been used to great success for investigating Aβ 
aggregation in solution, the extension of these same techniques to studying Aβ-lipid 
interactions on the membrane surface has been limited.  To date, only a few simulation 
studies (69, 74, 80, 136-139, 141) have been performed on an Aβ-model membrane 
system.  Of these studies, the majority (69, 136, 137, 141) have involved investigating the 
stability of a preinserted Aβ monomer into a membrane.  As Aβ is predicted to have an 
α-helical structure when inserted in a membrane (69, 136, 137, 141), these works have 
investigated if the Aβ monomer is stable while inserted in the bilayer and what residues 
on the peptide play a role in this process.  These studies have also investigated 
specialized aspects of this system; such as the angle the peptide takes with respect to the 
bilayer normal when inserted (69, 136, 137, 141).  These studies have shown that the 
protein is marginally stable as a monomer (69, 136, 137, 141), but is able to move out of 
the transmembrane region of the bilayer and favorably interact (69) with the interfacial 
region of the membrane, which induces some disordering of the peptide structure.  
Further, large-scale coarse-grain simulations (142) have been performed with a large 
system of generic amyloidogenic peptides that could be primed for aggregation in 
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different environments.  This work investigated (142) how membranes or vesicles would 
effect peptide aggregation, but the use of generic peptides and coarse-grain atoms meant 
that atomic level specificity was lost in the system and the connection to Aβ aggregation 
is not clear.  However, no published MD simulations had yet been done to study the 
binding process of Aβ to a model membrane surface and the interactions between Aβ and 
a model membrane on the surface of the membrane.   In the following chapters, MD 
simulations are described that explore this Aβ-membrane interaction at atomic resolution 
for both Aβ monomers and Aβ dimers.  These simulations provide a detailed portrayal of 
the different facets of Aβ-membrane interactions and how these interactions combine to 
promote Aβ aggregation on the membrane surface.  By studying specific systems with 
advanced MD techniques, using carefully chosen controls, and asking limited but 
poignant questions, these simulations are able to overcome many of the limitations of 
classic MD simulations and provide results that further our knowledge of the earliest 
stages of Aβ aggregation that are not yet available to current experimental techniques.  
The questions and hypotheses raised by these simulations, in combination with previous 
and future experimental studies, will hopefully provide an appropriate starting point 
towards achieving a substantial understanding of the earliest stages of Alzheimer’s 
disease.  The advancements of the past 20 years in understanding the biochemical cues of 
Alzheimer’s disease, and the current work being performed with advanced experimental 
and computational methods, provides hope that a cure for Alzheimer’s disease is 
forthcoming and one aspect of the predicted large-scale public health crisis due to the 
aging of the US population can be averted. 
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Advanced Molecular Dynamics Techniques  
 
 While the use of MD simulations has become widespread in the biophysics 
research community, new techniques are being adopted to improve upon the limitations 
of the current supercomputers used for these large-scale simulations.  MD simulations 
involve the iterative calculation of all forces in a system and use of Newton’s laws to 
advance the system a given step in time depending on this distribution of forces (143-
145).  Many of the details involved in MD simulations are with respect to the calculation 
of these forces.  Specific force fields are used to describe either bonded interactions, such 
as allowed bond lengths, bond angles and dihedral angels, or non-bonded van der Waals 
interactions between atoms (143-145).  Various methods are used to calculate 
electrostatic interactions between particles; however, in the MD simulations described in 
this thesis, the smooth particle mesh Ewald method (146) is employed for all 
electrostatics calculations.  Various other aspects, such as specific constraints and 
periodic boundaries, are used in these simulations to improve upon the speed in which the 
forces can be calculated or improve upon the apparent size of the system (143-145).  
However, due to the inherent limitations of current computer technology, these 
simulations still require a significant amount of time to even approach microsecond 
timescales.  Thus, in the simulations performed for this thesis work, two specific 
methods, umbrella sampling (147, 148) and replica exchange (149) molecular dynamics, 
were used to improve upon these limitations of MD simulations. 
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Umbrella Sampling Molecular Dynamics 
 While the introduction sections of each of the remaining chapters of this thesis do 
introduce details of the MD techniques used, it is important to give a brief introduction to 
two specific techniques used in these simulations.  The first of these two techniques is 
umbrella sampling (147, 148).  Umbrella sampling is a common method used to calculate 
the free energy change in a specific process, dependent upon the reaction coordinate 
used.  For a given system, a free energy barrier might exist that prevents a particle from 
undergoing some sort of transformation (Figure 1.6a).  An example would be a barrier 
that prevents an unfolded protein from folding or preventing a peptide from binding to a 
lipid bilayer.  In umbrella sampling, a harmonic potential is placed at specific steps along 
the reaction coordinate and these harmonic potentials allow the particle to explore the 
conformational space along the barrier (Figure 1.6b).  In a normal MD simulation, the 
particle would have a very low probability of exploring these barriers because of the high 
free energy cost required to move up the barrier, so the limitations of computational 
techniques would prevent the particle from exploring the full conformational space 
(Figure 1.6a).  However, the application of these harmonic potentials, or umbrellas, on 
top of the normal potential of the system forces the particle to move along the reaction 
coordinate and explore the conformational space of the barrier (Figure 1.6b).  Using a 
series of these umbrellas between the initial and final state of the transformation, a full 
description of the transformation process can be obtained.  Finally, the weighted 
histogram analysis method (150) can be employed to computationally reweight the effect 
of these umbrella potentials on the system and the probability of exploring a given state 
as a function of the reaction coordinate can be calculated.  Using simple thermodynamics, 
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this probability can be converted to a free energy.  Thus, using this umbrella sampling 
process (147, 148), the free energy along a given path is fully determined.  When 
extended to umbrella sampling along two dimensions, a free energy surface can be 
calculated, which is even more instructive with regards to the dynamics of the system. 
 
 The umbrella sampling process does have its limitations as well.  As free energy 
is calculated along a specific reaction coordinate, choice of that coordinate is crucial to 
understanding the system and is a necessary aspect for analyzing the results of the work.   
While some reaction coordinates, such as peptide binding to a lipid surface, can be fairly 
obvious, other reaction coordinates, such as in protein folding, can be very difficult to 
determine.  Next, it is important the umbrellas along the reaction coordinate overlap.  If 
there is not enough overlap between umbrellas, the particle will not be able to fully 
explore the entire barrier region and the calculated probability will not be complete.  
Finally, even within each umbrella, it is important that enough sampling is performed to 
fully explore that limited area.  While conventional MD is commonly used within an 
umbrella, advanced techniques such as replica exchange are being combined with 
umbrella sampling (151) to improve sampling even further.  Even considering these 
limitations, the increasingly parallel nature of current supercomputers makes umbrella 
sampling an ideal method for calculating the free energy change for a variety of 
biological processes. 
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Replica Exchange Molecular Dynamics 
 While umbrella sampling MD was used to calculate Aβ binding free energies and 
other free energy values for this thesis, replica exchange molecular dynamics (149, 152) 
was used to calculate Aβ structure.  On the bilayer surface, specific peptide-lipid 
interactions can slow down the dynamics of peptide motion.  Thus, over the timescales of 
reasonable MD simulations, the peptide would not have enough time to fully explore its 
conformational space on the bilayer surface.  In order to calculate secondary structure on 
the bilayer surface and overcome this suppressed structural motion, replica exchange 
molecular dynamics was used. 
 
 Replica exchange molecular dynamics (149, 152) uses temperature or external 
potentials to overcome free energy barriers in a given process.  The most common 
version of replica exchange used today employs temperature changes to overcome 
folding barriers (152).  In replica exchange, a series of MD simulations are run in parallel 
at different temperatures.  While the low temperature simulations are restricted by local 
free energy barriers, the energy imparted by the high temperatures in the highest 
temperature simulations allow the protein to fully explore the conformational space.  
Then, at a specific time step, the protein structures at adjacent temperatures are compared 
based on energy of the conformations and exchanged dependent upon a set of 
thermodynamic criteria usually dictated by the Metropolis conditions (149, 152).  In 
short, as the peptide explores the conformational space at high temperature and finds 
new, minimum energy structures, the minimum energy structures will be cycled down to 
the lowest temperature in a thermodynamically consistent process.  Thus, by analyzing 
31 
the system at the intended low temperature, a more expansive thermodynamic average for 
a given quantity can be calculated, as the system will explore multiple free energy basins 
instead of just one in a conventional MD simulation.  While a trajectory followed at a 
specific temperature will not be fully linear as a function of time, a thermodynamic 
average, such as average secondary structure, will be much more accurate than one 
calculated for a conventional MD simulation. 
 
 Much like umbrella sampling MD, replica exchange MD has limitations due to 
the nature of its implementation (153).  It is necessary that the temperatures are 
appropriately spaced so that exchanges between systems at adjacent temperatures will 
occur often to allow for expansive sampling (153).  Also, within each replica, 
conventional MD needs to be run for enough time to allow the system to fully explore the 
conformational space available at that temperature (153).  Finally, while these systems 
have been adapted for extensive use in solution, the application to membrane systems is 
limited.  As membranes dissolve at high temperatures, it is difficult to have both a fully 
atomic description of a membrane and a substantial range of temperatures.  Previous 
simulations with explicit membranes (151) have required very stringent constraints that 
prevent lipid motion within the membrane.  In chapter 3, we discuss an implementation 
of replica exchange with an all-atom membrane that is able to circumvent these 
limitations.  With the use of both umbrella sampling MD and replica exchange MD, the 
simulations described in this thesis involving Aβ-membrane model systems are able to 
overcome some of the significant limitations inherent to previously performed MD 
simulations. 
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Figure 1.1  Schematic depiction of Amyloid Precursor Protein processing by secretases 
in the cell membrane.  The normal processing (a) of APP results in production of the non-
toxic p3 fragment.  Alternative processing (b) of APP results in production of the 38-43 
residue Aβ peptide. 
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Figure 1.2  Representation of one proposed structure for a filament within an Aβ fibril 
determined using NMR depicted as a (a) side and (b) top view.  These structures are 
derived from PDB code 2BEG (49).  
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Figure 1.3  Physical methods in which membranes can effect protein aggregation. (a) 
The membrane can favor formation of a folded structure from an unfolded monomer that 
promotes aggregation. (b) Membrane binding locally increases protein concentration by 
limiting motion to a restricted area. (c) Protein binding to anionic lipids (represented by 
the red spheres/headgroups) leads to protonation of certain residues due to the local 
decrease in pH. 
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Figure 1.4  Predicted structure for a transmembrane pore of 24 Aβ(17-42) peptides taken 
from simulation.  The Aβ(17-42) peptides have an imposed β-hairpin structure.  
Reprinted from Trends in Biochemical Sciences, Vol. 33, Issue 2, H. Jang, J. Zheng, R. 
Lal, and R. Nussinov, New structures help the modeling of toxic amyloidβ ion channels, 
pages 91-100, Copyright (2007) with permission from Elsevier. 
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Figure 1.5  Circular dichroism spectra of Aβ(1-40) mixed with POPC/POPG vesicles 
(75/25 mol/mol lipid mixture).  Curve 1 represents a lipid:peptide ratio of 0 (pure Aβ).  
Curve 2 represents a lipid:peptide ratio of 22 and curve 3 represents a lipid:peptide ratio 
of 55.  When mixed with the POPC/POPG vesicles, Aβ converts from a random coil to 
predominantly β structure.  Reprinted from Journal of Molecular Biology, Vol. 252, Issue 
6, E. Terzi, G. Hölzemann, and J. Seelig, Self-Association of β-Amyloid Peptide (1-42) 
in Solution and Binding to Lipid Membranes, pages 633-642, Copyright (1995) with 
permission from Elsevier.
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Figure 1.6  A schematic of the umbrella sampling molecular dynamics technique.  In 
regular molecular dynamics (a), the particle is not able to transverse the barrier and is 
restricted by the energy provided in kT.  Using umbrella sampling (b), the potentials 
placed along the reaction coordinate allow the particle to explore the reaction coordinate 
along the entire barrier. 
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Abstract   
 The Amyloid-β (Aβ) peptide is a key aggregate species in Alzheimer’s disease. 
While important aspects of Aβ peptide aggregation are understood, the initial stage of 
aggregation from monomer to oligomer is still not clear.  One potential mediator of this 
early aggregation process is interactions of Aβ with anionic cell membranes.  We use 
unconstrained and umbrella sampling molecular dynamics simulations to investigate 
interactions between the 42-amino acid Aβ peptide and model bilayers of zwitterionic 
dipalmitoylphophatidylcholine (DPPC) lipids and anionic dioleoylphosphatidylserine 
(DOPS) lipids.  Using these methods, we determine that Aβ is attracted to the surface of 
DPPC and DOPS bilayers over the small length scales used in these simulations.  We also 
find supporting evidence that the charge on both the bilayer surface and the peptide 
affects the free energy of binding of the peptide to the bilayer surface and the distribution 
of the peptide on the bilayer surface. Our work demonstrates that interactions between the 
Aβ peptide and lipid bilayer promotes a peptide distribution on the bilayer surface that is 
prone to peptide-peptide interactions, which can influence the propensity of Aβ to 
aggregate into higher order structures.  
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Introduction  
Neurodegenerative disorders, including Alzheimer’s disease, share a similar 
mechanism of toxicity (45, 154), namely aggregation of unfolded peptides into 
amorphous oligomers that coalesce to form an ordered fibril.  It is of great importance to 
understand both the exact steps behind fibril formation from the monomer state and the 
means of toxicity in these diseases.  By further defining integral steps in the aggregation 
pathway for neurodegenerative disorders, in particular Alzheimer’s disease in this work, 
greater insight into the toxic mechanisms and potential therapeutic approaches for a host 
of fatal diseases will be gained. 
 
One of the major aggregate species in Alzheimer’s disease is the Amyloid-β 
peptide (Aβ) (3, 11, 12, 40).  Aβ is a 38-42 amino acid cleavage product of the amyloid 
precursor protein, a large transmembrane protein of unknown function in the cell (3, 11, 
12).  Aβ contains two domains:  a charged domain at the N-terminus and a hydrophobic 
domain situated at the C-terminus.  NMR results (26, 27) show that Aβ has a random coil 
structure in solution at pH7.  Upon onset of Alzheimer’s disease, Aβ forms soluble 
oligomers that aggregate to form ordered fibrils with β-sheet morphology in the 
hydrophobic domain, as determined through solid-state NMR and electron microscopy 
(46, 49).  In this aggregation process, the steps involved in the initiation of aggregation 
from monomers to small oligomer structures are not well determined.  There are many 
aspects of cellular function that may play a significant role in the early stages of Aβ 
aggregation, such as cellular pH (62), salt concentration (63), covalent attachments of Aβ 
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due to oxidation and interactions of Aβ with metal ions (64).  However, one hypothesis 
(4, 5, 66) that shows promise for explaining both the early steps of aggregation and the 
effect of certain risk factors in Alzheimer’s disease is the interaction between Aβ and 
cellular membranes.  This hypothesis postulates that interactions between Aβ and lipids 
promote conversion of disordered Aβ into a partially folded intermediate that will 
aggregate under favorable conditions.  The membrane can affect soluble proteins through 
a variety of ways:  electrostatic interactions between amino acids and charged headgroup 
(4, 5, 66-68), new partially folded or unfolded free energy minima at the surface (4, 5, 66-
68), increased aggregation due to faster diffusion over a 2-dimensional surface (4, 5, 66-
68) and a lower surface pH due to anionic lipid headgroups (57, 67, 68).  In this work, we 
will investigate these lipid-peptide interactions using molecular dynamics simulations 
and identify properties of lipid bilayers that may promote peptide-peptide interactions 
characteristic of aggregation.  
 
Experimental investigations have been able to replicate the aggregation of Aβ 
peptides in vitro quite accurately.  Most experimental conditions between in vivo and in 
vitro aggregation are in agreement; however, one significant difference is that in vitro 
aggregation requires a much higher peptide concentration (approximately µM) to induce 
aggregation than in vivo aggregation (approximately sub-µM peptide concentration) (58, 
59, 82).   One potential hypothesis (4, 5, 66) to explain this discrepancy proposes that 
interactions with the cell membrane are promoting altered function and aggregation in 
vivo.  This hypothesis is well founded in biology through signal peptide binding to 
bilayers during signaling cascades (155, 156) and in peptide-lipid binding in toxin-related 
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cell death (155, 156).  Early experiments using circular dichroism (6) spectroscopy to 
follow structural changes for Aβ incubated with lipid vesicles demonstrated that 
zwitterionic lipids headgroups (57, 58, 82), such as phosphatidycholine, did not 
significantly affect peptide structure.  However, when Aβ was incubated with anionic 
lipid headgroups (57, 58, 82), such as phosphotidylserine, a clear conversion from a 
random coil to β-structure was observed.  Further, imaging experiments demonstrated 
that Aβ was aggregating into fibrils at concentrations near in vivo aggregation conditions 
in the presence of vesicles (83, 157).  31P-NMR (81) and x-ray reflectivity (59) results 
have shown that Aβ peptides are interacting with anionic lipids and leading to significant 
alteration of properties of the bilayer itself.  These results provide a clear demonstration 
that lipids can fundamentally impact the aggregation pathway for Aβ; yet, they are not 
able to determine the exact interactions that are occurring on the bilayer surface that force 
this conformational change.  Some controversies (4) also exist regarding the extent of 
interactions between Aβ and anionic lipids.  In some experimental work, a claim is made 
that Aβ-anionic lipid interactions are weak or non-existent under certain conditions (4).  
Therefore, detailed understanding of interactions between Aβ and lipids at the bilayer 
surface will be integral to comprehending the basis for these controversies that exist in 
experiments. 
 
While most experimental approaches do not have the necessary resolution to 
determine direct protein-lipid interactions on a single molecule level, molecular dynamics 
(MD) simulations provide an ideal approach to this system.  MD with explicit (158-161) 
and implicit (159, 162-164) solvent and free energy (160, 162, 164) calculations have 
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been used previously for studying peptide-lipid interactions with good agreement to 
experimental results.  Further, MD has been used extensively with Aβ (29, 69, 129-131, 
136, 165-170).  Single peptide MD simulations confirm a random coil structure for Aβ in 
solution; however, transient β-hairpin structure is seen in longer time (69, 130, 131, 165, 
167), replica exchange (29, 170) and low pH (167) simulations.  Previous MD 
simulations of Aβ with lipid bilayers (69, 136) have investigated the stability of a 
preinserted Aβ in a zwitterionic bilayer and have not investigated the effect of headgroup 
charge and other bilayer properties on Aβ structure or stability near the bilayer surface.  
This previous computational work with Aβ further supports the use of MD for 
investigating unanswered details of Aβ peptide-lipid interactions. 
 
To examine peptide-lipid interactions in this system, we present here calculations 
of free energies of peptide binding to the bilayer surface for various lipid headgroup 
charges and peptide charges. The chosen lipids for these studies will have zwitterionic 
phosphatidylcholine (PC) and anionic phosphatidylserine (34) headgroups.  Lipids with 
PC headgroups are the most abundant lipids in neural membranes (96).  Lipids with 
anionic PS headgroups play an integral role in localization to cell membranes and 
programmed cellular death mechanisms (99).  Anionic lipids decrease local surface pH 
(57, 67, 68), so varying both lipid charge and peptide charge is essential to understanding 
the influence of electrostatics on the system.  By investigating both electrostatic and 
hydrophobic aspects of the Aβ-bilayer interaction, a more detailed picture of the 
influence of membranes on Aβ aggregation will be obtained.  The results from this work 
will help to determine the validity of the cell membrane as a catalytic element in Aβ 
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aggregation and, with knowledge of the toxic mechanism of this class of similar 
neurodegenerative diseases, will assist in future treatment and prevention of these 
diseases.  
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Materials and Methods 
Simulations in Solution   
 Two structures were chosen for simulations of the 42 amino acid Aβ peptide both 
in solution and near the bilayer surface.  By using two structures, some bias inherent with 
having an ordered starting structure will be eliminated.  The first structure is PDB code 
1Z0Q and represents a random coil with some helix content as determined by NMR (27).  
The structure used in calculations was the first NMR structure (27) given in the file 
deposited in the PDB.  The second structure is PDB code 2BEG, which is one peptide 
taken from the structure of an Aβ fibril as determined by solid state NMR (49).  Residues 
1-16 in the N-terminal tail were unstructured and were not included in the PDB file.  
Therefore, these residues were added using the SYBYL software program (Tripos Inc., 
St. Louis, MO).  This β-hairpin structure is controversial, as it is not universally accepted 
as the accurate monomer structure in fibrils (46). Recent results (46) have shown that the 
β-sheet structure detected in fibrils may be shared between two monomers.  However, for 
this work, the β-hairpin structure is used as it represents potential β-structure that can be 
formed from a monomer of Aβ.  All structures from the PDB were edited using 
GROMACS software to convert the structures to a united atom format described by the 
GROMACS force field (143, 144).  Along with using 2 initial structures for simulations, 
three charge states of Aβ were used.  At pH7, Aβ has a -3 charge due to 6 aspartic and 
glutamic acid residues and 3 lysine and arginine residues, assuming uncharged termini.  
At pH~5, three histidine residues become protonated (57) to give Aβ a neutral charge.  
Then, at low pHs, the aspartic and glutamic acid residues are protonated to give Aβ a +6 
charge.  The termini were uncharged in these simulations so that the effect of peptide 
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charge on the peptide-lipid interactions was isolated to the amino acid sidechains only.  
GROMACS utilities (143, 144) were used to change the protonation state of relevant 
histidines, aspartic acid and glutamic acid residues to give the appropriate charge for the 
peptide state.  The combination of 2 initial structures and 3 pH states for each structure 
produced a set of 6 simulations performed in solution. 
 
 Each structure was solvated in a 6.4nm x 6.4nm x 8.1nm box, with Na+ or Cl- 
counterions added to the system to balance peptide charge and NaCl salt added to 
produce a near physiological concentration of 0.1M NaCl (Table 2.1a).  The system was 
equilibrated with a 3ns molecular dynamics (MD) simulation, then 80ns MD simulations 
were performed for analysis.  Temperature was held constant at 323K using a Nose-
Hoover (171) scheme with a relaxation time of 0.5 ps under constant volume (NVT) 
conditions.  All bonds in the system were constrained with the LINCS algorithm (172), 
which allowed a time step of 3.5 fs.  Long range electrostatics were handled using the 
SPME algorithm (146) and periodic boundary conditions were used in all three 
dimensions.  The SPC/E model (173) of water was used for all simulations.  Secondary 
structure was calculated using the DSSP package (174) in GROMACS. 
 
Unconstrained Simulations on DPPC and DOPS 
 The 6 conditions used for Aβ simulations in solution were again used for 
simulations near a dipalmitoylphosphatidylcholine (DPPC) and dioleylphosphatidylserine 
(DOPS) bilayer. While direct biological considerations would promote use of lipids such 
as palmitoyloleoylphosphatidylcholine (POPC) and dipalmitoylphophatidylserine (DPPS) 
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for our simulations, bilayers containing these lipids differ substantially in their area per 
headgroup.  Since surface charge density is an important parameter for studying 
electrostatics, we decided to choose PC and PS lipids that have very close areas: 
dipalmitoylphosphatidylcholine (DPPC) and dioleylphosphatidylserine (DOPS).  Thus, 
our model lipid bilayers still contain biologically relevant headgroups. 
 
Initially, both bilayers were brought to an equilibrated state before placing a 
peptide near the bilayer.  For both the DPPC and DOPS bilayers, a single lipid molecule 
was built using the SYBYL package, which was then used to create a symmetric 128 
lipid bilayer.  The DPPC bilayer was equilibrated for 30ns with 3,654 water molecules on 
the bilayer.  The computational details for these simulations are similar to the previous 
simulations with Aβ in solution; however, a constant pressure ensemble (NPT) was used 
to allow the bilayer to reach an appropriate area per headgroup.  The Parrinello-Rahman 
pressure coupling scheme (175) was used with a barostat relaxation time of 2.0 ps at a 
pressure of 1atm.  Further, the lipid force field parameters were taken from the work of 
Berger (176).  These simulations used a time step of 4fs.  The DPPC equilibration 
resulted in an area per headgroup value of 63.6 Å2, which is in agreement with previous 
experimental (177) and computational (178) results.  The DOPS bilayer was also 
equilibrated for 30ns with 128 Na+ counterions and 4102 water molecules on the bilayer.  
The DOPS bilayer equilibration resulted in an area per headgroup value of 63.9 Å2, 
which is also in agreement with experimental (179) and computational (180) results.  
Once the bilayers were equilibrated, simulations could be performed with Aβ near the 
bilayer surface.  Both initial starting structures of Aβ at all 3 pH values were solvated 
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with SPC/E water molecules, Na+ or Cl- counterions and NaCl salt in a 6.4nm x 6.4nm x 
4.5nm box.  The solvated peptide box was then placed near the surface of the equilibrated 
bilayer.  To ensure that the system was symmetric except for the peptide, a box of SPC/E 
water with similar ion concentrations was placed below the DPPC and DOPS bilayers to 
give 1 peptide with SPC/E water molecules, 128 lipid molecules, and Na+/Cl- ions in a 
6.4nm x 6.4nm x 16.3nm box for DPPC simulations (Table 2.1b) and 1 peptide with 
SPC/E water molecules, 128 lipid molecules, and Na+/Cl- ions in a 6.4nm x 6.4nm x 
16.8nm box for DOPS simulations (Table 2.1c).  For these simulations on DPPC and 
DOPS bilayers, the peptide center of mass was placed at a distance of 6.0nm and 6.2nm, 
respectively, from the bilayer center of mass.  This distance ensured that the peptide was 
completely surrounded by solvent and that no portion of the peptide would be influenced 
by short-range interactions with the bilayer surface due to the initial configuration of the 
simulation.  The Aβ-bilayer system was then simulated, after energy minimization, for 
80ns.  Simulation conditions were similar to previously described simulations.  A 
constant volume (NVT) ensemble was used with a time step of 3fs at a constant 
temperature of 323K with periodic boundary conditions along all three dimensions.  All 
secondary structure analysis was performed using the DSSP package (174) in 
GROMACS. 
 
Umbrella Sampling Simulations with Aβ near DPPC and DOPS   
 To calculate free energies of binding of Aβ to the surface of DPPC and DOPS 
bilayers, umbrella sampling (147, 148) was performed.  The previous experimental 
evidence has demonstrated that Aβ had a random coil structure (26, 27) in solution.  
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Therefore, only one starting structure was used for umbrella sampling simulations as 
these calculations were setup to closely replicate an Aβ peptide approaching a bilayer 
from solution.  The final structures from the simulations using the β-hairpin initial 
configuration of Aβ in solution were all predominately random coil at the end of the 80ns 
simulation and thus were ideal as starting structures for these umbrella sampling 
calculations.  To improve sampling, three initial configurations were used for the Aβ-
bilayer system.  First, the peptide was placed so that it was parallel to the bilayer surface 
and that neither the charged N-terminus nor hydrophobic C-terminus was closer to the 
bilayer surface.  Then, the peptide underwent rigid-body rotation so that either the N-
terminus or C-terminus was close to the bilayer surface.  While these extra initial 
conditions cannot fully overcome sampling issues associated with limited timescales of 
MD simulations, the multiple free energy calculations from the 3 initial conditions at 
each pH on DPPC and DOPS will improve the validity of the calculated free energy 
profile.  For each initial configuration, the random coil peptide was solvated with SPC/E 
water molecules, Na+ or Cl- counterions and NaCl salt in a 6.4nm x 6.4nm x 4.2 nm box.  
This peptide box was then placed above the equilibrated DPPC or DOPS bilayers and a 
similar box of SPC/E water and ions without the peptide was placed below the bilayer for 
symmetry purposes.  This resulted in a system of 1 Aβ peptide above a bilayer of 128 
lipids with SPC/E water molecules and Na+ or Cl- ions in a 6.3nm x 6.3nm x 15.8nm box 
for simulations with DPPC (Table 2.2a) and 1 peptide above a bilayer of 128 lipids with 
SPC/E water molecules and Na+ or Cl- ions in a 6.3nm x 6.3nm x 16.1nm box for 
simulations with DOPS (Table 2.2b).  The center of mass separation for Aβ and the 
DPPC or DOPS bilayer in this initial configuration file was between 6.3nm to 6.6nm.  
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For each initial configuration, a short 3ns equilibration simulation was performed.  In 
these simulations, the z-dimension of the peptide was constrained so that the peptide-
bilayer center of mass separation would remain greater then 6.0nm but the system would 
still be able to equilibrate.  The simulation details of this short equilibration were the 
same as the previous unconstrained simulations except that a 1fs timestep was used. 
 
 For the umbrella sampling (147, 148), 14 windows were chosen.  These windows 
spanned peptide-bilayer center of mass separations from 6.0nm to 2.1nm.  Therefore, the 
spacing between each window was 0.3nm, which would enable sufficient sampling.  
Further, this range of distance allows the peptide to be pulled from a full solvated, 
solution-like environment onto the surface of the bilayer then into the interfacial region 
of the bilayer.  The pulling was accomplished by applying a harmonic force with a force 
constant of 500 kJ/(mol*nm2).  For each window with the parallel initial configuration, 
an 80ns MD simulation was performed.  After performing error analysis on the 80ns MD 
simulations, it was determined that 40ns simulations were sufficient to provide an error of 
+4.1kcal/mol for the free energy of binding, which is adequate for the free energies 
calculated in this work.  Error analysis was performed by using a block error analysis 
scheme.  In this scheme, a 40ns simulation was broken into smaller blocks and the 
average value and standard deviation for the potential of mean force at each center of 
mass separation was calculated.  The maximum standard deviation converged to 
4.1kcal/mol after splitting the simulation into blocks up to a total of 30 blocks.  Thus, 
only 40ns MD simulations were performed in each window for the N-terminus down and 
C-terminus down initial configurations.  Computational details of the simulations 
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performed in each window are exactly the same as in the previous unconstrained 
simulations except that a 3fs timestep was used.  Again, the system utilized a constant 
volume (NVT) ensemble with periodic boundary conditions along all 3 dimensions with a 
constant temperature of 323K.  For each window, secondary structure was calculated 
using the DSSP program (174) in GROMACS.  Free energy was calculated for each 
configuration using the Weighted Histogram Analysis Method (WHAM) (150) adapted 
for in-house code.  The center of mass fluctuations from the second 40ns of the parallel 
initial configuration MD simulations were used for free energy calculations to maintain a 
consistent 40ns simulation time amongst all initial configurations, while the center of 
mass fluctuations from the full 40ns MD simulations for the N-terminus down and C-
terminus down initial configurations were used for free energy calculations.  In order to 
calculate an averaged free energy of binding for the three initial configurations of Aβ at 
each pH on either DPPC or DOPS, the center of mass fluctuations for all three initial 
configurations were combined, then analyzed using WHAM.  If the free energies for each 
initial configuration were calculated with WHAM then averaged by obtaining an 
unweighted average of the sum of the exponentials of individual potentials of mean force, 
as previously described (181), one can also get a potential of mean force if enough 
orientationally dependent potentials are included in the unweighted average, and if the 
peptide is a rigid body. Since both of these conditions are strongly violated in our case, 
we expect that this method will produce a large error. Thus, free energies were calculated 
by combining center of mass fluctuations then analyzing with WHAM.  Nevertheless, we 
also calculated the free energy curves for each initial orientation of the peptide to perform 
a contact value analysis. A contact value for Aβ binding to the bilayer was calculated for 
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each umbrella sampling window throughout the umbrella sampling simulations.  Contact 
was defined as a separation of less than 5Å in the Z-coordinate between any atom on a 
given amino acid and the average position of the phosphate atom in the lipid headgroup, 
which was calculated using the 64 phosphate atoms on the bilayer leaflet that Aβ was 
closest to.  The residue was given a contact value of 1 if any atom in the amino acid was 
within 5Å of the average phosphate and a contact value of 0 if it was not.  Contact values 
were calculated for all amino acids in Aβ and averaged over all timesteps in the 
simulation, which gives contact values between 0 (no contact) and 42 (full 
contact/binding) for a given umbrella sampling window.  The contact values were then 
used to calculate a two dimensional free energy surface using the unweighted 
probabilities obtained from the previously-mentioned WHAM calculations on the center 
of mass separation coordinate and conditional probabilities calculated from the 
distribution of contact scores within each umbrella sampling window. 
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Results 
Simulations in Solution   
Initial simulations were performed with the 42-amino acid Aβ peptide in solution.  
These simulations were used as a test of the protein force field to determine if 
experimental solution structures would be obtained during simulations starting from 
ordered structures.  Further, these simulations provide a baseline for comparison with the 
results from simulations of Aβ-lipid systems.  Two initial structures were chosen for 
these simulations to eliminate any bias due to starting configuration (Figure 2.1, see 
Methods for further details of structures).  Both structures were fully solvated with 
appropriate counterions and with NaCl salt.  The simulations were performed with a 1ns 
equilibration followed by a full 80ns simulation.  The secondary structure of both the 
helix and β-hairpin starting structures changed drastically throughout simulation.  Both 
the helix and the β-hairpin structures lost the majority of the ordered structure content to 
become a full random coil (Table 2.3).  These results agree with previous experimental 
NMR (26, 27) and CD (27) results, as well as previous simulations (69, 130, 131, 165, 
167, 170), which show that Aβ has a random coil structure in solution at pH7. 
 
 In the studies of Aβ interactions with bilayers of various lipid headgroup charge, 
lipids with anionic headgroups were used as a model system.  It has been shown that 
anionic lipids can lower the pH (57, 67, 68) of solution near the bilayer, which will in 
turn alter the protonation state of proteins near these bilayers.  Calculations (57) fitting 
experimental data with Aβ bound to anionic palmitoyloleoylphosphatidylglycerol 
(POPG) lipids show that protonation of the 3 histidine residues upon binding does occur, 
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thus further supporting the use of multiple pH states for studying Aβ binding.  Therefore, 
we also investigated various protonation states of Aβ near bilayers.  Similar to the 
previous simulations of Aβ in solution at pH7, simulations of Aβ at different protonation 
states in solution were performed for comparison to simulations of the Aβ-lipid bilayer 
systems.  Aβ can undergo two major protonation events (termed pH5 and pH3 
simulations) which result in a neutral and +6 net charge of the peptide (see Methods 
section for further details).  Not only will studies with these 3 pH states provide insight 
into the effect of pH on Aβ structure in solution and near lipid bilayers, the use of an 
anionic, neutral and cationic peptide will demonstrate the direct importance of 
electrostatics on peptide-charged bilayer interactions.   
 
From our simulations, we observed that both initial peptide structures at pH5 and 
the helical peptide at pH3 lost essentially all secondary structure during the simulation to 
result in a random coil as the final structure (Table 2.3).  For the β-hairpin starting 
structure at pH3, the final structure was not completely random coil but had some 
transient turn content.  Thus, this final configuration can be considered as having some 
transient order as a turn (182) is not purely random but is a somewhat intermediate 
structure between a helix and a sheet.  Nevertheless, this amount of ordered structure at 
pH3 is small and it can be concluded that a random coil was the primary structure for Aβ 
in solution regardless of the starting structure used in the simulation and the total charge 
on the peptide.   
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Simulations near DPPC and DOPS bilayers   
The results from the simulations of Aβ in solution were then extended to 
simulations of Aβ with a zwitterionic dipalmitoylphosphatidylcholine (DPPC) bilayer 
and an anionic dioleylphosphatidylserine (DOPS) bilayer.  For simulations on the fluid 
DPPC and DOPS bilayers, both the helix starting structure and β-hairpin starting 
structure were again used.  Also, simulations were performed at all three charge states for 
the Aβ peptide.  While a DPPC bilayer would not affect local pH (57) and thus not 
induce protonation state changes on Aβ, performing these simulations of Aβ near neutral 
lipids will provide insight into the role of the protonation state on the structure of Aβ near 
a surface it should not interact with extensively.  The results of the simulations in solution 
demonstrated that 80ns was adequate simulation time to allow for the peptide to undergo 
significant conformational flexibility considering computational restraints.  While it was 
possible for Aβ to pass through the upper periodic boundary and interact with the bottom 
leaflet of the bilayer in the chosen simulation setup, this did not occur during simulations 
as Aβ was clearly attracted to the surface of the DPPC bilayer and was near the upper 
leaflet surface for the majority of the simulation time.  Near the DPPC bilayer, the helix 
starting structure at each peptide pH unfolded into a structure dominated by random coil 
and turns, while the β-hairpin starting structure unfolded into a full random coil, similar 
to the simulations performed in solution (Table 2.3).  For these simulations, it is clear 
that, while Aβ was attracted to DPPC near the bilayer surface, the DPPC bilayer is not 
affecting the overall secondary structure content of peptide.  These results agree with 
previous experimental results (57, 58, 82) that show vesicles composed of neutral lipids 
do not alter the secondary structure of Aβ when mixed.  Near the DOPS bilayer, 
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analogous to the simulations with DPPC, Aβ was attracted to the surface of the bilayer in 
all simulations, independent of peptide charge.  For simulations involving the helix 
starting structure at all 3 pHs, the DOPS bilayer strongly enhanced the helical structure, 
especially near the N-terminus of the peptide (Table 2.3).  For the β-hairpin starting 
structure, the β-hairpin configuration was mostly retained at pH7 and pH5 with some turn 
structure also developing.  At pH3, the β-hairpin did unfold slightly into a structure 
dominated by turns. Therefore, it appears that the DOPS bilayer is influencing the 
secondary structure of Aβ so that the random coil observed in solution or near a 
zwitterionic bilayer is not formed.  These results agree to an extent with previous 
experimental measurements (57, 58, 82), which show significant secondary structure in 
Aβ near anionic lipids; however, the time restrictions inherent in MD simulations prevent 
observation of any significant secondary structure change on the surface of DOPS 
bilayers.  These previous experimental measurements demonstrated that a random coil 
Aβ in solution will be converted to a β-sheet dominated structure upon addition of 
anionic vesicles (57, 58, 82, 183), which can be converted to an α-helix upon further 
addition of anionic vesicles.  While the time constraints of these simulations do limit 
potential structural conversion for a single peptide, they show the anionic bilayer 
stabilizes both β-structure and helix structure.  The qualitative results of simulations with 
Aβ near DPPC and DOPS prompted us to further study this system using a more 
quantitative method to help understand why Aβ appeared to be attracted to the bilayer 
surface regardless of the peptide charge or bilayer charge. 
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Umbrella Sampling Simulations   
To describe the Aβ-bilayer interactions using a quantitative method, umbrella 
sampling techniques were used.  Umbrella sampling (147, 148, 150) determines a free 
energy of binding of Aβ to the surface of the lipid bilayer using a systematic routine.  For 
these simulations, the initial Aβ structure was taken to be the final structure of the Aβ 
simulations in solution from starting β-hairpin structures.  The final structures of the Aβ 
β-hairpin simulations in solution had very little ordered structure and were predominantly 
random coil.  Therefore, the use of these random coil starting structures for umbrella 
sampling simulations will closely mimic the experimental conditions of an Aβ peptide in 
solution, which has a mostly random coil structure (26, 27), approaching a cell 
membrane.  Further, for each starting structure, three initial configurations of Aβ with 
respect to the bilayer surface were used; one with the N-terminus of Aβ close to the 
bilayer surface, one with the C-terminus of Aβ close to the bilayer surface and one in 
which Aβ is parallel to the bilayer surface so neither terminus is closer to the bilayer.  
The use of three initial configurations will improve the sampling of the free energy 
calculations (See Methods section for further details). From these simulations, a free 
energy of binding for Aβ from solution to the bilayer surface can be calculated and 
compared to experimental predictions. 
 
Calculated average free energies of binding are listed in Table 2.4 and presented 
as free energy profiles in Figure 2.2.  As was predicted from the unconstrained molecular 
dynamics simulations, Aβ was attracted to the bilayer surface independent of Aβ charge 
or bilayer headgroup charge.  For calculations on the DPPC bilayer, Aβ at all pH values 
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had ΔGbinding ≈ -16kcal/mol to -19kcal/mol (ΔA was actually obtained in our calculations, 
but, as common for condensed systems, ΔG ≈ ΔA).  This reduces to a ΔGbinding ≈ -
0.4kcal/mol*residue, which is close to previous experimental predictions for peptide-lipid 
binding interactions (183).  For calculations on the DOPS bilayer, the free energy of 
binding did depend significantly on the Aβ charge.  The free energy of binding for the 
pH5 and pH3 Aβ were within error, +4.1kcal/mol as described in the Methods section, of 
free energies of binding for Aβ with DPPC.  However, the free energy for binding of the 
anionic pH7 peptide to DOPS was less then half of the binding free energy of the pH5 
and pH3 peptide to DOPS.  This discrepancy in binding free energies is likely due to the 
interplay of electrostatic interactions with lipid headgroups and interactions between the 
hydrophobic residues of Aβ and the interfacial region of the bilayer.  For the highly 
negative free energies of binding on DPPC or DOPS, the majority of favorable 
interactions between the peptide and bilayer, which lead to the large, negative free energy 
of association, are derived from these interactions between the hydrophobic residues of 
Aβ and the interfacial region of the bilayer.  However, for the pH7 peptide binding to 
DOPS, while the hydrophobic C-terminus of the peptide allows for a negative free energy 
of association for Aβ to DOPS, the anionic DOPS headgroups, even partially screened by 
Na+ counterions, interact strongly with the charged N-terminus of Aβ and prevent the full 
association of the peptide with the interfacial portions of DOPS.   
 
Along with magnitude of the free energy of binding, the free energy profiles from 
these umbrella sampling calculations provide further information about the system 
(Figure 2.2).  The free energy profiles supply some insight into the length scales for 
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binding events.  In the profiles, the free energy decreases smoothly as the peptide 
approaches the bilayer.  For some of the Aβ-bilayer combinations, such as Aβ at pH3 
approaching a DOPS bilayer, small barriers are present in the free energy profiles.  These 
barriers have values in the range of 0.1 kcal/mol to 0.2 kcal/mol and are therefore 
insignificant at the considered temperature.  Thus, the point in the free energy curve in 
which the free energy begins to decrease marks the distance where Aβ becomes 
significantly attracted to the bilayer surface.  For Aβ binding to the DPPC bilayer and the 
pH7 peptide binding to the DOPS bilayer, this distance is at a center of mass separation 
of 4.5nm.  For, the pH5 and pH3 peptide binding to the DOPS bilayer, this distance is at a 
center of mass separation of 5.1nm.  Considering a bilayer leaflet thickness of ~2-2.5nm, 
the center of mass of the peptide is separated from the bilayer surface by over 2nm at 
these center of mass distances, which is a significant length and not appropriate for the 
interactions with the interfacial region of the bilayer that may be driving this binding.  
Thus, to better understand this binding and to demonstrate that this center of mass 
separation can be a deceiving coordinate, a contact value was calculated during the 
binding process (see Methods for details).  In short, a value of 1 is assigned to any 
residue of Aβ that is bound to the interfacial region of the bilayer while a value of 0 is 
assigned to any residue that is not bound.  This value is calculated for each residue and 
averaged over the full simulation.  The contact value is calculated for every window in 
the umbrella sampling and a two dimensional free energy surface as a function of center 
of mass separation and number of contacts was determined (Figure 2.3).  The plot shown 
in Figure 2.3 for the parallel initial configuration of the pH7 Aβ peptide binding to DPPC 
is characteristic of most free energy profiles for binding.  At large center of mass 
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separations, there is no contact between any amino acids and the bilayer surface.  Then, at 
the distances of approximately 4nm to 4.5nm, the first amino acids of Aβ come in contact 
with the interfacial region of the bilayer, as seen in snapshot 1.  As free energy begins to 
decrease significantly, more amino acids come into contact with the bilayer surface, as 
seen in snapshot 2.  Finally, at the free energy minimum, 90-95% of amino acids are in 
contact with the bilayer surface and the peptide is clearly bound to the interfacial region 
of the bilayer, as seen in snapshot 3.  Snapshot 3 also demonstrates the parallel binding of 
the Aβ peptide to a DPPC bilayer, mentioned previously as a causative factor in the large, 
negative free energy of binding of Aβ to DPPC.  Further, the free energy surface shows 
that the most probable path taken for binding is that the Aβ peptide will approach the 
bilayer surface without making significant contact.  Then once the peptide is close to the 
bilayer surface at center of mass separations around 4nm (Snapshot 1), the peptide will 
begin to quickly make contacts with the bilayer surface and the free energy will drop 
drastically as the peptide approaches the surface (Snapshot 2) and tightly binds with the 
surface (Snapshot 3).  An alternate path where the peptide creates contacts monotonically 
as it approaches the bilayer surface is not favored as it requires many more contacts at a 
given center of mass separation, which will force the peptide to extend and expose 
hydrophobic residues to solvent in order to have a similar free energy to the more favored 
binding path.  Interestingly, the pH7 Aβ peptide has a lower number of total amino acids 
in contact with the DOPS bilayer surface at the free energy minimum, with only 36 of 42 
amino acids in contact instead of ~40 of 42 amino acids in contact in the other systems.  
This lower extent of contact between the anionic peptide and DOPS, due to electrostatic 
repulsion on the bilayer surface, helps to explain the smaller free energy of binding of 
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pH7 Aβ to DOPS even though the contact of 36 amino acids to the bilayer surface 
provides a favorable free energy of binding and drives the binding process.  Further, the 
use of this contact score demonstrates that the large center of mass separations described 
by the free energy profiles are still compatible with binding driven by association of the 
peptide with the interfacial region of the bilayer.  Finally, the radius of gyration of Aβ 
was calculated as a function of center of mass separation (Data not shown).  For all 
peptide-bilayer combinations, the radius of gyration was constant until the peptide began 
to make contact with the bilayer surface.  The radius of gyration then increased and 
peaked as the peptide made extensive contacts with the bilayer surface.  Once the peptide 
had made a significant number of contacts with the bilayer surface, the radius of gyration 
decreased to a value slightly less then the pre-binding level and remained constant as the 
peptide finished the binding process.  These radius of gyration calculations demonstrate 
that, similar to the contact score calculations, the peptide is altering its structure to make 
extensive contacts with the bilayer as it begins to interact with the bilayer surface. 
 
 Along with inspecting quantitative aspects of Aβ binding to the bilayer surface by 
using umbrella sampling, the secondary structure of Aβ could be analyzed throughout the 
process.  As each umbrella involved a molecular dynamics simulation with a restrained 
center of mass separation (147, 148, 150), secondary structure analysis could be 
performed at each window for the entire simulation time.  In these simulations, only the 
earliest stages of binding could be investigated due to the temporal limitations of 
simulations.  In the Aβ-membrane binding process, we expect that the majority of 
conformational change will occur after significant binding has occurred.  Therefore, the 
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secondary structure analysis will provide insight towards the earliest stages of 
conformational change and may help to predict any significant secondary structure 
change after binding.  For all bilayer and Aβ combinations, the secondary structure was 
not greatly affected until the peptide came in full contact with the bilayer surface. Upon 
full contact with the bilayer surface, the secondary structure was influenced by the 
bilayer.  For the simulations on a DPPC bilayer, the secondary structure remained a 
random coil.  This is exactly as expected for the zwitterionic DPPC based on the 
unconstrained simulations previously mentioned and in experimental results (57, 58, 82).  
For simulations on the DOPS bilayer, both turn and β-structure content increased upon 
contact with the bilayer for all Aβ pH regimes, similar to the previous unconstrained 
simulations near the DOPS bilayer.  However, these resultant transient β-structures were 
not nearly as well ordered as the β-hairpin (49) used in the initial unconstrained 
simulations and thus only represent an intermediate Aβ structure.  The DOPS bilayer was 
able to introduce some ordering of the Aβ peptide, but not enough to fully structure a 
single peptide.  Similar to the unconstrained simulations, the time restrictions imposed by 
all-atom MD simulations prevent observation of significant secondary structure changes 
on the timescales analyzed here.  Potentially, other methods such as parallel tempering 
are required to observe any structural change, or perhaps the structural change observed 
in experiments are due to protein-protein interactions formed in oligomers and not stable 
on the single peptide level. 
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Unconstrained Simulations at Free Energy Minima 
To study the effect of peptide-lipid interactions occurring on the bilayer surface of 
the Aβ-bilayer system, we performed the density profiles analysis presented in Figure 
2.4. Density profiles for the system were calculated using GROMACS utilities (143, 
144).  To ensure that the center of mass constraints did not influence the distribution of 
the peptide on the bilayer surface, unconstrained MD simulations were performed.  For 
each of these simulations, the final structure from the umbrella sampling simulation in the 
window that was closest to the free energy minima was chosen.  For all three Aβ-DPPC 
simulations, the 2.1nm center of mass separation window was closest to the free energy 
minimum and was thus used for the initial structure of unconstrained simulations.  For 
the Aβ-DOPS simulations, the 2.4nm center of mass separation window final structures 
were used.  The computational details of these simulations were exactly the same as the 
previous umbrella sampling simulations except that the harmonic potential restraint was 
removed and each simulation was performed for 80ns.  The density profiles that are 
plotted on Figure 2.4 are taken from the initial configuration with a free energy profile 
closest to the average free energy profile, which indicates that this initial configuration is 
the heaviest weighted initial configuration for the calculations.  Thus, the density profiles 
plotted with DPPC are: pH7 – parallel initial configuration, pH5 – N-terminus down 
initial configuration, pH3 – C-terminus down initial configuration, and with DOPS: pH7 
– C-terminus down initial configuration, pH5 – parallel initial configuration, pH3 – 
parallel initial configuration. 
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Aβ was separated into two segments for density calculations: residues 1-22, 
which are primarily charged and hydrophilic residues, and residues 23-42, which are 
primarily hydrophobic residues.  In these density plots, both the charged and hydrophobic 
sections of Aβ on DPPC appear to be clearly bound to the bilayer where interactions with 
the interfacial regions of the bilayer dominate.  At all pH’s on DPPC, the charged section 
of Aβ and the hydrophobic section of Aβ overlap significantly with the interfacial 
portions of the DPPC density, creating an Aβ distribution wherein Aβ is parallel to the 
bilayer surface at the interface of the hydrophobic sections of the bilayer.  While these 
possible hydrophobic interactions with the bilayer may not involve hydrophobic insertion 
of the peptide into the bilayer core, binding to the interfacial region of the bilayer will 
lead to removal of water from the peptide and subsequent interactions with the interface 
of the hydrophobic core of the bilayer, which drives the binding.  For Aβ on DOPS, it is 
clear that electrostatic interactions are influencing the distribution of the peptide on the 
bilayer surface due to different peptide density distributions concurrent with pH.  At pH7, 
the charged section of the peptide is repelled from the bilayer surface and remains outside 
of the bilayer density while the hydrophobic section of Aβ is clearly distributed in the 
interfacial region of the bilayer.  This creates a peptide distribution where Aβ at pH7 is 
situated almost perpendicular to the bilayer surface, with the hydrophobic region 
interacting with the bilayer interfacial region and the charged section repelled from the 
surface (Figure 2.5).  For the pH5 and pH3 Aβ on DOPS, the charged and hydrophobic 
sections of the peptide both clearly overlap with the DOPS density.  However, overlap of 
the hydrophobic section of Aβ with the interfacial region of the bilayer is still more 
extensive then overlap of the charged section of Aβ with the interfacial region of the 
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bilayer (Figure 2.4).  Also, in comparison to the distribution of Aβ on the DPPC bilayer, 
pH5 and pH3 Aβ is more solvent exposed and less tightly bound to the interfacial surface 
of the bilayer, as seen from both the lower overlap of either region of the peptide with the 
DOPS bilayer in comparison to the significant overlap of both regions of Aβ with the 
DPPC bilayer and in snapshots from the simulations (Figure 2.5).  These peptide and 
lipid charge-dependent density distributions of Aβ on the bilayer surface clearly 
demonstrate the effect of both electrostatic and interfacial interactions with this region of 
the bilayer and may play a role in the availability of Aβ for peptide-peptide interactions 
near the bilayer surface, which drives aggregation. 
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Discussion 
 
 The results obtained from simulations with the 42 amino-acid Aβ peptide provide 
insight into the detailed interactions occurring between Aβ and lipids on the surface of a 
pure lipid bilayer.  The unconstrained simulations both in solution and near a DPPC or 
DOPS membrane demonstrate that the molecular dynamics techniques used for this study 
are effectively able to replicate various experimental results.  During the simulations in 
solution, Aβ unfolds into a random coil peptide from ordered starting structures.  Near 
bilayers, Aβ is attracted to both the DPPC and DOPS bilayer over the short length scales 
used in these simulations with the DOPS bilayer stabilizing secondary structure to a 
greater extent then the DPPC bilayer.  These results support previous experimental work 
using CD and NMR spectroscopy (57, 58, 82) which demonstrate that addition of anionic 
vesicles to a solution of random coil Aβ peptides will lead to a significant change in the 
secondary structure of the peptide while the addition of zwitterionic vesicles does not 
affect the peptide structure. 
 
 The most insightful results from this work are derived from the umbrella sampling 
simulations on DPPC and DOPS bilayers.  Not only did these calculations provide 
quantitative details for the extent of attraction of Aβ to the bilayer surface through free 
energies of binding, the setup of these simulations allowed for detailed analysis of 
peptide structure and distribution as Aβ systematically approached the bilayer surface.  
From this analysis, intriguing aspects of the Aβ-bilayer system were revealed.  The 
umbrella sampling simulations provided insight into the distribution of Aβ on the bilayer 
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surface dependent upon peptide and lipid headgroup charge.  From the density profiles in 
Figure 2.4 and the simulations snapshots in Figures 2.3 and 2.5, it is apparent that 
electrostatic interactions at the bilayer surface greatly influence peptide distribution.  On 
the DPPC bilayer, Aβ, independent of peptide charge, sits nearly parallel to the bilayer 
surface near the interface between the headgroup and hydrophobic core regions of the 
bilayer.  This orientation maximizes interactions with the interfacial region of the bilayer 
throughout the peptide without completely burying hydrophilic and charged residues 
found on the N-terminus of the peptide in the bilayer core.  On DOPS, Aβ does not adopt 
this parallel arrangement and instead promotes a much more superficial interaction with 
the bilayer surface for the neutral (pH5) and cationic (pH3) Aβ peptides.  Further, for the 
anionic pH7 peptide, an almost perpendicular arrangement is observed wherein the 
hydrophobic C-terminus of the peptide interacts with the hydrophobic core of the bilayer 
while the hydrophilic N-terminus becomes solvent exposed.  This configuration is due to 
the interplay of interfacial association of C-terminal tail of the peptide with the 
hydrophobic core of the bilayer and electrostatic repulsion between the anionic N-
terminal tail and anionic lipid headgroups.  Thus, for the neutral and cationic Aβ bound 
to DOPS, the energetically favorable electrostatic interactions between the peptide and 
the lipid headgroups prevent the extreme solvent exposure of the N-terminus.   However, 
these electrostatic attractions between the charged headgroups and the N-terminus amino 
acid side chains prevent the tight association of the N-terminus with the interfacial region 
of DOPS, in comparison to the peptide distributions on DPPC.  This attraction near the 
headgroup region of DOPS with the pH5 and pH3 peptides promotes a more solvent 
exposed distribution of the N-terminus of the peptide, which forces the entire peptide to 
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be bound less tightly to the bilayer interface and thus more exposed for protein-protein 
interactions that may drive oligomerization on the bilayer surface.   Therefore, the charge 
on Aβ during binding to an anionic bilayer surface will significantly influence the 
distribution of the peptide upon nonspecific binding. 
 
Further, secondary structure analysis during the binding process provides some 
insight into the computation approach to this system. Any peptide secondary structure 
change required that the peptide be in full contact with the bilayer, which occurred near 
the free energy minima presented in Figure 2.2.  Even though the peptide began to make 
contact with the bilayer at large center of mass separations, secondary structure change 
was only seen when the peptide was in full contact with the bilayer at center of mass 
separations of 2.1nm to 2.4nm.  Further, this secondary structure change was not very 
extensive.  Only in the extreme case of a pH3 peptide on a DOPS bilayer was any 
secondary structure change observed.  For the more physiologically feasible pH5 peptide 
on DOPS, there was some transient stabilization of β-structure, but not to the extent of 
formation of distinct β-structure as in the predicted fibril structure of Aβ.  Therefore, our 
results appear to support the hypothesis that the bilayer cannot fully order a single peptide 
into a fibril-like structure but likely acts to stabilize an intermediate state that is 
aggregation-prone.  Further, recent results have implicated that the β-structure observed 
in Aβ fibrils is not formed from a single peptide but is β-structure shared between two 
Aβ peptides (46).  If these structural predictions hold true, we are unlikely to see any 
physiologically relevant formation of a β-hairpin in these simulations, as β-structure 
formation would be due to peptide-peptide interactions, which the bilayer surface may 
69 
facilitate. It is also possible that the 40ns timescales used in this simulation are not 
adequate for observing significant secondary structure change.  The 80ns unconstrained 
MD simulations at the free energy minima were also analyzed for secondary structure 
change and very little structural change was observed.  Through 120ns of combined 
unconstrained and constrained MD simulations at the free energy minima, secondary 
structure change was transient at best.   Thus, approaches such as replica exchange, 
similar to some previously performed work (151), or coarse-grained MD will likely be 
required to adequately explore Aβ secondary structure formation on the bilayer surface. 
 
 The results of this work have lead to a rough mechanism for elucidating how the 
detailed balance between electrostatic and hydrophobic forces on the bilayer surface may 
affect Aβ aggregation.  Initially, the Aβ peptide is brought close to the surface of a 
bilayer due either to diffusion, through interaction with sugar groups on lipids such as 
gangliosides or after cleavage from the amyloid precursor protein.  Once the peptide is 
close enough to the surface, it will favorably bind with the lipids.  If this binding is on a 
mostly zwitterionic bilayer, the peptide will strongly interact with the interface at the 
hydrophobic core of the bilayer, as seen in the density profiles of Figure 2.4, thus 
precluding extensive interactions with other nearby peptides and preventing any 
secondary structure change, in agreement with previous experiments (57, 58, 82).  
However, if this binding occurs on an anionic bilayer, the peptide will not be as strongly 
associated with the bilayer core and more exposed to the solvent and other bound 
peptides. If the anionic headgroups on lipids are able to lower the local pH by 1-2 units, 
the hydrophobic portion of the peptide will become exposed, as demonstrated in density 
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profiles in Figure 2.4, and more likely to interact with other nearby peptides, thus driving 
oligomerization.  Also, previous research (62) has shown that fibrilization occurs more 
rapidly in solution at a lower pH≈5. Therefore, lowering pH near the anionic lipid surface 
may also promote aggregation by intrinsically increasing protein-protein interactions 
through reducing electrostatic repulsion between peptides, which along with altering 
peptide distribution on the bilayer, will promote oligomer formation.  Based on previous 
structural determination (46), it is likely that the resulting peptide-peptide interactions on 
the bilayer surface will drive the secondary structure changes observed in experiment (57, 
58, 82) and promote fibrilization.  Therefore, an anionic lipid membrane appears to 
promote aggregation by (1) increasing peptide diffusion by altering diffusion from a 3D 
to 2D process, (2) locally increasing Aβ concentration on the bilayer surface due to the 
highly favorable free energy of binding and (3) decreasing the local pH on the bilayer 
surface to promote an Aβ configuration that would be amiable to protein-protein 
interactions that can drive oligomerization.   
 
Many aspects of this system are still open for future MD simulations.  As 
mentioned previously, work with replica-exchange MD for analyzing Aβ secondary 
structure change will be very interesting for determining the direct role of the bilayer on 
peptide secondary structure near the bilayer surface.  Further, simulations using multiple 
peptides on the bilayer may provide insight into the role of peptide-peptide interactions 
on early oligomer formation near the bilayer surface.  Finally, a study similar to previous 
replica exchange MD work (151) using the WALP peptide on the DPPC bilayer, where 
both bilayer surface binding and peptide insertion into the bilayer core was simulated 
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with subsequent calculation of a 2D free energy surface, would be very informative for 
this system.  For the current study on only Aβ binding to the bilayer surface, a 2D free 
energy surface calculation using a second reaction coordinate similar to extent of helix 
formation used in the WALP-DPPC study is not applicable.  However, Aβ binding and 
insertion could be studied using a similar order parameter and a free energy surface for 
the full process could be calculated.  Performing such a study on the full insertion process 
would provide great insight into a full range of Aβ-bilayer interactions that would only be 
available on the detailed scale of MD simulations.  Thus, future experimental and 
computational endeavors with Aβ on the bilayer surface will be integral to confirming 
that the structural change observed in experiment is due to protein-protein interactions 
occurring during the early stages of oligomerization and also essential to further 
characterizing the influence of anionic membranes on Aβ aggregation in Alzheimer’s 
disease.  
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Table 2.1  Simulation contents for unconstrained simulations 
a) Simulations in Solution – 6.4nm x 6.4nm x 8.1nm box 
 
Starting Structure Aβ pH SPC/E Na+ Cl- 
pH7 10534 22 19 
pH5 10539 19 19 Helix 
pH3 10530 19 25 
pH7 10521 22 19 
pH5 10523 19 19 β-Hairpin 
pH3 10515 19 25 
 
b) Simulations with DPPC – 6.4nm x 6.4nm x 16.3nm box 
 
Starting Structure Aβ pH SPC/E Na+ Cl- 
pH7 15587 27 24 
pH5 15588 24 24 Helix 
pH3 15585 24 30 
pH7 15576 27 24 
pH5 15580 24 24 β-Hairpin 
pH3 15569 24 30 
 
 
c) Simulations with DOPS - 6.4nm x 6.4nm x 16.8nm box 
 
Starting Structure Aβ pH SPC/E Na+ Cl- 
pH7 15906 155 24 
pH5 15907 152 24 Helix 
pH3 15904 152 30 
pH7 15896 155 24 
pH5 15899 152 24 β-Hairpin 
pH3 15888 152 30 
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Table 2.2  Simulation contents for umbrella sampling simulations 
a) Simulations with DPPC - 6.4nm x 6.4nm x 15.8nm box 
 
Starting Structure Aβ pH SPC/E Na+ Cl- 
pH7 14764 27 24 
pH5 14762 24 24 Random Coil 
pH3 14759 24 30 
 
b) Simulations with DOPS - 6.4nm x 6.4nm x 16.1nm box 
 
Starting Structure Aβ pH SPC/E Na+ Cl- 
pH7 15083 155 24 
pH5 15081 152 24 Random Coil 
pH3 15078 152 30 
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Table 2.3  Average structures for unconstrained Aβ simulations.  Starting structure refers 
to if the peptide was originally the 1Z0Q (Helix) or 2BEG (β-Hairpin) derived structure.  
Aβ pH refers to the charge on the peptide during the simulation. 
 
Initial Conditions  Final Structure   
Starting Structure Aβ pH  In Solution On DPPC On DOPS 
Helix pH7 Coil Coil/Turn Helix 
Helix pH5 Coil Coil/Turn Helix 
Helix pH3 Coil Coil/Turn Helix 
β-Hairpin pH7 Coil Coil β-Hairpin 
β-Hairpin pH5 Coil Coil β-Hairpin 
β-Hairpin pH3 Coil/Turn Coil β-Hairpin/Turn 
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Table 2.4  Calculated free energies for binding of Aβ to the bilayer surface 
Bilayer Type Aβ pH state Free Energy (kcal/mol) 
pH7 -16.0 kcal/mol 
pH5 -18.4 kcal/mol DPPC 
pH3 -18.9 kcal/mol 
pH7 -6.6 kcal/mol 
pH5 -14.1 kcal/mol DOPS 
pH3 -15.6 kcal/mol 
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Figure 2.1  Initial configurations of Aβ used for simulations.  Figure 2.1a, PDB code 
1Z0Q is a coil-dominated structure (27) while Figure 2.1b, PDB code 2BEG, is a 
preformed β-hairpin (49). 
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Figure 2.2  Free energy profiles for binding of Aβ to the surface of the (a) DPPC or (b) 
DOPS bilayer. The error associated with the minimum of these potentials is 4.1kcal/mol. 
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Figure 2.3  Free energies of binding of Parallel pH7 Aβ to DPPC bilayer as a function of 
Aβ-bilayer center of mass separation and number of contacts.  The surface shows, using 
the color scale next to the figure, the relative free energy change as the peptide binds to 
the bilayer surface.  Other peptide-bilayer combinations showed a similar free energy 
surface.  The snapshots represent points along the binding trajectory and show the extent 
of contact at (1) 4.2nm, (2) 3.0nm and (3) 2.1nm center of mass separations. 
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Figure 2.4  Density profiles of Aβ on DPPC and DOPS bilayers calculated from 80ns 
simulation at center of mass separation closest to the free energy minima of profiles in 
Figure 2.2.  All plots on DPPC are at a COM separation of 2.1nm. All plots on DOPS are 
taken from simulations at a COM separation of 2.4nm.  The “Abeta Charged Section” is 
with reference to residues 1-22 of the peptide and the “Abeta Hydrophobic Section” is 
with reference to residues 23-42.   
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Figure 2.5  Comparison of simulation snapshots from 80ns unconstrained MD 
simulations of (a) pH7 Aβ and (b) pH5 Aβ on DOPS at the free energy minima center of 
mass separation. 
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Abstract 
 
The Amyloid-β (Aβ) peptide, the 39 to 43 amino acid peptide that plays a 
substantial role in Alzheimer’s disease, has been shown to interact strongly with lipids 
both in vitro and in vivo. Aβ-lipid interactions have been proposed as a considerable 
factor in accelerating Aβ aggregation through the templating role of membranes in 
aggregation disorders.  Previous work has shown that anionic lipids are able to 
significantly increase Aβ aggregation rate and induce a structural conversion in Aβ from 
a random coil to a β-structure that is similar to the monomer structure observed in mature 
fibrils.  However, it is unclear if this structural change occurs with the Aβ monomer due 
to direct interactions with the lipids or if the structural change results from protein-
protein interactions during oligomerization.  We use extensive replica exchange 
molecular dynamics simulations of an Aβ monomer bound to a homogeneous model 
zwitterionic or anionic lipid bilayer.  From these simulations, we do not observe any 
significant β-structure formation except for a small, unstable β-hairpin formed on the 
anionic dioleylphosphatidylserine bilayer.  Further, we see that the Asp23-Lys28 salt 
bridge that plays a role in β-hairpin formation is not substantially formed on the bilayer 
surface and that Lys28 preferentially interacts with lipids when bound to the bilayer.  
These results suggest that the structural conversion seen in experiments are not due to the 
ordering of monomeric Aβ on the bilayer surface but are a result of protein-protein 
interactions enhanced by Aβ binding to the cell membrane. 
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Introduction 
 
 The Amyloid-β (Aβ) peptide is an amyloidogenic protein whose aggregation has 
been linked to neural degeneration (3, 11, 12, 40) that is a hallmark of Alzheimer’s 
disease.  Due to the association of Aβ with Alzheimer’s disease, Aβ has been extensively 
studied (3, 11, 12, 40) over the past 20 to 30 years.  In particular, the structure of the Aβ 
peptide, through its passage from monomer to small aggregate to fibril, has been a subject 
of great interest for both experimental (4, 5, 57-59, 81, 85, 87, 91, 95, 157, 184) and 
computational (27-29, 69, 121, 123-131, 136) researchers.  Knowledge of the structure of 
Aβ at each step of the aggregation pathway will provide insight into the mechanism of 
aggregation that can hopefully be exploited for therapeutic benefits.  Previous research 
has already made significant progress on this front as the dogma of Aβ neurotoxicity has 
been shifting away from mature fibrils and towards small oligomers as one of the main 
neurotoxic species in Alzheimer’s disease (4, 5, 37).  This knowledge places even further 
impact on gaining a fundamental understanding of the earliest stages of Aβ aggregation 
as a major target for prevention of extensive neurodegeneration. 
  
While it is clear that the first stages of Aβ aggregation are vital to the progress of 
Alzheimer’s disease, it has not yet been determined what factors influence this initial 
conversion from monomer to oligomer.  While oligomerization does occur naturally in 
solution, there are other possible factors that may catalyze this reaction.  Recent work (4, 
5, 57-59, 81, 85, 87, 91, 95, 157, 184) has demonstrated that cell membranes may play a 
significant catalytic role in increasing Aβ aggregation rates. The Aβ peptide is derived 
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from the transmembrane Amyloid Precursor Protein (APP) (3, 11, 12).  Upon cleavage 
from APP, the C-terminus (3, 11, 12) of Aβ maintains a significant portion of the 
transmembrane region of APP.  Extensive experimental work (4, 5, 57-59, 81, 85, 95) has 
shown that Aβ, when mixed with lipid vesicles of various structure and headgroup 
charge, will aggregate at a much faster rate then in solution.  Further results have 
demonstrated that this interaction between Aβ and lipids will induce a structural 
conversion (4, 5, 57-59, 81, 85, 87, 91, 95, 157, 184) from a disordered peptide into a 
peptide dominated by β-structure.  Mixing Aβ peptide with anionic lipids, in the form of 
vesicles or bilayers, induces a substantial increase in both aggregation rate and secondary 
structure formation (4, 57-59, 81, 87, 91, 184).  Also, it has been shown that extensive 
interactions with cell membranes can lead to pore formation and disruption of ion balance 
(157, 185) across the bilayer, which may play a role in Aβ neurotoxicity. 
  
While experimental results have demonstrated an extensive interaction of Aβ with 
lipid bilayers, these same experimental techniques are limited in resolution.  Circular 
dichroism, nuclear magnetic resonance, electron microscopy and other common 
techniques (5, 57-59, 81, 85, 87, 91, 95, 157, 184) require a low concentration to study 
Aβ without immediate aggregation, which prevents these techniques from being able 
distinguish if Aβ is in a monomeric or small oligmeric state.  This subtle shortcoming due 
to the nature of Aβ does cloud one aspect of these results: Is the secondary structure 
change observed in experiment inherent to the Aβ monomer or does the structural 
conversion occur due to peptide-peptide interactions that are enhanced on the lipid 
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surface?  Thus, molecular dynamics (MD) simulations would be ideal to determine the 
structure of Aβ as a monomer on an atomic level. 
   
MD simulations have been extensively performed on the Aβ peptide.  Simulations 
on the full length monomer (27-29, 69, 121, 136), on monomer fragments (124, 126-128, 
130), on small oligomers (125, 126, 131) and on full fibrils (129) using all atom (27-29, 
69, 121, 123-125, 127-131, 136) or coarse grain techniques (126, 131) in both explicit 
(27, 29, 69, 123, 124, 127-131, 136) and implicit (28, 121, 125, 126) solvent have 
produced significant insight into the structure of Aβ at each step of aggregation.  Replica 
exchange MD simulations (28, 29, 121, 123-125), which allows for much more extensive 
motion of the peptide through its configurational space by effectively overcoming 
barriers on the conformational free energy surface, have been particularly insightful for 
Aβ structure studies.  These replica exchange studies (28, 29, 121, 123-125) on Aβ have 
shown that the peptide does have a predominantly random coil structure in solution but 
can still form stable secondary structure, such as β-hairpins or small helices, that may 
help to accelerate aggregation.  However, these same studies have not yet been extended 
to Aβ in an explicit membrane environment.  Previous studies have investigated the 
stability of a preinserted (69, 136) Aβ into either an explicit or implicit membrane 
environment, but these works did not concentrate on Aβ structure when bound to the 
membrane surface.  A previous work of ours (138) investigated Aβ binding free energies 
to various bilayers of differing headgroup charge, but we did not investigate Aβ structure 
due to lack of sampling without replica exchange.  In this work, we use the replica 
exchange method to study Aβ structure and the effect of both peptide charge and lipid 
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charge on peptide structure.  As anionic lipids bilayers are able to decrease local pH (57, 
68), it is necessary to study the effect of lipid binding on Aβ with different total charges.  
The results of this work will help to elucidate the mechanism of structural change 
experimentally observed in Aβ aggregation at a molecular level not available to many 
current experimental techniques.   
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Materials and Methods 
Initial Conditions   
 The initial structures used for replica exchange simulations were obtained from a 
previous work (138) by our group.  In that work, a random coil structure of the 42 amino 
acid Aβ peptide was systematically pulled to the surface of an equilibrated 128 lipid 
dipalmitoylphosphatidylcholine (DPPC) or dioleylphosphatidylserine (DOPS) bilayer 
using the umbrella sampling technique, and a free energy of binding was calculated.  The 
initial conditions for the replica exchange simulations presented here were obtained from 
the final snapshots of MD simulations at the bound free energy minimum, as determined 
from the calculated free energy profiles for binding. These final snapshots from the 
simulations occurred at an Aβ-bilayer center-of-mass separation of 2.1nm with DPPC 
and 2.4nm with DOPS.  Thus, the initial structures chosen for the replica exchange 
simulations described here represent configurations where the 80ns of restrained MD 
simulations allowed for extensive simulation time to equilibrate the Aβ-bilayer system.  
The Aβ-bilayer center-of-mass restraint used in the previous work was removed for 
replica exchange, ensuring that the Aβ was not restrained to the bilayer surface. 
 
Peptide and Lipid Parameters   
Replica exchange simulations were performed using the GROMACS 4.0 
simulation package (143, 145, 149, 186).  The Aβ peptide was described using the 
united-atom GROMOS96 force field (143, 145, 186).  The DPPC and DOPS lipids were 
described using the Berger (176) force field parameters.  These force fields were chosen 
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to match our previous work (138) and because of the extensive use of each force field in 
previous molecular dynamics studies.  The system was solvated with SPC/E model (173) 
water and included counter-ion and co-ion Na+/Cl- salt.  As the local pH near anionic 
lipid bilayers is lower then bulk (57, 68), it was important to perform these simulations at 
physiological pH and also at a lower pH to determine if peptide protonation state could 
affect Aβ structure near lipids.  Thus, simulations were performed with Aβ at a -3 total 
charge, which is the physiological charge of Aβ, and with a net 0 total charge due to 
protonation of three histidine residues.  This 0 total charge state would be a close 
approximation of the charge on Aβ at pH5, which is a feasible pH for Aβ bound to an 
anionic bilayer surface.  Therefore, the -3 total charge simulations are termed the pH7 
simulations and the 0 total charge simulations are termed the pH5 simulations 
throughout, for simplicity.  The N-terminus was represented by NH3+ and C-terminus 
was represented by COO- to match the most likely charge state at physiological pH.  
Thus, four total replica exchange simulations are performed with two peptide charge 
states on either a DPPC or DOPS bilayer.  Exact contents of the simulation are given in 
Table 3.1.  For each replica, temperature was held constant using a Nose-Hoover (171) 
scheme with a relaxation time of 0.5ps under constant volume (NVT) conditions.  All 
bonds were constrained using the LINCS algorithm (187), which allowed for a time step 
of 3fs.  Long range electrostatics were maintained using the SPME algorithm (146) with 
periodic boundary conditions in all three dimensions.  Secondary structure was calculated 
using the DSSP algorithm (174) within GROMACS and all other analysis was performed 
using GROMACS utilities.  As a clarification note for the tables and figures, a 
discontinuous trajectory refers to a system trajectory obtained at a fixed temperature 
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during the replica exchange, while a continuous trajectory refers to a trajectory obtained 
by reordering the set of discontinuous trajectories so that one initial structure is followed 
through the temperature space during the full simulation time. 
 
Replica Exchange Details   
The temperature exchange simulations involved 83 replicas spaced between 325K 
and 502K.  The exact temperatures of all replicas are provided in Table 3.2.  The 
temperatures were chosen using the Temperature Generator for REMD-simulations (188) 
associated with the GROMACS package. Thus, 80ns (pH7) or 110ns (pH5) molecular 
dynamics simulations were performed for each of the 83 replicas at random initial 
velocities with exchanges attempted every 3ps and coordinates written every attempted 
exchange.  The pH5 simulations were extended to 110ns to determine the stability of 
secondary structure formed at the end of the 80ns simulation.  With a minimum of 80ns 
total simulation time and 3ps exchanges, over 26,000 exchange attempts are made during 
the span of the simulation.  Further, results from the simulations showed an exchange 
probability of 0.2 - 0.35 over all temperatures.  The combination of a rate of exchange 
greater then 1ps and over 20,000 exchange attempts should guarantee at least one full 
transit for the replicas through the temperature space and, subsequently, a well-mixed 
(153) replica exchange simulation.  All details involving the replica exchange and the 
replica temperatures were the same for the four initial conditions. 
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Bilayer Constraint   
 At the high temperatures used in this simulation, neither the DPPC or DOPS 
bilayer was stable.  Thus, a restraint was necessary to keep the fidelity of the bilayer 
while still allowing the peptide significant conformational flexibility.  Further, it was 
important to maintain individual lipid flexibility within the bilayer as lipid-protein 
interactions may play a significant role in Aβ structure.  A restraint was chosen to keep 
the average separation along the Z-axis between the phosphate groups of the two leaflets 
of the bilayer constant.  In order to impose this restraint, the 64 phosphate atoms from 
each leaflet were grouped together and a harmonic constraint was applied to the average 
distance along the Z-axis between the center-of-mass of these two groups.  By imposing 
the constraint on the center-of-mass separations of the group instead of each phosphate 
individually, it allows for each lipid to fluctuate significantly as long as the average Z 
value for each leaflet remains relatively constant.  To calculate the average constraint 
distance for the DPPC and DOPS bilayers, we used the final 20ns of the umbrella 
sampling simulations of our previous work (138).  From these previous simulations, we 
calculated that the average phosphate-phosphate distance on DPPC was 3.90nm and the 
average distance on DOPS was 4.16nm. It was necessary to impose a force constant of 
4kJ/ (mol*nm2) to prevent the bilayer from breaking apart and to prevent exceptional 
amounts of water from penetrating the bilayer.  However, visual inspection of the 
trajectories at 502K show that the bilayer remains together throughout the 80ns 
simulation and the extent of bilayer fluctuations are not significantly different in 
comparison to the simulation at 325K.  Further, we calculated the number of water 
molecules that interact with the hydrophobic core of the bilayer.  At 502K, the number of 
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water molecules interacting with the bilayer core is three times larger then the number of 
water molecules interacting with the bilayer core at 325K and both values are stable over 
the length of the simulation.  Both the leaflet to leaflet restraint and the constant volume 
(NVT) simulation condition, which also acts as a restraint on the system, prevent this 
increase in water molecules near the hydrophobic core from disrupting the bilayer 
structure, which would, in turn, force more water molecules into the hydrophobic core 
and eventually dissolve the bilayer.  As previously mentioned, the leaflet to leaflet 
restraint on the bilayer was the only specific restraint applied on the system and the 
peptide was not restrained to the bilayer surface during replica exchange. 
 
 
92 
Results 
Aβ-Bilayer Replica Exchange MD Setup   
In order to properly assess the structure of monomeric Aβ at the surface of the 
bilayer, replica exchange simulations were performed for the 42 amino acid form of the 
Aβ peptide at pH7 (-3 total charge) or pH5 (0 total charge) on either a homogeneous 
DPPC or DOPS bilayer.  The initial structures for each of the four replica exchange 
simulations were taken as the final equilibrated structures at the membrane-bound free 
energy mimima determined in a previous work (138).  Figure 3.1 is a representative 
example of one of the initial configurations for Aβ bound to the bilayer surface.  The 
initial configurations for Aβ represent an Aβ structure where the peptide is strongly 
bound to the interfacial region of the bilayer with some amino acid sidechains inserted 
into the bilayer hydrophobic core and some sidechains either fully solvent exposed or 
interacting with the lipid headgroups.   
 
MD simulations using the replica exchange methodology were then performed 
using these 4 initial configurations over a temperature range of 325K to 502K.  As 
demonstrated in Figure 3.2, the replica exchange setup employed in this work allows 
each replica to adequately explore the temperature space during the duration of the 
simulation, which was consistent over all 4 initial conditions. In combination with the 3ps 
exchange rate of these simulations, the extensive motion through the temperature space 
should allow these replica exchange simulations to be considered well mixed and the 
configurational space well sampled (153).  Further analysis at the lowest temperature 
(325K) should provide an appropriate estimate to the conformational space of Aβ while 
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bound to a bilayer surface.  The use of a weak restraint between the average positions of 
the phosphate groups from each leaflet of the bilayer allows for some natural fluctuations 
of the bilayer surface without allowing the bilayer to dissolve.  Allowing the bilayer to be 
more flexible may play a significant role in the dynamics of a protein bound to the bilayer 
surface. 
 
Aβ Secondary Structure on the Bilayer Surface   
Secondary structure content of the protein was calculated at 325K for all 4 
systems as a means of determining how the membrane surface influences Aβ structure 
(Figure 3.3).  From these calculations, it is clear that Aβ remains in a predominantly 
random coil configuration throughout the duration of the simulation.   In particular, at 
pH7, the protein contains almost no ordered structure except for a small amount of β-
sheet formed near the end of the simulation of pH7 Aβ on DOPS.  However, at pH5, Aβ 
is able to adopt structures containing more ordered secondary structure.  Most notably, 
the pH5 protein on DOPS develops a turn/ β-sheet structure from residues 21-34 
beginning at 76ns of the simulation, which can be seen more clearly in Figure 3.4a.  This 
structure is reminiscent of a β-hairpin, which has been postulated to be the building block 
(47, 48) of Aβ fibrils.  On DPPC, it appears that a similar structure is formed, also at 
75ns, but this structure spans fewer residues and is more transient.  The replica exchange 
simulations at pH5 on DPPC and DOPS were both extended 30ns to test the hairpin 
stability.  From Figure 3.3, it is obvious that this structure is still not stable over the 
length of the simulation and has quickly disappeared after 86ns of total simulation time.  
This β-hairpin structure only appears for 10ns of the 110ns of total simulation time and 
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does not significantly influence the average structure of the peptide during simulation.  
Finally, a turn and some β-sheet structure are transiently formed in the last 5 residues of 
the pH5 Aβ during the simulation on DOPS.  This small turn has been previously seen 
(29) in studies of Aβ, due to Gly37 and Gly38, which have been predicted to strongly 
favor formation of turns.  These replica exchange simulations confirm that this turn is 
feasible, yet it is not stable in the interfacial membrane environment. 
 
Asp23-Lys28 Salt Bridge Stability   
The salt bridge that can be formed between Asp23 and Lys28 has previously been 
implicated (47, 124, 127, 128, 189) to be a major factor in fibril formation by Aβ and has 
been observed in structures of Aβ fibrils (47).  A recent experimental work (189) has 
demonstrated that a covalent lactam bridge created between Asp23 and Lys28 
substantially increases the Aβ aggregation rate.  Further, many computational studies 
(124, 127, 128) have shown that this salt bridge is significant in the formation of a β-
hairpin in monomeric Aβ.  However, it is still a point of contention if this salt bridge is 
necessary for fibril-like β-sheet formation Aβ or if hydrophobic interactions drive this 
sheet formation and the salt bridge is a secondary effect of β-sheet formation.  To 
understand the properties of the salt bridge in our system, we calculated the distance 
between the Cγ group of Asp23 and the Nζ group of Lys28 during the pH5 Aβ replica 
exchange simulations at 325K from 75ns to 81ns on the DOPS bilayer, where the hairpin 
is transiently stable (Figure 3.4a).  Salt bridges between these two residues have 
previously (124) been described as close-contact salt bridges for separations less than 
4.5Å and mediated salt bridges for separations within 4.5Å - 7Å.  The snapshots shown in 
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Figure 3.4b and the Nζ-Cγ distance plot in Figure 3.4c demonstrate that Aβ tends to adopt 
one of two structures depending on the Asp23-Lys28 distance.  When Asp23 and Lys28 
are separated by a significant distance (labeled (1) in the Figure), Aβ adopts a β-hairpin 
structure with a turn between residues 21-24 (Ala-Glu-Asp-Val).  However, when a 
mediated salt bridge is formed between Asp23 and Lys28 (labeled (2) in the Figure), the 
turn is shifted from residues 21-24 to approximately residues 18-22 (Val-Phe-Phe-Ala-
Glu) and a new, smaller turn is created between Asp23 and Lys28 to accommodate this 
salt bridge formation.  From Figure 3.4c, Aβ appears to fluctuate between these two 
strand-loop-strand structures over the time period studied and that neither structure 
appears to be significantly more stable then the other.  Further, no close-contact salt 
bridges appear to be formed between Asp23 and Lys28, in contrast to simulations (124) 
performed in solution that investigated this salt-bridge formation.  It is important to note 
that these ordered β-structures were not significantly stable over the full simulation time 
and were only formed with the pH5 peptide interacting with either bilayer. 
 
Aβ Distribution on the Bilayer Surface   
While the secondary structure and salt-bridge calculations did not show a 
significant difference between Aβ structure on the two bilayers, we also performed 
density distribution calculations to determine if regions of the Aβ peptide interacted 
differently with the zwitterionic or anionic lipids.  For this analysis, Aβ was separated 
into a charged section (residues 1-23) and a hydrophobic section (residues 24-42) to see 
how the peptide interacted with the charged headgroups on the bilayer surface.  In Figure 
3.5, the left panel shows the pH5 Aβ density distribution on DPPC.  This plot shows that 
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both the hydrophobic and charged sections of Aβ are interacting with the interfacial 
region of the bilayer.  Further, the density of the phosphate atoms in DPPC is also shown, 
which further supports an interfacial distribution for the peptide.  The charged and 
hydrophobic sections of the peptide appear to be distributed very similarly, both in the 
peak location and the width of the distribution.  It also appears that the hydrophobic 
section of the peptide is not significantly inserted into the bilayer core.  For the 
distribution on the DOPS bilayer given on the right panel of Figure 3.5, a similar pattern 
is observed.  Both sections of the peptide appear to be sitting in the interfacial region of 
the bilayer and the distributions from both the charged and hydrophobic sections overlap.  
However, one significant difference is that the hydrophobic section of the peptide appears 
to have a broader distribution on DOPS, including significant tails on both sides of the 
distribution indicating either partial insertion of the hydrophobic section into the bilayer 
core or more solvent exposure of the hydrophobic residues at the C-terminus.  Further, 
the charged section of the peptide also is able to become significantly solvent exposed by 
being distributed outside of the DOPS density, which is not seen in the DPPC bilayer.  
Thus, while Aβ on the DPPC bilayer has an almost parallel arrangement with both 
sections of the peptide bound to the interfacial region of the bilayer, Aβ bound to DOPS 
is able to adopt a larger range of distributions on the bilayer surface, including a 
distribution with a more exposed hydrophobic C-terminus, which may play a significant 
role in peptide-peptide interactions that drive aggregation. 
 
Finally, we investigated the distribution of various amino acids on Aβ with 
respect to the bilayer.  In particular, we looked at Lys28, which has been shown to be 
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integral to bilayer association (81, 184, 185), as well as its importance in the Asp23-
Lys28 salt bridge described previously.  As shown in Figure 3.5, Lys28 tends to 
distribute on the interfacial region of the bilayer near the hydrophobic core, independent 
on the charge of the lipids.  Interestingly, while the Lys28 density does overlap somewhat 
with the phosphate density from the lipid headgroups, the lack of complete overlap and 
different density peaks for Lys28 and the lipid phosphate atoms demonstrates that Lys28 
is likely not bonding strongly to these atoms throughout the entirety of the simulation.  
Further, the Lys28 distribution near the lower end of the Aβ hydrophobic density 
distribution indicates that Lys28 may be playing a role in anchoring the peptide to the 
interfacial region of the bilayer through interactions with the glycerol backbone or 
hydrophobic tails of the lipids.  These results of the Lys28 density distribution studies are 
evidence that the role of Lys28 in Aβ interactions with the bilayer surface is to stabilize 
the interaction of Aβ with the interfacial region of the bilayer, thus contributing to the 
strong binding free energies predicted (138) for Aβ binding to either the DPPC or DOPS 
bilayer surface.  
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Discussion 
 
 The results of the replica exchange simulations of the Aβ 1-42 peptide on the 
zwitterionic DPPC or anionic DOPS bilayer surface provides insight into the structure of 
the monomeric peptide when bound to a membrane.  These simulations appear to be 
well-mixed replica exchange simulations and the weak restraints applied to prevent the 
bilayer from dissolving at high temperature allow for significant bilayer motion, which 
may influence peptide structure or distribution on the bilayer surface.  Bilayer restraints 
were also used in a previous all-atom replica exchange study (151) with a peptide-bilayer 
system, although those restraints were much more constricting since the temperatures 
used in the replica exchange simulations were over a much larger range (350K – 800K).   
  
The secondary structure results from these simulations show that, even when 
bound to the bilayer surface, monomeric Aβ does not adopt a stable secondary structure.  
Many replica exchange simulations (28, 29, 121, 123-125) have previously been 
performed using full-length (28, 29) Aβ or Aβ fragments (123, 124) in both explicit and 
implicit solvent.  These studies (28, 29, 121, 123-125) have shown that Aβ prefers a 
random coil structure in solution, but it is able to form stable secondary structure, which 
can range from strand-loop-strand structures to small helices, for times during the 
simulation.  One of the most important aspects of these previous studies is that Aβ is able 
to adopt a multitude of structures and is a highly flexible peptide in solution, considered 
an integral aspect of Aβ aggregation, over timescales comparable to the simulations 
performed in this work.  However, our results indicate that the interactions of Aβ with the 
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lipid bilayer do not promote structural ordering similar to observations made in aqueous 
solution and that conformational motion is likely restricted due to direct protein-lipid 
interactions.  At pH7, Aβ does not form any stable secondary structure on either bilayer, 
while at pH5, Aβ is able to form some transient β-hairpin structure, especially when 
bound to the DOPS bilayer.  Further, our results show that different β-hairpin structures 
are formed when bound to DOPS and the Asp23-Lys28 salt bridge interaction may play a 
significant role in determining which structure is stabilized. These results may appear 
contrary to experimental results (4, 57-59, 81) showing a significant increase in β-
structure when Aβ is mixed with anionic lipid vesicles.  It is important to note that these 
studies are not able to distinguish between Aβ monomers and those small Aβ oligomers 
on the lipid surface and our results imply that the β-structure seen in experiment is due to 
peptide-peptide interactions that occur during oligomerization, which are promoted when 
Aβ is bound to the anionic lipid surface. 
  
The results from the Aβ density distribution analysis also illustrate important 
aspects of Aβ interactions with lipid bilayers.  The density distributions show that the 
peptide interacts strongly with the interfacial region of the bilayer.  Further, residues such 
as Lys28, when not engaging in intrapeptide salt bridge interactions, are likely interacting 
with the glycerol backbone or carbon tails of lipid molecules, which stabilizes this 
binding.  The extent of contact between the bilayer surface and Aβ was also calculated at 
the extreme of the replica exchange simulation, 502K (Figure 3.6).  Even at 502K, at 
least 25 of the 42 residues of Aβ maintain strong contact with the bilayer surface and on 
average greater then 35 residues remain in contact, independent of bilayer or peptide 
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charge. These results are not surprising in light of our previous calculations of significant 
binding free energies for Aβ to the bilayer surface, which are substantially larger than kT 
even at a system temperature of 502K.  These results also agree with previous molecular 
dynamics studies of pre-inserted Aβ which show either partial or full removal of a 
transmembrane Aβ from a DPPC bilayer over simulation time due to favorable 
interactions of Aβ with the interfacial region (69, 136, 138) of the bilayer.  Further, 
previous experimental work (85) has observed favorable interactions of Aβ with the 
interfacial region of the bilayer both in full length Aβ and Aβ fragments. 
  
The results of these replica exchange molecular dynamics simulations provide 
significant insight towards the role of cell membranes in Aβ aggregation.  While the 
bilayers used in this study are only simplified models of the complex lipid and cholesterol 
mixtures that cellular membranes are composed of, these model bilayers do provide an 
appropriate system for testing Aβ-bilayer interactions on the atomic levels available to 
molecular dynamics simulations.  Further, even though the replica exchange techniques 
used in this work do improve upon sampling of the conformational free energy surface of 
Aβ when bound to the bilayer, there are still limitations to the ability of MD to overcome 
significant free energy barriers over the course of a simulation.  It is unknown, solely 
from this work, if Aβ is able to fully explore its conformational space over the 
temperature range and time scales adapted for this study and it is likely that large barriers 
do exist which prevent our study from being able to fully explore this surface over 
reasonable simulation timescales.  Nevertheless, in comparison to previous replica 
exchange simulations (28, 29, 121, 123-125) of the Aβ peptide in solution with similar 
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temperature ranges and timescales that show significant peptide flexibility, the motion of 
the Aβ peptide is severely retarded when bound to the bilayer surface.  This comparison 
between similar replica exchange studies of Aβ in solution and on the bilayer surface 
implies that Aβ interactions with the bilayer surface substantially affect Aβ dynamics in 
comparison to Aβ dynamics in solution.   
 
Further, the results of this work imply that the role of the bilayer in Aβ 
aggregation may be multi-fold, as has been previously postulated (4, 5, 66).  First, due to 
the strong binding of Aβ to the bilayer surface, Aβ peptides will accumulate on the 
surface of the bilayer.  This will transiently increase local peptide concentration and 
increase diffusion by limiting motion to two dimensions, which will speed up aggregation 
in comparison to aggregation rates in solution.  Next, when bound to the anionic bilayer, 
the local pH will drop.  As has been observed in vitro, Aβ aggregation rates increase in 
solution at lower pH (62) and the same pattern may hold on the bilayer surface.  Finally, 
the results imply that the hydrophobic section of Aβ is more exposed and accessible on 
the bilayer surface, which will promote protein-protein interactions through mutual 
hydrophobic regions of adjacent Aβ monomers that will drive the earliest stages of 
aggregation.  However, these results do not observe any significant structure formation of 
the monomeric Aβ peptide on the surface of the bilayer, which had been postulated as 
playing a role in the increased aggregation rate due to lipid interactions.  Our results 
predict that the strongly promoted secondary structure formation in Aβ when mixed with 
lipids observed in experiment is likely due to the peptide-peptide interactions that are 
greatly enhanced by interactions with the bilayer.  Thus, experimental studies using 
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highly precise methods for determining Aβ structure both in monomer and small 
oligomer (dimer, trimer, tetramer) form when bound to a lipid surface will be necessary 
to determine where the secondary structure formation observed previously is originating.  
Further, future all-atom or coarse-grain MD studies using a similar replica exchange 
setup employed in this work with multiple Aβ peptides bound to a bilayer in which direct 
peptide-peptide interactions and potential secondary structure change are followed would 
also be very insightful for determining if protein-protein interactions are the cause of the 
secondary structure change seen in experiment during Aβ aggregation near a membrane 
surface. 
 
Conclusions 
 
 In this work, replica exchange MD simulations were performed on all-atom 
representations of the 42 amino acid Aβ peptide on model lipid bilayers using novel 
restraints to maintain bilayer integrity at high temperatures.  The replica exchange 
simulations appear to be well mixed and allow for significant conformational freedom for 
the peptide on the bilayer surface in comparison to MD simulations previously performed 
at 323K (138).  The results of these simulations show that no stable secondary structure if 
formed by the Aβ monomer at either pH7 or pH5 when bound to the homogeneous DPPC 
or DOPS bilayers.  A salt bridge between Asp23 and Lys28, which may play a significant 
role in Aβ aggregation, is formed on the DOPS bilayer when the peptide has a net neutral 
charge, and the formation of the salt bridge imposes a β-hairpin like structure on the 
peptide.  However, this salt bridge is not stable and this secondary structure is not 
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maintained due to the extensive peptide-lipid interactions that are precluding the 
intrapeptide interactions necessary for stable secondary structure.  In particular, Lys28 
substantially interacts with the phosphate moiety and glycerol backbone of the lipid, 
which stabilizes protein binding to the lipid even at 502K.  It appears, from these results, 
that the strong lipid-protein interactions which force the tight binding of Aβ to the bilayer 
surface also prevent the internal interactions which would promote the secondary 
structure change observed during Aβ aggregation in experiment. 
 
 The results of this work raise interesting questions regarding the earliest stages of 
Aβ aggregation near the bilayer surface.  Experimental techniques have observed 
significant β-structure formation when Aβ is incubated with anionic lipid.  Our 
observations tend to indicate that this β-structure formation is not due to structuring at a 
monomer level but is potentially due to peptide-peptide interactions that are enhanced on 
the bilayer surface.  Further, the lack of secondary structure for monomeric Aβ bound to 
the bilayer surface may also shed some insight into the large diversity of oligomers that 
have been observed during Aβ aggregation.  As the Aβ monomer is more extended in its 
membrane-bound, unstructured form, aggregation on the bilayer surface may lead to 
oligomer structures that are less compact then oligomers observed in solution.  In the 
least, oligomers formed on the bilayer surface should be less structured then oligomers in 
solution that are forced to have a more compact, ordered structure due to interactions 
with water.  Our work demonstrates that interactions with a membrane significantly 
effects structural dynamics of the Aβ monomer in comparison to Aβ in solution, which 
may in turn considerably alter the pathway of Aβ aggregation near the cell membrane. 
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TABLE 3.1  Contents of the initial conditions for replica exchange simulations. 
 Simulations on DPPC - 6.4nm x 6.4nm x 15.8nm box 
Aβ pH DPPC SPC/E Na+ Cl- 
pH7 128 14764 27 24 
pH5 128 14762 24 24 
 
Simulations on DOPS - 6.4nm x 6.4nm x 16.1nm box 
Aβ pH DOPS SPC/E Na+ Cl- 
pH7 128 15083 155 24 
pH5 128 15081 152 24 
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TABLE 3.2  Temperatures for all replicas used in replica exchange simulation. 
Replica Temperature (K) Replica Temperature (K) 
1 325.00 43 407.85 
2 326.81 44 410.01 
3 328.63 45 412.17 
4 330.45 46 414.35 
5 332.29 47 416.53 
6 334.13 48 418.72 
7 335.97 49 420.92 
8 337.82 50 423.13 
9 339.69 51 425.35 
10 341.56 52 427.58 
11 343.44 53 429.82 
12 345.32 54 432.07 
13 347.22 55 434.33 
14 349.12 56 436.59 
15 351.03 57 438.87 
16 352.94 58 441.16 
17 354.87 59 443.44 
18 356.80 60 445.75 
19 358.75 61 448.06 
20 360.69 62 450.39 
21 362.65 63 452.72 
22 364.62 64 455.07 
23 366.59 65 457.42 
24 368.58 66 459.79 
25 370.57 67 462.22 
26 372.57 68 464.61 
27 374.57 69 467.01 
28 376.59 70 469.40 
29 378.62 71 471.81 
30 380.65 72 474.24 
31 382.69 73 476.65 
32 384.74 74 479.09 
33 386.80 75 481.55 
34 388.87 76 484.02 
35 390.94 77 486.50 
36 393.02 78 488.99 
37 395.10 79 491.24 
38 397.21 80 493.74 
39 399.32 81 496.27 
40 401.44 82 498.78 
41 403.57 83 501.32 
42 405.70  
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Figure 3.1  Initial structure of pH7 Aβ peptide on DPPC bilayer.  Solvent and ions were 
removed for clarity. 
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Figure 3.2  Time series of temperature exchange for replica starting at 325K for the pH7 
Aβ peptide on a DPPC bilayer. 
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Figure 3.3  Secondary structure for each residue at 325K for the discontinuous 
simulations of (a) pH7 Aβ on the DPPC bilayer, (b) pH7 Aβ on DOPS bilayer, (c) pH5 
Aβ on the DPPC bilayer and (d) pH5 Aβ on the DOPS bilayer.  The secondary structure 
calculations are for the full 80ns simulations for pH7 Aβ and the full 110ns for pH5 Aβ.  
Secondary structure readout was produced using DSSP within GROMACS.   
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Figure 3.4  (a) Secondary structure for pH5 Aβ on the DOPS bilayer for the 
discontinuous simulations at 325K from 75ns to 81ns of simulation time.  (b) Aβ 
structure at timepoints of 77.805ns and 78.363ns showing the average protein structure.  
Residues Asp23 and Lys28 are shown in space filling mode.  (1) and (2) on the snapshots 
are labels for the salt bridge that could be formed between these residues.  (c) Plot of the 
distance between the Cγ of Asp23 and Nζ of Lys28 over simulation from 75ns to 81ns.  
The labels (1) and (2) on the plot represent the Asp-Lys distance shown in the snapshots 
from (b).   
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Figure 3.5  Density distribution of Aβ on DPPC or DOPS bilayer at 325K.  The Abeta - 
Charged density distribution represents residues 1-23 of the Aβ peptide while the Abeta – 
Hydrophobic density distribution represents residues 24-42.  The phosphate density 
distribution represents the distribution of P8 atoms on the individual DPPC or DOPS 
lipids within the bilayer. 
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Figure 3.6  Plots of contact score between Aβ and the bilayer during the replica 
exchange simulation at 502K.  The contact score was calculated so that a given residue 
had a contact value of 1 if any atom of the residue was within 5Å of the average center-
of-mass of the 64 phosphate atoms on the leaflet of the bilayer closest to the peptide.  The 
contact value was zero if there were no atoms within 5Å of the phosphate center-of-mass.  
As Aβ is 42 amino acids long, the contact score can range from 0 to 42. 
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Abstract  
 
 As research progresses towards understanding the role of the amyloid-β (Aβ) in 
Alzheimer’s disease, certain aspects of the aggregation process for Aβ are still not clear.  
In particular, the accepted constitution of toxic aggregates in neurons has shifted towards 
small oligomers.  However, the process of forming these oligomers in cells is still not 
fully clear.  Even more interestingly, it has been implied that cell membranes, and, in 
particular, anionic lipids within those membranes, play a key role in the progression of 
Aβ aggregation, but the exact nature of the Aβ-membrane interaction in this process is 
still unknown.  In this work, we use a thermodynamic cycle and umbrella sampling 
molecular dynamics to investigate dimerization of the 42-residue Aβ peptide on model 
zwitterionic dipalmitoylphosphatidylcholine (DPPC) or model anionic 
dioleoylphosphatidylserine (DOPS) bilayer surfaces.  We determined that Aβ 
dimerization was strongly favored through interactions with the bilayer.  Further, our 
calculations showed that the DOPS bilayer promoted Aβ release upon dimerization, 
while DPPC favored tight dimer binding.  By promoting dimer formation and subsequent 
dimer release into the solvent, the DOPS bilayer acts as a catalyst in Aβ aggregation 
through converting Aβ monomers in solution into Aβ dimers in solution without 
substantial a free energy cost. 
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Introduction 
 
 Aberrant protein aggregation and function are the hallmark of a variety of 
neurodegenerative disorders found in humans.  In Alzheimer’s disease, the neural 
degeneration that characterizes this disease has been linked to the aggregation of the 
amyloid-β (Aβ) peptide, among other potential aggregate species in neurons (3, 11, 12, 
40, 45, 154).  Because of this direct link between properties of the Aβ peptide and 
progression of Alzheimer’s disease, the Aβ peptide has been at the center of extensive 
biological research over the last 30 years (3, 11, 12, 40).  In particular, both experimental 
(4, 5, 57-59, 81, 82, 85, 87, 91, 95, 157, 184) and computational (27-29, 69, 74, 121-139) 
biophysics approaches have focused on this peptide.  Along with many other aspects of 
Aβ function and activity, the underlying processes connected to Aβ aggregation have 
been of substantial interest to researchers.  A more thorough and clearer understanding of 
the aggregation pathway from Aβ monomer to full Aβ fibril is considered to be crucial to 
development of any targeted therapeutic against this aspect of Alzheimer’s disease. 
 
 As our understanding of the aggregation pathway of Aβ has progressed, our view 
of Aβ toxicity in Alzheimer’s disease has evolved (4, 5, 10, 37).  Initially, it was believed 
that full Aβ fibrils or possibly protofibrils were the toxic species in Alzheimer’s disease.  
However, further investigation into this process shifted the focus from full fibrils to Aβ 
oligomers as the toxic species in neurons (4, 5, 37).  Research has shown that these 
oligomers were able to disrupt cell function and also disrupt homeostasis across the cell 
membrane (10, 52, 98, 157, 185).  Further, it has been postulated that these oligomers 
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could form ion channels that would allow unregulated flow of ions such as calcium 
across the cell membrane (79, 98, 185, 190).  Recent work has also shown that amyloid 
fibrils are not harmless but can act as reservoirs of oligomers that can be released if the 
fibrils are placed under stress (35, 36).  Another interesting aspect of this system is the 
underlying structure of oligomers and fibrils. Aβ monomers have been shown to be 
mostly random coil in solution (26, 27) with some transient β-sheet or α-helical structure.  
The Aβ monomer structure can be altered by placing the protein in different 
environments, promoting either a α-helical or predominantly β-sheet structure (191).  
However, for Aβ oligomers, the predicted structures of Aβ units are not as clear.  The 
structures of Aβ oligomers have been shown to be highly variable (52-56).  Structures 
that are fibril-like have been observed (55, 56), as well as completely amorphous 
structures (52-56), or cylindrical structures inserted in cell membranes (74, 79, 80).  
Thus, it is expected that Aβ oligomer formation is highly heterogeneous and that ordered 
structure for Aβ is not locked until the protein begins to aggregate into a fibril.  Even at 
the fibril level, there is substantial heterogeneity both on the scale of the fibril as a whole 
(50, 51), considering the size and shape of the fibril, and the predicted underlying 
structure of the Aβ units within a fibril (46-49).  Thus, a better understanding of the 
physical processes that dictate Aβ oligomerization and impart such a heterogeneous class 
of structures to the smallest oligomeric units is essential. 
 
 Aβ is a 38-43 amino acid cleavage product of the transmembrane Amyloid 
Precursor Protein (3, 11, 12).  Thus, the Aβ peptide contains significant portions of 
hydrophobic and hydrophilic residues and shows favorable interactions with cell 
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membranes (4, 5, 57-59, 81-83, 87, 91, 95, 157).  Further, the phenomena dictating the 
earliest stages of Aβ oligomerization are still not clear.  While experimental work is able 
to replicate most aspects of in-vivo Aβ aggregation with in-vitro methods, these studies 
still require orders-of-magnitude higher Aβ concentrations to match the aggregation rate 
of Aβ in cells (58, 82).  While many physical attributes of the system, such as cellular pH 
(62), salt concentration (63), and oxidation of methionine and other residues (64), may 
play a role in promoting Aβ aggregation in vivo, interactions with cell membranes have 
been postulated to assist in this process.  Cell membranes can affect peptide aggregation 
through direct electrostatic, hydrophobic or hydrogen bonding interactions with residues 
of the peptide (4, 5, 66-68), new partially folded free energy states at the bilayer surface 
(4, 5, 66), faster aggregation rates over a two dimensional lipid surface (4, 5, 66), higher 
transient peptide concentration as proteins are restricted to the surface and, through lower 
surface pH due to the attraction of H+ ions in solution to anionic lipid headgroups (57, 67, 
68).  All of these factors may play a role in Aβ aggregation on the bilayer surface.  
Previous experimental work (4, 5, 57-59, 81, 85, 87, 157) has demonstrated that 
interactions between Aβ peptides and lipid vesicles strongly promote a conversion to an 
amyloid-like structure.  Further research (4, 5, 57-59, 81, 87, 91) has shown that mixing 
anionic lipids with Aβ peptides leads to a substantial increase in aggregation rate.  
Finally, extensive interactions with cell membranes can lead to Aβ pore formation and 
disruption of ion balance across the membrane (74, 79, 80, 185).  While these results 
demonstrate the importance of protein-lipid interactions in Aβ aggregation, one 
shortcoming of these methods is the lack of resolution that results from the low 
concentration of Aβ necessary to prevent substantial aggregation during the experiment.  
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Thus, it is unclear what the aggregation state of Aβ is during these investigations using 
cell membranes.  Further work with more detailed methods will be necessary to 
understand the particulars of atomic-level interactions during Aβ aggregation at the 
membrane surface. 
 
 Towards this end, we use molecular dynamics (MD) simulations to study the 
earliest step in Aβ aggregation: formation of a dimer.  Computational studies have been 
used with great success to study Aβ structure at the monomer (27-29, 54, 69, 121, 123, 
124, 126-128, 130, 132, 135-139), small oligomer (54, 122, 125-127, 131-133, 135), and 
fibril level (129, 134, 135), using either full-length Aβ (27-29, 69, 121, 122, 125, 131, 
133, 135-139) or Aβ fragments (54, 123, 124, 126-130, 132, 134, 135).  These studies 
have used all-atom (27-29, 54, 69, 121-125, 127-130, 133-139) and coarse-grained (126, 
131, 132) techniques in various explicit (27, 29, 54, 69, 123, 124, 127-131, 133, 136-139) 
or implicit (28, 121, 122, 125, 126, 132, 134, 135) solvents to understand this system.  
More recent works use advanced computational techniques such as replica exchange for 
even more encompassing studies (28, 121-125, 132, 135, 139).  However, the extent of 
computational research (69, 74, 80, 136-139, 141) on Aβ-lipid interactions is more 
restricted.  Most research that has been previously performed on an Aβ-lipid system has 
involved use of Aβ monomers (69, 136-139, 141).  These works have also been heavily 
biased towards studying pre-inserted Aβ over interactions between Aβ and the bilayer 
surface.  Our previous work with this system has investigated both the properties of Aβ 
binding to a model bilayer surface (138) and the structure of Aβ on the bilayer surface 
(139).  Nevertheless, it is of upmost importance to begin to expand these studies to the 
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small oligomer structure of Aβ.  Work has been done towards predicting Aβ pore 
structure within the bilayer (74, 80), but there is a substantial dearth of investigations in 
the specific interactions between Aβ and the surface of cell membranes that may promote 
Aβ dimerization.  Recent works (52, 53) have demonstrated the fundamental role that the 
Aβ dimer plays as a unit of Aβ aggregation.  A more complete understanding of the 
physical processes that dictate Aβ dimer formation at the cell surface is necessary to fully 
appreciate Aβ aggregation.  In this work, we use a thermodynamic cycle to calculate the 
free energy of dimerization on a model lipid bilayer for two specific Aβ dimers.  The 
results of this work, including comprehensive information gleaned from each process of 
the thermodynamic cycle, provide molecular level details of Aβ aggregation that can be 
utilized towards a greater understanding of the earliest stages of aggregation and the toxic 
role of cell membranes in this process. 
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Materials and Methods 
Initial Dimer Structures   
 For the calculations presented in this work, two initial dimer structures were 
selected.  These two structures are termed the “extended” and “hairpin” structures 
throughout the paper.  Both structures are derived from possible configurations of 2 Aβ 
units within a full fibril structure.  All Aβ structures used in this work are the 42 residue 
peptides.  The structure of Aβ peptides within a fibril is still controversial as there 
appears to be a significant amount of heterogeneity in fibril structure (46, 47, 49).  .  The 
extended dimer represents a separate dimer unit that has been observed within fibrils (46) 
where two C-terminal units of adjacent Aβ peptides are shared in an antiparallel structure 
with non-interacting N-termini.  As a crystal structure for the fibril did not exist at the 
time of these simulations, an idealized structure was manually created from a 42 residue 
monomer unit within the 2BEG (49) NMR structure.  To create the extended C-terminal 
region, the monomer was placed in a vacuum and a constraint was placed between 
residue 17 and residue 42 of the peptide.  GROMACS 4.0 (143, 145, 186) was used to 
increase the length between these residues to 7.0nm along the x-axis.  A second monomer 
was created by translating and rotating the first monomer and the two monomers were 
placed in the appropriate position to create an idealized, antiparallel extended dimer, as 
shown in Figure 4.1a.  The hairpin dimer represents what is believed to be the more 
consensus structure for a dimer unit within a fibril.  The hairpin unit is taken as two 
monomers from the Protein Database (PDB) code 2BEG fibril structure (49) as edited to 
include the full N-terminal residues as described in our previous work and pictured in 
Figure 4.1b of that work (138).  In order to create the ideal hairpin dimer structure, we 
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added the appropriate N-terminal residues to a monomer from the 2BEG structure, then 
spaced two 42 residue Aβ monomers to exactly reproduce a 2 unit structure from within 
the 2BEG file (Figure 4.1b).  For all structures used in this work, the N-terminus was 
represented by NH3+ and the C-terminus was represented by COO-.  Further, a united 
atom GROMOS96 forcefield (143, 145, 186) was used in all calculations to represent the 
dimer. 
 
 As mentioned in our previous works (138, 139), anionic lipids are able to 
decrease the local pH near the bilayer surface due to attraction of H+ ions from solution to 
the headgroups at the bilayer surface (57, 68).  For Aβ it has been shown that binding of 
the peptide to a purely anionic palmitoyloleoylphosphatidylglycerol membrane is 
sufficient to protonate the three histidine residues on Aβ (57).   At a physiological pH, 
Aβ has a net charge of -3.  However, upon binding to anionic lipids, the protonation of 
these three key histidine residues changes the net charge to neutral.  Thus, it is important 
to study Aβ at both the charged and neutral states.  We repeated the above procedure for 
dimer creation for both the charged and neutral states of Aβ.  The charge on the histidines 
was changed using utilities within GROMACS (143, 145, 186).    
 
 Once the idealized dimers were created, it was clear that they were unlikely to be 
stable in their ideal structures and required significant equilibration.  Both dimers were 
solvated in a large box of SPC/E water molecules (173), a steepest descent energy 
minimization was used to remove clashes in the system, and a short 8ns MD simulation 
was performed under constant pressure (NPT) conditions to equilibrate the structure.  For 
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the charged system, 6 Na+ ions were added for charge neutrality.  For the neutral system, 
no ions were added.  After the short equilibration, a full 150ns MD simulation was 
performed under the same conditions in order to compare the stability of these idealized 
structures in solution versus on the bilayer surface during equilibration.  For these 
simulations and all future simulations, including the umbrella sampling simulations, 
temperature was held constant at 323K using a Nosé-Hoover scheme (171) with a 
relaxation time of 0.5ps.  All bonds were constrained using the P-LINCS algorithm (187).  
For the full MD steps during all production runs, both during equilibration and umbrella 
sampling, this constraint allowed for a 3ps time step.  Long-range electrostatics used the 
SPME algorithm (146) with periodic boundary conditions applied in all three dimensions.  
SPC/E water (173) was used for all simulations.  For the systems described under NPT 
conditions, a Parrinello-Rahman pressure coupling scheme (175) was used with a barostat 
relaxation time of 0.5ps at a pressure of 1atm.  For all umbrella sampling simulations, a 
constant volume (NVT) constraint was used.  If the system was not specifically described 
as being under NPT conditions, then the system was under a constant volume (NVT) 
constraint.  Secondary structure during the full MD simulations in solution was calculated 
using the DSSP algorithm (174) with GROMACS. 
 
Thermodynamic Cycle Calculations   
 The goal of this work is to study Aβ dimerization on the bilayer surface.  As 
described in more detail in the Discussion section, direct calculation of this value through 
umbrella sampling MD simulations would be exceptionally cumbersome and fraught with 
potential sources of error.  Thus, we have decided to use a thermodynamic cycle to 
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calculate this dimerization free energy indirectly.  As demonstrated in Figure 4.2, we are 
able to calculate a value for ΔGDimerization through use of the relationship: 
2*ΔGBinding + ΔGDimerization + ΔGRelease + ΔGDissociation = 0     (4.1) 
As long as the final structures for the dimer dissociation process results in two 
equilibrated, non-interacting monomers in solution, the above relationship should hold.  
The values for ΔGBinding were calculated for an equilibrated Aβ monomer in a previous 
work (138).  Further, values for ΔGRelease and ΔGDissociation can be calculated directly using 
umbrella sampling techniques (147, 148).  The process of dimer release and dimer 
dissociation does not have as significant of sources of error as the direct calculation of 
ΔGDimerization.  Thus, the use of this thermodynamic cycle allows us to study the 
dimerization of Aβ using a more accurate technique considering the current restrictions 
of computational power available today.  Of note, the dimerization free energy is being 
calculated for only two specific dimer structures.  This choice was made so that we could 
directly investigate how properties of the dimer structure affect the oligomerization 
process.  Thus, the value of ΔGDimerization calculated in this work is not a generic 
dimerization free energy, as would be expected in experiment, but a specific dimerization 
free energy for a idealized structure at a given charge state. 
 
Dimer Equilibration on the Bilayer Surface   
 In order to perform the umbrella sampling simulations required for our 
thermodynamic cycle calculations (Figure 4.2), it was necessary for the dimer structures 
to be extensively equilibrated on the bilayer surface.  For the dimer release step of the 
cycle, the initial structure should be a well-equilibrated, specific dimer structure on the 
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bilayer surface.  Structures for the dimers after the short 8ns equilibration in solution 
were used for the initial structures for equilibration on the bilayer surface.  In our 
previous work (138, 139), we used a 128-lipid bilayer system.  However, because the 
dimer is larger, we decided to use a 200-lipid system for this study in order to prevent 
virtual interactions through the periodic boundaries along the bilayer surface.  For a 
model zwitterionic system, we used a dipalmitoylphosphatidylcholine (DPPC) bilayer 
and, for a model anionic system, we used a dioleylphosphatidylserine (DOPS) bilayer.  
DPPC was chosen as the zwitterionic system due to its preponderance both in neurons 
(96) and in simulation studies (178) and DOPS was chosen in part because of its 
importance to biology (99), but also because of a similar area per headgroup value to 
DPPC.  As we are studying protein-lipid interactions at the bilayer surface, area per 
headgroup is an important physical parameter with regards to charge density.  These 
same lipids were used for our previous investigations, so bilayer equilibration was 
exactly as described in a previous work (138, 176).  Both lipids were described using the 
Berger force field parameters (176).   
 
 Starting with both the equilibrated bilayer and equilibrated dimer structures, the 
dimer was solvated and placed at a distance away from the bilayer surface.  Only the 
charged dimer was used in simulations with DPPC and only the neutral dimer was used 
in simulations with DOPS.  This pairing created 4 initial conditions:  charged Aβ/DPPC 
for the extended and hairpin dimers and neutral Aβ/DOPS for the extended and hairpin 
dimers.  For the charged Aβ/DPPC system, 30Na+ and 24Cl- ions were added to 
approximate a 0.1M NaCl system.  For the neutral Aβ/DOPS system, 224Na+ and 24Cl- 
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ions were added.  The extra 200 Na+ ions were necessary to counteract the charge on the 
DOPS lipids and were already included in the equilibration process for the DOPS bilayer.  
A more detailed description of exactly how a similar system was built using an Aβ 
monomer instead of Aβ dimer is provided in a previous work (138).  After the system 
was built and energy minimization was applied, a short 500ps simulation was performed 
under NPT conditions to allow the peptide-bilayer system to reach a transient 
equilibration.  Because of the constraints that the bilayer surface places on building a 
peptide-bilayer system, the dimer was originally placed in solution at approximately 2nm 
above the bilayer surface.  A 4ns equilibration under NVT conditions was then performed 
with an umbrella constraint placed between the dimer center of mass and bilayer center of 
mass.  This equilibration forces the dimer to bind to the bilayer surface without creating 
any significant clashes.  For the simulations on DPPC, the constraint minimum was at a 
center of mass separation of 2.1nm while, with DOPS, the constraint minimum was at 
2.4nm.  A force constant of 500 kJ/(mol*nm2) was used.  After the 4ns simulations with 
the constraint, the umbrella constraint was removed and another 4ns equilibration 
simulation was performed.  Once these equilibration steps were finished, the dimer was 
strongly bound to the bilayer surface.  However, the dimer had not been given adequate 
time to reach equilibration on the bilayer surface.  The equilibration under NVT 
conditions was then extended for another 150ns to allow for an extensive dimer 
equilibration.  The secondary structure of the dimer during equilibration was calculated 
using the DSSP algorithm. 
 
 
125 
Dimer Release from the Bilayer Surface   
 To calculate the free energy for dimer release from the bilayer surface, an 
umbrella sampling procedure (147, 148) was utilized.  Umbrella sampling allows us to 
directly calculate this free energy while providing full MD trajectories within each 
umbrella that are available in order to understand the dimer removal process in a stepwise 
fashion.  We initially attempted to pull the equilibrated dimer from the bilayer surface 
using the final structure of the 150ns dimer equilibration on the bilayer surface.  
However, upon placing a constraint on the dimer and removing the dimer from the 
surface, strong protein-lipid interactions led to significant bilayer disruption.  To 
overcome this issue, we decided to model dimer release as the negative free energy of 
dimer binding.  Using enough umbrellas and a long enough MD simulation within each 
umbrella, dimer binding should be similar to dimer release with regards to the potential 
of mean force profiles calculated using the Weighted Histogram Analysis Method 
(WHAM) (150).  As long as the initial dimer structure is the same as the equilibrated 
dimer on the bilayer surface, the dimer will not have enough time during the quick 
pulling process for any substantial internal motion to change the equilibration it shared 
with the bilayer.  The dimer structure from the final snapshot at the end of the 150ns 
equilibration on the bilayer surface was used for this process.  Similar to the procedure 
for initially creating the dimer-bilayer system, the dimer was placed at a significant 
distance away from the pre-equilibrated lipid bilayer and solvated with SPC/E water and 
either 30Na+/24Cl- (charged Aβ) or 224Na+/24Cl- (neutral Aβ) ions.  After energy 
minimization, a short 4ns equilibration was performed under NVT conditions with an 
umbrella restraint between the dimer center of mass and bilayer center of mass.  For the 
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charged/DPPC systems, the constraint minimum was 7.0nm and, for the neutral/DOPS 
system, the constraint minimum was at 8.0nm.  This constraint was necessary during the 
equilibration to prevent any dimer-bilayer interactions.  Once the system was 
equilibrated, umbrella sampling could be performed. 
 
 For umbrella sampling, the reaction coordinate used for the pulling process was 
the dimer – bilayer center of mass separation.  Thirteen windows were placed between 
center of mass separations of 1.8nm to 6.9nm along the reaction coordinate.  This results 
in a 0.3nm distance between windows, which allowed for adequate sampling in our 
previous umbrella sampling calculations (138).  A spring constant of 500 kJ/(mol*nm2) 
was placed on each center of mass separation.  Starting from the same initial condition, 
150ns MD simulations were performed within each window.  In our previous work (138) 
investigating Aβ monomer binding to lipid bilayers, 80ns simulations were performed in 
each window.  However, because of the larger size of the dimer and the use of a larger 
bilayer, the lengths of MD simulations performed within each window were extended to 
improve upon sampling.  Within each window, analysis was performed using either 
GROMACS code or the DSSP algorithm within GROMACS.  Once the MD simulations 
within each window were finished, a potential of mean force was calculated using the 
WHAM methodology adapted for in-house code.  The potential of mean force curves 
calculated for this process are given in Figure 4.4a.  The difference between the minimum 
and maximum on the potential of mean force curve are given in Supplementary 
Information.  Further, block error analysis was used to calculate the error in this process.  
Using the charged Aβ/DPPC system for the extended dimer, the error converged to 
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7.0kcal/mol after separating the system into 40 blocks.  While this error appears to be 
rather large, it is similar to the error calculated for Aβ monomer binding to the bilayer 
surface.  For both procedures, the error is 25% of the value calculated for the minimum-
maximum separation on the potential of mean force curve.  Further, a ΔGRelease could be 
calculated from the potential of mean force curve as described previously (192).  In short, 
the following equation was used for this calculation, where W(z) represents the potential 
of mean force curve: 
€ 
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∫       (4.2) 
In obtaining ΔGRelease, l0 was determined as the reaction coordinate value where the 
potential of mean force reached a value of zero once appropriate shifting of the potential 
of mean force curves was performed.  However, in performing these calculations, we 
observed that the values for ΔGRelease were resistant to the value chosen for l0; thus, 
ΔGRelease was fairly robust.  Values for ΔGRelease are provided in Table 4.1.  Also, since the 
values that were reported in our previous work (138) for ΔGBinding were the difference 
between the minimum and maximum values of the potential of mean force curves, we 
recalculated ΔGBinding from these curves using equation 4.2.  These values are also 
reported in Table 4.1.  Comparing these ΔGBinding values to the values reported in the 
previous work (138), it is clear that there is not a significant difference between the two 
values and all patterns presented in the previous work hold for ΔGBinding. 
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Dimer Dissociation   
 To calculate the final necessary step in the thermodynamic cycle, umbrella 
sampling simulations were performed to approximate the dimer dissociation process.  For 
these simulations, it was necessary to separate the two monomers from a well-
equilibrated dimer in solution and allow the two monomers to reach equilibration in 
solution without interacting.  Due to the procedure used in the dimer release calculations, 
a well-equilibrated dimer in solution was already available.  The final dimer structure 
from the 6.9nm center of mass separation umbrella after 150ns of MD simulation was 
isolated and used as the initial structure for the dimer dissociation calculations.  The 
isolated dimer was solvated in a large box of SPC/E water with either 30Na+/24Cl- 
(charged Aβ) or 24Na+/24Cl- (neutral Aβ) ions.  Again, this procedure was repeated for 
both the extended and hairpin dimers, creating 4 initial conditions for umbrella sampling.  
Further, the water box was quite large (12.0 nm) along the z-axis, which was the chosen 
axis for the reaction coordinate, to prevent the monomers from interacting through 
periodic boundaries.  After energy minimization, a short 1ns MD simulation was 
performed to allow the system to come to equilibration.  After equilibration, umbrella 
sampling was performed.  For the reaction coordinate of this system, the center of mass 
separation along the z-axis of the box was chosen.  This coordinate ensured a final system 
of two separated, non-interacting monomers.  Twenty umbrellas were placed between 
center of mass separations from 0.1nm to 5.8nm, providing a separation of 0.3nm 
between umbrellas.  A spring constant of 500 kJ/(mol*nm2) was placed on each center of 
mass separation.  For the neutral Aβ hairpin dimer system, an extra umbrella was added 
at 6.1nm to provide further data for the largest center of mass separations.  Within each 
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umbrella, 150ns of MD simulations were performed.  Similar to the dimer release step, 
analysis was performed using GROMACS utilities and potential of mean force curves for 
dimer dissociation wers calculated using WHAM adapted for in house code.   The 
potential of mean force curves are provided in Figure 4.3b, the difference between the 
minimum and maximum values of the potential of mean force are provided in 
Supplementary Information, and the ΔGDissociation, calculated using equation 4.2, is given 
in Table 4.1.  The error in the potential of mean force curves for dimer dissociation was 
calculated in the same manner as for the dimer release step, using the charged Aβ 
extended dimer to calculate an error of 5.0 kcal/mol.  Similar to the binding and release 
steps, this was close to an error of 25%.  Finally, ΔGDimerization was calculated from 
equation 4.1 and provided in Table 4.1.  
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Results 
Equilibration Simulations   
 As described in the Methods section, two initial dimer structures (Figure 4.1) 
were used to calculate a specific dimerization free energy for each Aβ dimer on the 
bilayer surface.  The first of these structures, the extended dimer (Figure 4.1a), represents 
shared C-termini between two Aβ monomers as predicted from electron microscopy data 
(46).  The other structure, the hairpin dimer (Figure 4.1b), represents two monomer units 
from within an Aβ fibril as determined by x-ray crystallography (49).  Thus, intense 
equilibration is necessary in order to bring each structure to an equilibrated state on the 
bilayer surface from which our thermodynamic cycle calculations could begin.  Initially, 
each structure was equilibrated in solution for a short time to remove any clashes due to 
the placement of each monomer in the dimer.  Then, the dimer was placed on the surface 
of a model lipid bilayer and 150ns MD simulations were performed.  These simulations 
allowed the dimer adequate time to equilibrate to the bilayer environment with the 
intention that this long equilibration time will reduce the bias due to initial conditions in 
the free energy calculations for removal of the dimer from the bilayer surface.   
 
 However, aside from just equilibration, these 150ns simulations provided an ideal 
opportunity to study the stability of the idealized dimer structures on the bilayer surface 
versus in solution.  Along with the 150ns equilibration on the bilayer surface, we also 
continued the short equilibration in solution for an analogous 150ns.  By comparing the 
evolution of the dimer secondary structure over these equilibration events, it is possible to 
study the stability of these specific, ideal dimer structures in either environment.  
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Representative plots of the DSSP secondary structure readout are given in Figure 4.3.  As 
can be seen for all four plots shown, the dimer structure is not exceptionally stable and 
does tend to fluctuate in all cases.  In comparing the extended charged dimer in solution 
(Figure 4.3a) versus on the surface of a DPPC bilayer (Figure 4.3b), it is clear that the 
dimer in solution maintains its structure to a greater extent then the dimer on the bilayer 
surface.  It appears that the only secondary structure feature that is maintained throughout 
both simulations is the turn on the second monomer approximately near residue 20 
(residue 62 on the plots).  In solution, a much stronger beta sheet region is formed 
between residues 30 and 40 on both monomers.  For the extended dimer structure, this 
represents the region of overlap between the two monomers, where the monomers can 
strongly interact with each other.  When this dimer is in solution, the almost entirely 
hydrophobic section of each monomer preferentially interacts with the other monomer 
over being fully exposed to the solution, thus forcing the more stable secondary structure.  
However, when bound to the surface of DPPC, the hydrophobic C-terminus of each 
monomer can preferentially interact with the interfacial region of the lipid bilayer, thus 
providing favorable options outside of protein-protein interactions for each monomer, 
which decreases the stability of the dimer secondary structure.  For residues 1-20 of both 
monomers, which are more hydrophilic and are not able to undergo interprotein 
interactions between monomers due to the geometry of the dimer, the residues are mostly 
unstructured in either environment.   
 
 Figures 4.3c and 4.3d demonstrate the secondary structure comparison for the 
uncharged hairpin dimer in solution versus on the surface of the DOPS bilayer.  Similar 
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to the extended dimer, the presence of the lipid bilayer alters the stability of certain 
elements of secondary structure.  Unlike the extended dimer, all regions of the hairpin 
dimer are able to undergo interprotein interactions as the two monomers are stacked on 
one another.  In comparing dimer stability in the two environments, it is clear that β-sheet 
structure is stabilized to some extent both in solution and on the bilayer surface.  In both 
environments, though, the β-sheet structure does tend to dissipate over time and the 
amount of dimer secondary structure decreases.  This is not surprising as the secondary 
structure of the hairpin is largely derived from the very regular arrangement of Aβ within 
a fibril.  By removing stabilizing interactions on both sides of the dimer unit by removing 
it from a fibril, it would be expected that the peptide would become more disordered.   
Interestingly, in solution, a turn is formed between residues 25-29 in one of the 
monomers that quickly dissipates on the bilayer surface.  It appears that the hydrophobic 
residues in this turn region, such as glycine or alanine, plus the positive charged lysine 28 
begin to interact with aspects of the lipid bilayer that tend to unfold this turn and disrupt 
the dimer structure.  Further, it is also of note that the ordered, stacked β-sheet structure 
is maintained for longer on the bilayer surface.  It is possible that the bilayer acts to 
replace one of the missing surfaces that is lost when the dimer structure was removed 
from the fibril.  From the plots, though, it appears that the bilayer surface is not an ideal 
replacement of the fibril as the β-structure is still largely lost by the end of the 150ns 
simulation.  For all four initial conditions that were investigated, the effects described 
here are consistent.  The comparison of these simulations demonstrates that the lipid 
bilayer does play an interesting role in dimer stability and that neither of these ideal 
dimer structures are fully stable with regards to secondary structure either in solution or 
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on the bilayer surface.  Nevertheless, for all equilibration simulations, the two monomers 
do stay tightly bound to each other during the extent of the equilibrations. 
 
Thermodynamic Cycle Calculations   
 Once the dimers were appropriately equilibrated on the bilayer surface, the 
thermodynamic cycle calculations could be performed, as demonstrated in Figure 4.2.  
The thermodynamic cycle allowed us to calculate a quantity, ΔGDimerization, that would be 
very difficult to calculate directly due to bias created from the choice of reaction 
coordinate for the pulling procedure.  By calculating quantities with more obvious 
reaction coordinates that are less affected by this initial bias, we are able to have more 
confidence in this free energy calculation.  Further, by calculating ΔGDimerization for two 
specific dimers instead of one generic dimer calculation, we can draw more specific 
conclusion regarding the effect of the bilayer on this process.  A more detailed 
description of our logic for using a thermodynamic cycle for these calculations is 
included in the Discussion. 
 
 The results of these calculations are summarized in Table 4.1.  The dimerization 
free energy is calculated using the results as shown in equation 4.1.  The free energies 
presented in Table 4.1 are calculated from the potentials of mean force as described in 
equation 4.2.  The errors presented in the Materials and Methods section are calculated 
using block error analysis from the potentials of mean force on the charged Aβ + DPPC 
free energy calculations for dimer release or the charged Aβ in solution free energy 
calculations for dimer dissociation.  All data for step 1 is taken from a previous work 
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(138).  For a thorough discussion of the monomer binding process, please see our 
previous work (note that Aβ charged is referred to a pH7 and Aβ neutral is referred to as 
pH5 in the previous work).  To better understand the results in Table 4.1, it is best to 
present each step individually and then investigate the calculated dimerization free 
energy. 
 
Dimer Release from the Bilayer Surface   
 The release of the Aβ dimer from the bilayer surface is the third step in our cycle.  
The potentials of mean force calculated for this process are given in Figure 4.4a.  From 
examining both the potential of mean force curves and the calculated free energies, it is 
clear that the largest source of distinction between systems is the charge on the lipid.  For 
the charged peptide on DPPC, the structure of the dimer does not affect the dimer release 
free energy to any extent.  The free energies for release are similar and the shapes of the 
potentials are also similar.  Further, the release free energy of the dimer is quite large, 
implying a very strong attraction of the dimer to the bilayer surface.  It is interesting that 
the magnitude of the release free energy is very close to twice the magnitude of the 
binding free energy of the monomer.  Also, the potential curve for dimer release is 
remarkably similar to the monomer binding curves presented in our earlier work (138).  
This implies that the Aβ dimer is still preferentially interacting with the interfacial region 
of the lipid bilayer and the protein-protein interaction within the dimer is not particularly 
strong.  The minimum of the potential of mean force curve also implies a strong 
interaction with the interfacial region of the bilayer surface.  Thus, as the dimer is 
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removed from the bilayer surface, the peptide-lipid interaction becomes weaker and the 
peptide-peptide interaction becomes dominant in order to retain the fidelity of the dimer. 
 For the neutral Aβ dimer interacting with the DOPS bilayer, the structure of the 
dimer also does not effect the dimer release process.  Both the extended and hairpin free 
energies of dimer release and the potentials of mean force curves are very similar.  
However, in contrast to the calculations on DPPC, the release free energy on DOPS is 
much smaller.  Further, the potential of mean force curves are also more rugged near the 
free energy minimum.  For the calculations on DPPC, there is a sharp drop in potential 
when approaching the minimum on the surface.  Yet, on DOPS, there is no sharp drop in 
the potential and the dimer center of mass can explore approximately anywhere within a 
2nm range of the free energy minimum without a substantial gain in free energy.  All of 
these aspects of the potential of mean force curves imply a weaker interaction between 
the dimer and the bilayer surface.  Also, the location of the free energy minimum 
provides evidence towards a weaker interaction.  While the free energy minimum is 
sharply centered around a dimer-bilayer center of mass separation of 2nm on DPPC, the 
free energy minimum on DOPS is closer to a 3-3.5nm center of mass separation.  A one-
dimensional center of mass separation reaction coordinate can be a very deceiving 
coordinate, but visual inspection and analogies to our previous work (138, 139) do show 
that the DOPS dimer is not strongly interacting with the interfacial region of the bilayer, 
as in the case of the dimer on DPPC, but is only transiently interacting with the head 
group region of the bilayer.  Further, the weak free energy of dimer release demonstrates 
that the DOPS bilayer biases the system towards strong peptide-peptide interactions due 
to weaker protein-lipid interactions.  This is in direct contrast to the strong peptide-lipid 
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and weak peptide-peptide interactions observed on the surface of the DPPC bilayer.  This 
result may have implications for the biological differences in Aβ interactions between 
zwitterionic and anionic lipids as described in more detail in the Discussion section. 
 
 Along with the analysis of the free energies for dimer release and potential of 
mean force curves, we also investigated secondary structure change during the dimer 
release process.  Use of umbrella sampling for free energy calculations provides 150ns 
simulations at a series of dimer-bilayer center of mass separations.  By analyzing 
secondary structure content within each umbrella, we are able to obtain some insight into 
how secondary structure changes as the dimer is released from the bilayer surface.  
Figure 4.5a shows the average β-structure for each of the dimers studied as a function of 
center of mass separation.  For these calculations, β-content is termed as any residue with 
β-bridge or β-sheet structure as determined by DSSP calculation.  From this plot, it 
appears that the amount of β-content slowly increases as the dimer is removed from the 
bilayer surface.  For the charged and neutral extended dimer and the neutral hairpin 
dimer, the average β-content is approximately the same, between 10-20 residues.  For the 
charged hairpin dimer, the average β-content is somewhat higher than the same structure 
with a neutral charge.  However, it is important to note that this average is very 
deceiving.  The average value for β-content does increase as the dimer is pulled from the 
surface, but it is not clear if these averages are due to a population of a few structures 
centered on one average structure or if the average is due to a large range of structures 
over a significant variation in β-content.  To investigate this discrepancy, we calculated 
free energy surfaces as shown in Figures 4.5b and 4.5c.  Figures 4.5b and 4.5c show the 
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free energy surface for either the charged extended dimer (Figure 4.5b) or the charged 
hairpin dimer (Figure 4.5c) as a function of bilayer-dimer center of mass separation and 
the number of β-residues.  What is obvious from these plots is how similar these two 
surfaces are.  In both cases, there are no substantial free energy wells at a given bilayer-
center of mass separation.  Actually, if the value of bilayer-center of mass separation is 
fixed, there appears to be no favored number of β-residues.  This implies that the 
secondary structure content for either the extended dimer or the hairpin dimer is very 
fluid and there is not a “dominant” structure throughout this process.  Also, this 
demonstrates that the apparent slight increase in average β-structure as the dimer is 
removed from the surface is not significant.  It appears that the averages shown in Figure 
4.5a are a numerical value with little physical significance as the average is not 
representative of the expansive population of potential secondary structures available to 
the dimer at any dimer-bilayer center of mass separation.  These results are consistent for 
the dimer release process neutral dimer from the DOPS bilayer as well.  What can be 
concluded from these plots is that neither lipids in bilayer surface or water molecules in 
solution greatly bias the dimer towards a specific secondary structure but allow for 
substantial structural flexibility.  What does appear to effect secondary structure more 
substantially is the dimer structure.  Yet, because of the wide range of available 
secondary structures for both extended and hairpin dimers, it would be difficult to draw 
any strong conclusion.  We also investigated other secondary structure elements, such as 
helix content, as it has been predicted that Aβ can adopt a helical shape when inserted 
near the bilayer interface (69).  However, as the initial dimer structures were heavily 
biased towards β-sheets, the extent of helix structure was negligible and any helix 
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structure that appeared was transient. For the dimer release process, it appears that the 
nature of the lipid headgroup significantly affects the energetics of the release process, 
but does not bias the system towards a favored secondary structure content during 
release. 
 
Dimer Dissociation   
 The fourth step in the thermodynamic cycle involved calculation of the free 
energy required to dissolve the specific Aβ dimer structure in solution, leaving two non-
interacting Aβ monomers.  For this calculation, the final Aβ structure from step 3 at the 
largest bilayer-center of mass separation was used as the initial structure for step 4.  The 
dimer was placed in a water box large enough so that periodic images would not interact 
at the largest monomer-monomer center of mass separation.  Again, as in the dimer 
release calculation, umbrella sampling was used to calculate the potential of mean force 
curves (Figure 4.4b) and the ΔGDissociation was calculated. 
 
 From both the ΔGDissociation values and the potential of mean force curves, it is 
apparent that a significant amount of free energy is required to dissolve both dimer 
structures.  In solution, the protein-protein interactions for both dimer structures are very 
strong, thus leading to the high free energy of dissociation.  Further, the potentials of 
mean force for all four structures show a similar shape.  The curves are smooth until 
close to the free energy minimum, where a sharper drop occurs until a broad free energy 
minimum is reached.  The basis behind such a free energy profile is reminiscent of a 
dock-and-lock mechanism similar to those proposed for monomer addition to an amyloid 
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fibril (134).  However, this is a very tenuous comparison as the dock-and-lock 
mechanism has a very ordered pathway with important intermediate steps while this 
dimer dissolution seems to be much more fluid.  Yet, it still appears that the two 
monomers quickly form an ordered structure once the two monomers are close enough 
together.  Once the monomers are separated enough to break this ordered structure, the 
profile shows a smooth release of one monomer from another, as peptide-peptide 
interactions are smoothly and consistently broken as the center of mass separation 
increases. 
 
 For the charged extended, neutral extended and charged hairpin dimer structures, 
both the ΔGDissociation and the potential of mean forces curves are very similar.  This is not 
surprising considering the interactions that are stabilizing the dimer.  For both extended 
dimer structures, the monomers are overlapping from approximately residues 28 – 42 on 
the C-terminus.  The majority of residues in this region of Aβ are hydrophobic and derive 
from the transmembrane portion of the APP peptide before secretase cleavage.  As there 
are no histidines in this region of the peptide, there should be no difference within the 
overlapping regions of the monomer for the charged and neutral dimer.  The difference in 
charge between these two species is at the N-terminus of the peptide and these regions of 
the dimer do not participate in any extensive interprotein interactions.  This information 
also provides an important baseline for the strength of the hydrophobic interaction at the 
C-terminus of the peptide.  With ΔGDissociation values between -15kcal/mol and -
20kcal/mol, the hydrophobic interactions and potential hydrogen bonding interactions 
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between the two C-termini of the monomers provide a substantial stabilizing force for 
this dimer structure.  
 The hairpin dimer also shows a very interesting pattern in the potential of mean 
force profiles.  For the charged hairpin dimer, the ΔGDissociation and potential of mean force 
profiles are very similar to the extended dimers.  This implies a very similar peptide-
peptide interaction to the interactions observed for the extended dimers.  However, the 
neutral hairpin dimer is very different from the three other conditions.  While the 
potential of mean force curve is similar in its shape, the ΔGDissociation for the neutral dimer 
is more then 50% larger than the ΔGDissociation of the charged peptide.  Thus, extra 
interactions are occurring in the neutral dimer that are not available to charged dimer.  As 
mentioned previously, the difference between the charged and neutral dimer are the 
protonation of three histidines (His 6, His 13 and His 14) on the N-terminal tail of Aβ.  
While, for the extended dimer, the geometry of the dimer prevents the two N-terminal 
tails from interacting, the hairpin dimer almost promotes N-terminal tail interaction due 
to the geometry.  As mentioned in more detail in the Methods section, high temperatures 
are used in the equilibration of the hairpin dimer to randomize the structure of the N-
terminal tails and prevent any bias due to the initial structure of the N-terminus.  
However, once the dimer is placed on the bilayer surface, it is possible for these tails to 
interact.  Further, because of the strong interactions occurring between residues 28 – 42 
of the two monomers, as demonstrated by the large ΔGDissociation of the extended dimers, 
the N-terminal tails are restricted in their motion.  It is also a fallacy to state that these 
tails are fully charged or hydrophilic.  While the tails do contain the majority of charged 
or hydrophilic residues in the peptide, a significant number of amino acids in the N-
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terminus are still hydrophobic.  Thus, strong interactions could occur between the two N-
terminus tails.   
 To investigate if the N-terminus residues are the cause of the significant 
difference between the ΔGDissociation of the charged and neutral hairpin dimers, we 
calculated center of mass distances between residues of the two monomers (Figure 4.6).  
The reasoning behind these calculations was to see if specific interactions were occurring 
for the neutral peptides that were not occurring for the charged peptides due to the 
protonation of the three histidines.  Figure 4.6 shows four representative plots for these 
distances.  Also, for each pair of residues, the distance was calculated for three different 
windows.  Each window corresponds to the free energy minimum and the use of three 
different windows shows that these effects are not due the choice of a specific simulation.  
It can be observed for three of these plots that the two analyzed residues are much closer 
for the neutral dimer and the separation between them fluctuates much less, implying a 
more stable dimer structure.  For His61 and Asp72 (where the subscripts identify the 
monomer) and His61 and Glu32, there is a much larger fluctuation for the charged tails.  
This demonstrates that the far N-terminal tails of the charged dimer show some 
electrostatic repulsion between the two tails which prevents them from coming close 
enough to form stable electrostatic or hydrogen bonding interactions.  For His142 and 
Glu111, the fluctuations are less extreme than the first two examples for the charged 
dimer, but the extent of fluctuations is still larger than for the neutral dimer.  The smaller 
fluctuations for these two residues for the charged dimer are likely due to the geometric 
restrictions of being closer to the “fixed” points of the hydrophobic region of the peptide.  
Further, the neutral dimer shows a smaller distance between the two residues, implying 
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that a direct electrostatic interaction is formed.  Once again, this shows that electrostatic 
interactions are occurring between residues of the N-terminal tails that act like a glue to 
stick to the tail together, which helps to form hydrophobic or hydrogen-bonding 
interactions that are not seen between the two N-terminal tails for the charged dimer.  The 
interaction between His131 and Asp112 is included to show that this pattern does not hold 
for all pairs of charged residues on the N-terminal tails.  However, analysis of all pairs of 
nearby charged residues with His6, His13 and His14 in the N-terminal tails shows 
patterns closest to the first three plots shown in Figure 4.6 for the majority of pairs.  
Further, similar analysis was done with some hydrophobic pairs within the N-terminus.  
While the results were not as dramatic as the pair distance plots shown in Figure 4.6, the 
neutral dimer did show closer pair distances and less fluctuation then the charged dimer.  
These results imply that the much stronger ΔGDissociation for the neutral hairpin dimer is 
due to interactions between the N-terminus of the two monomers.  They also emphasize 
the importance of the N-terminus and the role of pH and protein charge in the Aβ 
aggregation process. 
 
Dimerization on the Bilayer Surface   
 The value for ΔGDimerization is calculated using equation 4.1 from the free energy 
values calculated in this work and a previous work (138).  Further, in Table 4.1, a value 
for ΔGDimerization + 2*ΔGBinding, which can be termed the total dimerization free energy, is 
also provided.  This second value represents the free energy gain in binding two non-
interacting Aβ monomers in solution into a specific dimer structure on the bilayer 
surface.  The values for ΔGDimerization show that dimerization on the bilayer surface is 
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strongly favorable for all conditions except the neutral extended dimer.  For this 
structure, the weak ΔGRelease is not compensated for by a strong ΔGDissociation, as in the case 
of the neutral hairpin dimer, which results in an unfavorable dimerization free energy.  
For the other three conditions, the ΔGDimerization is similar, demonstrating that an 
interaction with the bilayer can act to drive dimerization.  For all conditions, the total 
dimerization free energy (ΔGDimerization + 2*ΔGBinding) is very favorable.  Even for the 
neutral extended dimer, the large free energy gain upon monomer binding is able to drive 
a favorable dimerization process.  It is important to consider this total dimerization free 
energy in comparison to the directly calculated ΔGDimerization as binding of the monomer to 
the bilayer surface may be one of the key aspects of membrane-assisted Aβ aggregation.  
A discussion of the role of the membrane in this process and the information contained in 
ΔGDimerization versus the total dimerization free energy has been reserved for later in the 
Discussion section.  Overall, these results of the calculations from the thermodynamic 
cycle presented in this work demonstrate the effect of the membrane on multiple aspects 
of Aβ dimerization process. 
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Discussion 
 
 The results from this work using thermodynamic cycles to calculate dimerization 
free energies for the Aβ peptide on a membrane provide a wealth of insight into the early 
stages of the Aβ oligomerization process on lipid membranes.  One of the first, and most 
fundamental, points of discussion in this work is the choice of two specific dimer 
structures.  The two dimer structures which we used for this work are derived from a 
theoretical dimer structure within a fibril as predicted through electron microscopy (46) 
and a structure obtained directly from a x-ray crystallography structure of an Aβ fibril 
(49).  For this work, we are deriving no actual conclusions as to which of these structures 
is correct or which structure is most likely within a fibril.  Previous work has 
demonstrated that the small oligomer structures of Aβ are very heterogeneous, including 
structures containing significant β-sheet, α-helix and unstructured sections.  Further, it 
has been proposed that the ordered structures seen in fibrils are not a function of the 
smallest oligomer structures but get locked in depending on the aggregation pathway a 
given oligomer takes (52, 53).  Thus, our choices for dimer structures were not motivated 
by pure predictive power of the method, but more for the structural differences between 
these dimers that do have some basis in biology.  The extended dimer is a much more 
exposed dimer with the N-terminal sections of the peptide not able to interact.  The 
hairpin dimer is more compact, has N-terminal sections that are able to interact and has a 
different potential β-structure as the two monomers are parallel versus antiparallel in the 
extended dimer.  Further, the hairpin dimer has an important biological function when 
considering its interaction with membranes.  Computational studies on potential Aβ pores 
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created by inserted Aβ oligomers commonly use β-hairpins as a stable building block for 
the oligomer subunits of the pore (74, 80).  Thus, these two dimer structures provide 
enough diversity in their structures to allow us to investigate fundamental aspects of the 
peptide-lipid interaction at the dimer level. 
 
 In concert with the importance of choosing the two dimer structures is the use of 
the thermodynamic cycle to calculate ΔGDimerization.  In principle, it would be feasible to 
take two equilibrated Aβ monomers on a bilayer surface and bring these two monomers 
together using umbrella sampling to calculate a dimerization free energy.  However, the 
problems with this calculation would be with the reaction coordinate and with the 
sampling of the system.  First, the reaction coordinate that is chosen for the pulling would 
highly bias the system to a particular dimer structure.  If the center of mass separation 
between two monomers was chosen as the reaction coordinate, the initial configuration of 
the monomers would effect what portions of each peptide are in contact during the 
pulling process, thus effecting dimer structure.  If other positions are chosen for the 
reaction coordinate, such as N- or C-terminus position, pulling with this coordinate will 
also dictate final structure.  Thus, with the current restrictions to sampling in all-atom 
molecular dynamics, pulling together two monomers on the bilayer surface will not give 
a global ΔGDimerization but give a path-dependent ΔGDimerization for a specific structure.  
Within our thermodynamic cycle, the choice of reaction coordinate is more obvious.  The 
reaction coordinate for monomer binding is explained in a previous work (138).  Much 
like the monomer binding, the use of dimer-bilayer center of mass separation is also a 
clear reaction coordinate for dimer release.  For dimer dissolution, the reaction coordinate 
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of monomer-monomer center of mass separation also appears to be fairly apparent.  
Because the end point of dimer dissolution is two non-interacting Aβ monomers, which 
should be able to reach equilibration in the simulation time, using monomer-monomer 
center of mass separation is an appropriate reaction coordinate.  Thus, by using a 
thermodynamic cycle with more explicit reaction coordinates, we can calculate a 
ΔGDimerization for a specific dimer that is reaction coordinate independent and more general 
then a ΔGDimerization calculated by directly pulling two monomers together. 
 
 As mentioned, another reason for utilizing the thermodynamic cycle was 
sampling issues.  In a previous work, we observed that interactions with a cell membrane 
slow down structural transitions for monomeric Aβ (139).  This would imply that directly 
calculating ΔGDimerization through pulling two monomers together would suffer from this 
same sampling issue, where the restrictions of all-atom molecular dynamics would not 
allow enough conformational sampling in reasonable simulation times.  For the other 
steps of the thermodynamic cycle, the conformational sampling issue is not as substantial.  
The free energy surfaces of dimer release (Figure 4.5b and 4.5c) show that the dimer is 
not restricted in sampling a variety of secondary structures.  Further, our calculations are 
for a specific dimer structure, not the generic dimer, so full equilibration for all possible 
structures is less necessary.  For dimer dissolution, the monomeric Aβ peptide in solution 
is mostly a random coil and that is what we observe in this calculation.  Thus, while more 
sampling would be ideal for all steps of this calculation, the penalties for lacking of 
complete sampling for dimer release and dimer dissolution are much less significant than 
if a direct dimerization free energy was calculated through an umbrella sampling scheme 
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on the bilayer surface.  Finally, of note, our calculations have been developed in order to 
calculate ΔGDimerization for a specific dimer.  Our intention was not to calculate a generic 
ΔGDimerization of Aβ on a bilayer surface, such as would be measured in experiment.  This 
would require substantial sampling due to the heterogeneous nature of Aβ oligomer 
structure that would only be obtained through extensive coarse-grained or replica 
exchange methods.  While these methods are becoming more common for protein-lipid 
systems, our goal has been to use all-atom simulations to investigate the details of this 
process.  Thus, we have strived to use two specific, different structures to investigate 
protein-lipid interactions at the Aβ dimer level and to use the ΔGDimerization as a tool to 
differentiate the effects of lipid and peptide charge on this process. 
 
 Within the thermodynamic cycle, each step reveals interesting aspects of this 
process.  As mentioned, a detailed analysis of monomer binding is provided in our 
previous work (138).  For the dimer release process, the potentials of mean force and 
ΔGRelease are very insightful.  What appears to be the deciding factor in this process is the 
charge on the bilayer surface and not the specific dimer structure.  On the DPPC surface, 
both the extended and hairpin dimer are tightly bound with a very large ΔGRelease.  Similar 
to the results seen with monomeric Aβ, both the hairpin and extended dimer interact 
strongly with the interfacial region of the bilayer.  Because of the zwitterionic nature of 
the phosphatidylcholine headgroup, charges within the N-terminus of each monomer are 
able to interact favorably with the headgroup and glycerol backbone of the lipids, which 
allows the hydrophobic portions of the dimer to interact with the interfacial region of the 
lipids.  Further, comparison of the ΔGBinding and ΔGRelease shows that, as ΔGRelease is very 
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close to 2*ΔGBinding in magnitude, the monomers within the dimer are still acting very 
much like monomers and the strong peptide-peptide interactions reflected in ΔGDissociation 
do not occur until the dimer is in solution.  Thus, peptide-lipid interactions are still 
dominant on DPPC.  However, on DOPS, the dimer is much more weakly bound to the 
bilayer surface.  On a pure DOPS bilayer, it is possible for the three histidines in Aβ to 
become protonated due to the higher concentration of H+ ions near the phosphatidylserine 
headgroups (57).  Thus, our simulations with DOPS use a neutral Aβ peptide.  From 
analysis of the potential of mean force curves, both the neutral hairpin and extended 
dimer are bound near the free energy minimum at a larger dimer-bilayer center of mass 
separation.  While it can be difficult to determine the dimer location just from a dimer-
bilayer center of mass separation as the dimer can tumble around a fixed separation, 
visual analysis of trajectories confirms that the dimer is associating with the headgroup 
region of the bilayer.  It is possible for the dimer to interact with the interfacial portion of 
the bilayer, but this is not a strong, stable interaction.  Because the dimer is not 
interacting strongly with the core of the bilayer, the interaction with the bilayer is weaker 
and ΔGRelease is much smaller.  Further, in comparison to the dimers on DPPC, ΔGRelease is 
much smaller then 2*ΔGBinding.  Because the values for ΔGDissociation are large for the 
neutral dimer, we can assume that peptide-peptide interactions are favored on DOPS over 
much weaker peptide-lipid interactions.  On DOPS, the dimer is not acting as two 
monomers but is acting as a unit that binds more weakly to the lipid surface.   
 
 Along with the information obtained from free energy profiles of dimer release, 
we also investigated secondary structure change as a function of dimer-bilayer center of 
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mass separation.  By analyzing at the average β-structure of each dimer as a function of 
the reaction coordinate, it appears that the β-content slightly increases as the dimer is 
pulled into solution.  This might seem appropriate as water molecules would force a more 
ordered structure in the hydrophobic region of the peptide that was not required on the 
lipid surface due to the lipid-protein interactions.  However, looking closely at the data 
through free energy surfaces (Figure 4.5), it appears that this trend is deceiving.  These 
free energy surfaces provide a more general perspective of the interplay between β-
structure and center of mass separation by demonstrating the probability (or free energy) 
of the dimer having a particular β-structure at a specific center of mass separation.  At a 
given center of mass separation, there is not any favored value for the extent of β-content.  
The dimer is able to freely move and change secondary structure as it is released.  Again, 
it does not appear that there is a favored β-structure for any dimer and structural 
flexibility is a hallmark of these dimers.  This also harkens back to the notion of 
heterogeneous dimer structure and lack of a dominant single structure for small Aβ 
oligomers. 
 
 In the dimer dissociation step of the thermodynamic cycle, the role of dimer 
structure in this process becomes more apparent.  From both the ΔGDissociation and free 
energy profiles, it is clear that the neutral hairpin dimer has a drastically different 
dissociation free energy than the extended dimer.  Further, the neutral hairpin dimer 
dissociation also differs from the charged hairpin dimer, while the charged hairpin dimer 
dissociation is almost exactly the same as the two extended dimer calculations.  While 
this does appear to be a contradiction at first, further analysis shows the importance of the 
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N-terminus in this process.  For the two extended dimer conditions, the N-termini are 
physically separated and are not able to interact.  The only difference between the 
charged and neutral dimer is the protonation of three histindines that reside in the N-
terminal tail of Aβ.  Thus, there is no significant difference in the dissociation 
calculations for the charged and neutral dimers as the regions of the two monomers that 
are able to interact in the dimer are the same for both systems.  However, for the hairpin 
dimer, this is not the case.  Due to the parallel β-sheet structure of the overlapping 
hairpins in the dimer, the N-terminal sections of both monomers are restricted to being 
near each other.  Even though these N-terminal tails are extensively equilibrated to 
prevent initial structure bias, they are able to interact if favorable.  For the charged 
hairpin dimer, electrostatic repulsion between the tails prevents extensive interaction.  
Thus, the interactions, either electrostatic, hydrophobic or hydrogen-bond, that bind the 
two monomers together for the charged hairpin are isolated to the C-terminal half of the 
peptide, which is the same region of interaction as the extended dimer.  This is clearly 
seen in the similarities of the ΔGDissociation and free energy profiles of the charged hairpin 
and two extended dimers.   
 
 However, for the neutral hairpin dimer, the charged histidines in the N-terminal 
tail of each monomer are now available for favorable electrostatic interactions with the 
anionic residues with the opposing monomer.  These more favorable interactions are 
demonstrated by the closer and more stable center of mass distance measurements 
presented in Figure 4.6.  By changing the N-terminal interaction from unfavorable to 
favorable and allowing for extensive electrostatic and hydrophobic interactions amongst 
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the tails, the monomers are more tightly bound and the magnitude of ΔGDissociation 
increases significantly.  These calculations show the importance of the N-terminal tail 
charge state when studying Aβ peptide oligomerization.  When Aβ is at physiological 
pH, the N-terminal tail is negatively charged and the dimerization energy is strongly 
based on mutual hydrophobic or hydrogen-bonding interactions between the C-terminal 
tails.  Because of this interaction, the structure of the dimer is somewhat irrelevant as 
long as the C-terminal regions are interacting.  At a lower pH such as pH 4 of pH 5, when 
histidine becomes protonated, the N-terminal tails no longer mutually repel to such a 
significant extent.  Monomer interactions are no longer dominated by only the C-terminal 
end of the peptide and dimer structure becomes more critical.  From the ΔGDissociation of 
the extended and charged hairpin dimer calculations, it is clear that hydrophobic or 
hydrogen-bonding interactions on the C-terminus of the dimer are strong enough to 
tightly bind the two monomers.  However, N-terminal interactions can provide extra free 
energy towards binding by increasing ΔGDissociation by over 50%.  These results raise an 
important caveat to future experimental and computational studies of this system.  While 
studies using Aβ fragments, especially C-terminal fragments, have been very important 
and necessary to extending our knowledge of this system, it is important to note that the 
N-terminal half of Aβ can play a significant role in this process. If studies are performed 
to investigate effects of peptide charge on aggregation, use of the full Aβ peptide will be 
crucial to obtaining a full understanding of this system. 
 
 Using the thermodynamic cycle presented in this work, we have been able to 
estimate a dimerization free energy, ΔGDimerization, as presented in Table 4.1.   From this 
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calculation, it appears that the formation of a dimer on the bilayer surface for three 
different conditions, the charged extended dimer and both hairpin dimers, is favorable 
while formation of the neutral extended dimer is not.  However, we believe that this 
ΔGDimerization is a somewhat misleading number.  While this number would provide insight 
for dimerization of nascent Aβ peptides after APP cleavage but before membrane release, 
it does not describe the effect of a cell membrane on soluble Aβ.  To determine this 
value, it is best to look at the sum of ΔGDissociation + 2*ΔGBinding.  Considering this value, 
dimerization is highly favorable for all potential dimer structures.  There are 
discrepancies in these values and it appears that the hairpin dimer would be favored over 
the extended dimer on DOPS, which would contradict the expected heterogeneity of Aβ 
dimers.  Nevertheless, it is important to remember that our calculations are only for 
thermodynamic properties of the system, not kinetic properties.  In considering the 
system, it is not a stretch to imagine that it would be much quicker to arrange 14 residues 
at the two C-terminals of two monomers so that they have some sort of unstructured 
interaction, similar to the extended dimer, instead of fully arranging all 42 amino acids of 
two monomers into a hairpin structure.  Thus, the most important result of this 
ΔGDimerization calculation is that the dimerization free energies calculated for all dimer 
structures are favorable considering the full membrane binding and membrane-assisted 
dimerization process. 
 
 The limitations of this work are very similar to previous computational studies.  
Simple one-dimensional reaction coordinates are not perfect for describing most 
biological systems and sampling will continue to be an issue for all-atom molecular 
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dynamics calculations with the current computing environment.  Because of these 
limitations, we were not able to directly calculate ΔGDimerization.  However, it is our belief 
that use of this thermodynamic cycle helps to avoid these issues while still providing us 
with a substantial amount of data that is helpful towards understanding this system.  
While the data may not be quantitatively perfect due to sampling issues, we believe the 
trends and conclusions we have drawn in this work are reasonable.  In the future, use of 
coarse-grain, replica exchange or other techniques that expand the sampling capabilities 
of molecular dynamics would be ideal for studying this system and testing our results.  
The ideal test would be direct experimental validation of the patterns we observed in our 
data.  Hopefully, experimental techniques will progress enough in the near future and 
resolution can be improved to the extent that direct Aβ protein-protein interactions on the 
cell surface can be studied.  Our work demonstrates that the interaction between Aβ 
proteins and lipid membranes during the aggregation process is a delicate balance that 
encompasses a variety of interactions, from hydrophobic to hydrogen-bonding to 
electrostatic interactions, which dictate the structure and feasibility of Aβ aggregation on 
a cell membrane. 
 
Conclusion 
 
 From the results presented in this work, it appears that the interactions between 
Aβ dimers and cell membranes plays a significant role in aggregation.  The ΔGDimerization 
+ 2*ΔGBinding values we have calculated do not seem to support experimental evidence 
that shows anionic lipids strongly promote aggregation while zwitterionic lipids do not.  
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However, the reported values are deceiving.  It does appear that the free energy of 
dimerization is much more favorable on DPPC.  Yet, it is necessary to consider the 
results of the dimer release calculations.  With these calculations, we demonstrated that 
the dimer on DPPC does not act much like a dimer, but as two monomers with weak 
interpeptide interactions and strong peptide-lipid interactions.  Only through dimer 
release, which is highly unfavorable, does the dimer strength become significant.  On 
DOPS, the situation changes substantially.  DOPS favors a very strong protein-protein 
interaction and weak protein-lipid interactions.  Even though the free energy values tend 
to make one believe that DPPC strongly favors dimer formation, it is actually DOPS that 
is more likely to create viable dimers for aggregation.  With the small ΔGRelease, DOPS 
actually acts much like a factory for creating Aβ dimers.  An Aβ peptide binds to DOPS, 
where concentration effects increase local Aβ concentration, increasing the probability of 
two Aβ peptides coming into contact.  Due to the anionic nature of the lipid headgroup, 
the local pH drops and Aβ can take a neutral charge.  The lipids promote strong protein-
protein interactions between monomers while weakening protein-lipid interactions during 
dimerization.  The dimer is free to be released from the bilayer surface while maintaining 
very strong peptide-peptide interactions.  Previously, experimental results have 
implicated the dimer as a key building block in Aβ aggregation (53).  Further, a dimer 
could act as a seed for more extensive aggregation.  Also, this favored dimerization on 
the bilayer interface would support subsequent peptide insertion, either in monomer or 
oligomer form, and pore formation.  Finally, if these dimers are being released from the 
surface of the bilayer, the local concentration of dimers near the surface should be higher 
than in solution, promoting further aggregation.  While DPPC promotes strong monomer 
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binding and weak dimerization interactions, DOPS forces dimerization and release of Aβ 
from the bilayer surface.  Because of these complicated interactions between Aβ and 
membrane surface, the importance of lipid charge and properties of the Aβ peptide in 
aggregation becomes clearer.   
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TABLE 4.1  Free energies calculated for steps of the thermodynamic cycle shown in 
Figure 4.2.  All free energy values are in units of kcal/mol. 
 
Dimer Structure ΔGBinding  ΔGDimerization1   ΔGRelease  ΔGDissociation 
 Step 1 Step 2 2*Step1+Step2 Step 3 Step 4 
Extended      
Charged Aβ + DPPC -14.42 -14.59 -43.43 27.74 15.69 
Neutral Aβ + DOPS -12.52 4.19 -20.85 6.73 14.12 
Hairpin      
Charged Aβ + DPPC -14.42 -17.07 -45.91 28.69 17.22 
Neutral Aβ + DOPS -12.52 -11.16 -36.20 4.55 31.65 
 
1ΔGDimerization = -1 * (2*ΔGBinding  + ΔGRelease + ΔGDissociation) 
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Figure 4.1  Initial structures used for the (a) Extended and (b) Hairpin dimer simulations. 
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Figure 4.2  Representation of the thermodynamic cycle used to approximate the free 
energy of dimerization for Aβ on a lipid bilayer. 
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Figure 4.3  Secondary structure output for DSSP for 150ns equilibration simulations of 
Aβ in the following conditions: (a) Extended charged dimer in solution (b) Extended 
charged dimer on DPPC bilayer (c) Hairpin uncharged dimer in solution (d) Hairpin 
uncharged dimer on DOPS bilayer. 
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Figure 4.4  Potentials of mean force for (a) Aβ dimer release from the lipid surface into 
solution (Step 3 of thermodynamic cycle) and (b) Aβ dimer dissolution in solution (Step 
4 of thermodynamic cycle) 
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Figure 4.5  (a) Plot of average number of residues with β-structure, where β-structure 
contains β-Bridge and β-Sheet residues, as a function of dimer-bilayer center of mass 
separation for the dimer release step of the thermodynamic cycle. (b) 2D free energy 
surface of number of residues with β-structure and center of mass separation with free 
energy in units of kcal/mol for the Extended charged dimer on DPPC. (c) Same plot as 
(b) except for the Hairpin charged dimer on DPPC.   
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Figure 4.6  Distance measurements between the centers of mass of indicated residues for 
either charged or neutral Hairpin dimer in solution.  Distances were calculated within the 
0.4nm, 0.7nm and 1.0nm umbrellas to show that the explained phenomenona were not 
due to a specific structure or initial condition.  Amino acids are listed with the monomer 
number followed by the residue number on that monomer.  For example, Asp2,7 is 
actually Asp7 on the second monomer. 
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